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Abstract 
 
Antimicrobial resistance (AMR) has arisen as one of the most important public health 
concerns in the last 60 years. AMR results from pathogenic strains of bacteria adapting to 
antimicrobial-containing environments through mutations or through horizontal gene transfer 
(HGT) of genetic material containing resistance genes. Conjugation machinery offers an efficient 
method for acquisition of AMR and virulence genes, which may be responsible for propelling 
the evolution of pathogenic bacteria. This dissertation explores the factors, specifically 
catecholamines and antimicrobials that influence the conjugation frequencies of enteric bacteria 
including Salmonella, E. coli and Enterococcus. We found that the catecholamine 
norepinephrine (NE) at physiological concentrations enhanced conjugation efficiencies of a 
conjugative plasmid from a clinical strain of Salmonella Typhimurium to an E. coli recipient in 
vitro.  Additional experiments determined the influence of the antimicrobial concentrations 
above, equal to and below the minimum inhibitory concentration (MIC) under in vitro conditions 
on conjugation efficiencies using an Enterococcus to Enterococcus mating pair in addition to the 
Salmonella to E. coli mating pair. Conjugation occurred in all concentrations, but efficiencies of 
transfer were consistently low in 0 MIC and 1 MIC, with increased activity both above and 
below 1 MIC. These data were fit to a previously described mathematical model and the rate 
constant E that relates the rate of gene transfer to drug concentration was determined.  The data 
showed highly similar patterns of conjugation efficiencies when compared to the rate constant E.  
A final study we measured conjugation frequencies when donor Salmonella Typhimurium and 
the E. coli recipient were exposed to both variable concentrations of oxytetracycline and NE.  
Conjugation was increased pre- and post- MIC, but conjugation frequencies were not enhanced 
further by the combination of the oxytetracycline and the NE.  This dissertation defines the role 
of outside factors in conjugative gene transfer, and may provide future insight into better control 
of AMR. 
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Preface 
“What does not kill me, makes me stronger.” – Friedrich Nietzsche, Twilight of the Idols, 1889.
1 
 
 
Chapter 1 - Factors that Effect Horizontal Gene Transfer in Enteric 
Bacteria, a Literature Review 
 Abstract 
Antimicrobial resistance (AMR) has arisen as one of the most important public health 
concerns in the last 60 years.  AMR results in pathogenic strains of bacteria adapting to 
antimicrobial-containing environments through mutations or through horizontal gene transfer 
(HGT) of genetic material containing resistance genes.  There are three main methods of HGT, 
including transformation, transduction and conjugation.  In this thesis, conjugation has been 
shown to be enhanced by the presence of catecholamines as well as antimicrobials.  This has 
been shown in a mating pair of Enterococcus to Enterococcus (Chapter 3) and Salmonella to E. 
coli (Chapters 2-4).   Research has shown that HGT may be controlled through a variety of 
mechanisms, including the damage repair SOS system as well as the pheromone system of 
Enterococcus.  Future research will continue to define the role of these factors in HGT.   
 Antimicrobial Resistance  
Bacterial infection has been the leading cause of death historically, allowing for the most 
minor injury to lead to a patient‟s eventual demise. All this changed in the last 60 years with the 
discovery and widespread usage of antimicrobials, one of the most important discoveries in the 
last century.  Since the first report of AMR among Staphylococcus spp. as early as the 1940s, the 
problem of AMR has increased into a serious public health concern leading to economic, social 
and environmental crisis (122).  Bacteria are able to acquire resistance via various genetic 
phenomena, and multi drug resistance is considered a global consequence of antimicrobial use in 
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both human and veterinary medicine.  Unfortunately, with improper use of these drugs, 
antimicrobial resistance has developed in bacteria such as vancomycin resistant Enterococcus 
(VRE) and methicillin resistant Staphylococcus aureus (MRSA).  Rise of AMR among 
pathogenic bacteria is one of the most telling signs that we have failed to take the threat of 
infectious diseases seriously, and there are many unanswered questions related to the prevalence, 
amplification and dissemination of phenotypic resistance and genetic resistance determinants 
created by medical use of antimicrobials (89, 98, 100).   
While recipients of AMR genes survive in environments that contain antibiotics (17, 33, 
36, 57, 61, 98-100, 107), recipients of virulence genes are better equipped for invasion and 
spread (59, 60, 82, 83, 91).  The World Health Organization has referred to AMR as the next 
pandemic (121), and the Centers for Disease Control and Prevention has characterized AMR as 
one of the world‟s most pressing public health problems (16). AMR can increase the duration of 
infection, duration of follow-up care, treatment outcome, and associated costs. The economic 
impact of AMR has been estimated to extend healthcare costs to over $7 billion annually in the 
U.S. (4, 58) and over €7 billion annually in the EU alone (40). 
 Horizontal Gene Transfer  
Bacteria display extraordinary variation in their genotype and phenotypes, considering 
they are single-celled organisms with haploid genomes. The modification, inactivation, or 
differential regulation of the genes has contributed to the genetic diversification of bacteria on an 
evolutionary timescale; however, the significant diversity is difficult to account for  by mutations 
alone (85, 88).  Bacteria are asexual organisms that reproduce by binary fission resulting in the 
genetic replication of one cell into two daughter cells. This type of reproduction produces 
genetically identical organisms that now have equal susceptibilities to environmental pressures, 
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such as antimicrobial.  Over time, systems including transformation, transduction and 
conjugation have evolved over time to fill the need to diversify the genome to allow for faster 
adaptation to environmental changes, thereby reducing exclusive dependence of bacteria on 
random beneficial genomic mutations (97, 106).   
 Transformation 
Transformation increases genetic variation through a competent bacterium uptaking DNA 
from its immediate environment and incorporating it into the host genetic material to 
complement its cellular functions allowing for beneficial traits to be passed without evolution 
(5).  Initial indications of this occurrence were first noticed by Dr. Fredrick Griffith in 1928. In 
these experiments he noted that a strain of Streptococcus pneumoniae had two different 
phenotypes with differing effects on mice (51).  A rough strain was found to be nonvirulent, 
while a smooth strain would cause death in the mouse.  Interestingly, if the heat-killed smooth 
strain bacteria were mixed with the rough strain, a bacterial phenotype was produced that was 
again able to kill the mouse.  The benign bacteria had been “transformed” into a virulent strain 
by some unknown cause, which we now know to be DNA.  
  A limitation to transformation is that not all bacteria in a population will simultaneously 
become competent to uptake DNA, be able to take in high enough amounts of the “correct” gene 
needed for survival, or the “correct” gene would be in the immediate environment of bacteria 
(71).  Additionally, with the relatively short shelf life of DNA in the environment (0.017 hrs to 
28 hours; depending on the matrix) there is even less of a chance for this horizontal transfer 
method to benefit the recipient cells for their survival (69, 71, 112).   
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 Transduction  
Transduction involves DNA transferred from one cell to another through the use of 
bacteriophages (80). This type of HGT was shown to be originally responsible for the movement 
of shiga-toxin producing genes (stx1 and stx2) from Shigella species into the now highly virulent 
E. coli O157:H7 (91).  Once the shiga-toxin producing genes are in the recipient E. coli, they can 
then be spread to other strains of E. coli to make them pathogenic (82, 83).  A limitation to HGT 
by transduction is that it is completely phage-dependent, and, similar to transformation, relies on 
the right gene being present and taken up into the right phage at the right time.  Additionally, 
both the donor and recipient strains must be sensitive to the same bacteriophage (71).  
 
                                           Conjugation 
            The most significant of horizontal transfer methods bacteria use is conjugation (85).  This 
transfer has been shown to be important to the survival and evolution of many bacterial species 
(106). Conjugation works by a host cell physically adhering to a recipient cell, and horizontally 
transferring genetic elements packaged as plasmids or transposons into the cytoplasm for the 
passage into the recipient cell (85). These transposons and plasmids allow for high efficiency 
transfer of antimicrobial and virulence genes from single resistant donor bacterium to many 
recipients which can in turn donate the resistance genes to more recipients (106). Horizontal 
transfer by conjugation is not exclusive to bacteria of the same species. This is exemplified by 
the occurance of Vancomycin Resistant Enterococcus (VRE) and vancomycin resistant S. aureus 
in ecosystems where they coexist (17, 33, 36, 57, 61, 98-100, 107).  Conjugative horizontal 
transfer has been shown to be not exclusive between bacteria. Studies have shown transfer of 
genetic elements by conjugation between bacteria to yeast (54), bacteria to plant cells (115), and 
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recently bacteria to mammalian cells (120).   Conjugative transfer between bacteria, especially 
that of antimicrobial resistance genes, has a considerable impact on human and animal health 
(112).  Many experimental studies have accomplished conjugative transfer using shuttle plasmids 
including incN, incP, incQ, and incW groups, and by the conjugative transposon Tn916 and 
Tn925 (7, 20, 31, 66, 69, 108, 109).  Of significance, was a study where the plasmid pAT191 
which encodes resistance to kanamycin was transferred from gram-positive E. faecalis to 
recipient strain of E. coli in the gastrointestinal environments of laboratory mice (31, 37).  In 
another study transposon Tn916 which encodes tetracycline resistance was transferred from a 
gram-positive E. faecalis to a variety of gram-negative bacteria including E. coli, from which the 
Tn916 was reverse transferred to a Tn916-negative strain of E. faecalis (12).  Recent studies 
have identified conjugative plasmid-carrying Salmonella strains that contain many different 
AMR genes that are capable conjugative HGT to recipient strains of E. coli (15, 47).  The 
plasmid most studied in this thesis is contained within Salmonella Typhimurim strain 5678 
(Chapters 2-4). 
 Plasmid Transfer (tra) Genes 
Conjugative transfer of this blaCMY-2 carrying plasmid involves a complex activation 
sequence of approximately 30 different transfer (tra) genes encoding proteins for direct cell-to-
cell mating.  Some examples of important proteins include TraI, which encodes a relaxase-
helicase and is the central catalytic component of the multiprotein relaxasome complex 
responsible for beginning the conjugative DNA transfer; TraH, which stabilizes the relaxasome 
structure; TraJ, which recruits the relaxasome complex to the oriT site; TraY, which imparts 
single-stranded DNA character on the oriT site; TraR, which is a LuxR-type quorum-sensing 
transcription factor; TraG, which is essential for pili assembly and mating pair stabilization; and 
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TraM, which mediates interaction of relaxase to oriT by stimulating relaxed DNA formation 
(49). 
 Transposon Integrase Genes 
By comparison, transfer of a conjugative transposon between Enterococcus strains 
(Chapter 3) is rather simple.  Transposons are known as “jumping genes” for their ability to 
remove themselves from their current location and deposit themselves at another site.  
Transposons are typically flanked by two genes including an integrase (int) and an excisase (xis) 
gene.  It is the role of excisase to cut the transposon from the genome or plasmid of the host and 
it is the role of the integrase gene to encode an enzyme that re-integrates the now-free transposon 
back into a desired location (64, 101).  Unlike plasmids containing transfer genes, however, 
transposons are unable to form a pilus or any type of aggregation factors through which to pass 
to the recipient cell, so they are reliant on the host cell‟s machinery to provide the necessary 
conjugal instigation.  
 Stress Hormones 
In Chapter 2 of this thesis, we explored the role of stress hormones on HGT of a 
conjugative plasmid.  Physiological and psychological stresses of the host have been slow to play 
an important role in incidence, duration, severity and outcome of host diseases, especially those 
caused by infectious agents (21, 72-74, 76, 77).  Catecholamines are a large group of amine 
hormones, derived from tyrosine and include epinephrine (adrenaline), norepinephrine (NE; 
noradrenaline) and dopamine. They are synthesized in the L-DOPA pathway.  Adrenaline and 
NE, are sympathetic neuroendocrine mediators of “fight or flight” (acute stress) response of the 
host. NE-containing sympathetic synapses are distributed throughout the body, including the 
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enteric nervous system (ENS), and interestingly, more than half of the NE in the body is 
synthesized and utilized within the ENS (29, 45).  In the gastrointestinal tract the physiological 
concentration of NE has been shown to be as high as 50 μM (3).   
The human gut, especially the colon, harbors a dense, mixed population of bacteria (10
11 
-
10
12
/g of contents), and the microbial ecology of the gut is dependent on health and disease states 
of the host.  The gut flora evolved specific detection systems to sense host mediators of stress 
and use such mediators as environmental cues to alter their growth and virulence.  The first 
experimental evidence that the catecholamines increased bacterial growth was gained using a 
serum-based (iron-depleted) medium (76), and this growth-promoting effect was determined to 
be due to enhanced iron acquisition and utilization via a catecholate-specific iron transport 
system with involvement of enterobactin and enterochelin pathways (11, 14, 44, 102). 
Subsequent studies have demonstrated that catecholamines can influence production of virulence 
factors, such as toxins and adhesins, biofilm formation, and quorum sensing even in iron-replete 
conditions (74, 75, 77, 104).  For example, E. coli O157 responds to catecholamines by increased 
expression of shiga-toxin (116), exalted chemotaxis, and adherence to eukaryotic cells (6, 21), 
enhanced attachment and effacement (A/E) lesions (96), attachment to murine cecal mucosa 
(21), and increased flagella expression and motility (25).  In Salmonella, catecholamines have 
been implicated to enhance motility and colonization in the GI tract of pigs (10).  This concept 
provided a non immunological explanation for increased incidence and severity of infectious 
diseases among stressed individuals.  However, the effects of catecholamines on HGT between 
bacteria in general, especially those in the GI tract, are currently unknown. 
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Antibiotic Pressure 
Past research has shown that the improper use of antimicrobials may be a contributing 
factor to HGT and AMR.  Past studies have shown the enhancement of various antimicrobials to 
HGT.  A common trend in bacteria is that below, or “pre-MIC” levels of antimicrobials cause an 
increase in mutation rates as well as increases in the efficiencies of HGT of the susceptible 
recipient bacteria (9, 24, 56).  In mating experiments with Enterococcus, donor strains containing 
a conjugative transposon were incubated in pre-MICs of tetracycline have been shown to 
increase the conjugative HGT frequencies of a transposon up to 119-fold when the donors were 
subsequently added to recipient B. thuringiensis bacterial cultures (103, 108).  
 Tetracycline and Oxytetracycline 
The antibiotics that were used in Chapters 3 and 4 of this thesis were tetracycline and 
oxytetracycline.  The tetracyclines are broad spectrum antibiotics that are commonly produced 
by Streptomyces aureofaciens (34).  They were first discovered in 1948 by Dr. Benjamin Minge 
Duggar (39).  Through binding to the 30S ribosomal subunit of prokaryotes they are able to 
inhibit protein production, leading to bacteriostatic effects (50, 53, 110).   
Oxytetracyclines were the second group of tetracyclines to be discovered.  They were 
first identified in 1950 as being produced by the bacteria Streptomyces rimosus (43), and are 
used against a broad range of bacteria as a bacteriostatic antimicrobial through binding to the 
30S ribosomal subunit of prokaryotes (50, 53, 110).  Oxytetracycline has been used in livestock 
feed as a prophylactic against infection and as a growth promoter (23, 41). 
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The effectiveness of tetracyclines has declined in recent years due to the rise of 
tetracycline resistance among bacteria primarily from the development of drug efflux pumps (50, 
68, 123).  These pumps are encoded by genes including tetA (27, 28).   Additional protection is 
gained through the tetM gene operates by protecting the ribosome from the tetracycline (23, 28, 
95).         
 SOS Cellular Response to DNA Damage 
DNA can be damaged by a variety of environmental stresses (79).  Two well known 
stresses are with UV light and two different classes of antibiotics (9, 79). The antibiotics include 
fluoroquinolones (such as ciprofloxacin and ceftiofur) and dihydrofolate reductase inhibitors 
(such as Trimethoprim) (9).  Fluoroquinolones act on the DNA topoisomerase to inhibit it‟s 
function, which leads to DNA damage (38), and dihydrofolate reductase inhibitors inhibit the 
cell‟s uptake of folic acid from the host environment, leading to the inability to replicate DNA 
(13).  These agents can cause single stranded or double strand breakages of cellular DNA, 
leading to the activation of the cell‟s SOS system.  The SOS system serves as a major defense 
against environmental damage to cells, and DNA repair machinery which is present in all 
bacteria (79). In response to DNA damage, activation of SOS genes allows replication to bypass 
DNA damage and continue replication which can minimize cell death, mutations, replication 
errors, persistence of DNA damage and genomic instability (79).   
The SOS system is regulated and controlled by the proteins LexA and RecA.  RecA 
functions in DNA repair as an ATP-dependent protein that binds tightly to damaged ssDNA, and 
drives the movement of the three-stranded intermediate in one direction by forming a 
nucleoprotein filament in which it "spins out" a newly recombined DNA strand (32, 84).  
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Promoter fusions to luxCDABE of recA in E. coli showed dose-dependent responses to a variety 
of sub-lethal stresses including antibiotic, and UV light (117).   
RecA has been also been shown to interact with the protein LexA (46).  LexA is a 
dimeric protein repressor of SOS response, and in E. coli, RecA-dependent cleavage of LexA 
correlates to increases in SOS system activation (46).  The SOS system repairs DNA with the 
activation of three main pathways, the Nucleotide Excision Repair (NER), RecFOR, and the 
RecBCD (79).  The NER pathway is relatively non-specific and is first activated in response to 
DNA damage by activating genes uvrA, uvrB, and uvrC (70, 113).  The RecFOR pathway 
performs recombinational single strand gap repairs and is mediated by RecD, RecF, RecO, and 
RecR proteins and aids in the loading of RecA onto damaged DNA strains (55).  Finally, the 
RecBCD Complex DNA repair of dsDNA breaks by using the Chi sequence 5'-GCTGGTGG-3' 
that occur.   When DNA is damaged, RecBCD attaches to the damaged strand and destroys all 
ssDNA until reaches this sequence (22, 65, 67).  The RecBCD then switches strands to give 3‟ 
protrusion, and RecA is then loaded onto 3‟ protrusion (22, 65, 67).  Two studies in E. coli have 
shown that the LexA SOS inhibitor has control over approximately 40 different genes (30, 42, 
79).  While the majority of these are damage repair genes (not listed), there are several of 
unknown function (Table 1) (30, 42, 79).  Additional studies were conducted in Enterococcus 
where cellular damage by antimicrobials including erythromycin and vancomycin was monitored 
by microarray and 2D gels, respectively (1, 119).  A series of genes were shown to upregulate in 
these studies as well in response to the cellular damage (Table 1).  
 SOS and HGT 
Induction of the SOS system has been linked to HGT in several different studies.  It was 
observed in early experiments that UV exposure to some bacterial cells allowed for more than 
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just inhibition of growth, but also contributed to the lytic activation of phages (94, 105, 111).  
Later studies in E. coli began to show that the genes that activate bacteriophage production were 
shown to be RecA dependent (81).  Additionally, in a microarray screen of E. coli genes 
controlled by LexA that were activated under UV stress showed the upregulation of prophage 
genes (Table 1) (30).  In E. coli, stx2 phage genes were shown to activate after quinolone 
exposure and phages were found to be produced because of SOS induction, leading to spread of 
stx2 gene through phage transduction and increases in toxin production (62, 63, 81, 118).  This 
effect has been observed in an in vitro mouse model as well (124).  Additional studies with 
Vibrio cholera, identified a conjugative transposon called STX that contained multiple 
antimicrobial resistance genes was induced to horizontally transfer with the activation of the 
SOS system (8, 9).  STX encodes SetR which is a repressor that inhibits the transcription of 
phage related integrase genes that allow for HGT (8, 9).  However, when the SOS response to 
DNA damage was activated, the effects of SetR were inhibited and transcription and the 
subsequent transfer of STX were allowed to take place (8, 9).  A similar phage gene mediated 
movement of genes is present in S. aureus (60, 78, 86, 87, 111).  Various pathogenic islands (PI) 
including SaPI1-SaPI4, SaPbov1, SaPIbov2 and SaPIn1-SaPIn3 have been shown to encode 
genes that allow for prophage production and HGT by transduction (60, 78, 86, 87, 111).   
Conversely to utilizing the activation SOS system for induction of integrase genes, some 
conjugative plasmids have actually been shown to have unique machinery which has been shown 
to inhibit SOS function (48, 90).  During conjugation, plasmids enter the recipient cell as single 
stranded DNA, which is an activator of the SOS response (48, 90).  The actions of the SOS can 
be potentially damaging to the single stranded plasmid DNA, a protein called PsiB protein 
(present in the blaCMY-2 containing plasmid used in Chapters 2-4 (47)) is utilized (48, 90).  PsiB 
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translation activates in a dose-dependent response to increasing levels of RecA protein and binds 
to free RecA protein to inhibit the activation of SOS by the recipient cell (48, 90).  The PsiB has 
been shown to inhibit the cleavage of the LexA protein as well to further suppress the SOS 
response (90).  
 Salmonella 
Throughout this thesis we used two types of bacteria as donor strains for HGT mating 
experiments.  These were Salmonella enterica and Enterococcus faecalis.  Gastrointestinal tracts 
of both humans and animals are a major habitat of Salmonella enterica.    In 2005, over 36,000 
clinical cases of Salmonellosis were reported to the CDC (19).  Of these, 15,000 resulted in 
hospitalization and 400 were fatal (52).  In 2007, the number of cases reported in a 10 U.S. state 
survey was 6,790 and the incidence per 100,000 population was 14.92 (18).  Salmonellosis can 
also cause severe enteritis, decreasing weight gain and reproductive performance in livestock and 
thereby has a significant economic impact (2).  Recent studies have identified plasmid carrying 
Salmonella strains that contain many different AMR genes that are capable of conjugative HGT 
to recipient strains of E. coli (15, 47).  
 Enterococcus  
Enterococcus faecalis is a gram positive facultative anerobe that is commonplace in the 
gut flora.  It has been shown in multiple studies capable of both donating and receiving genetic 
material horizontally, making it a potential reservoir for antimicrobial resistance in the gut (114).  
This genetic material can include plasmids, and transposons that have been known to carry AMR 
genes (89).  Many strains of E. faecalis have been shown to be multidrug resistant (MDR) and of 
particular interest has been the recent emergence of vancomycin resistant strains.  These strains 
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have been associated with nosocomial infections (114) and in many cases the Enterococcus has 
been shown capable of transferring this vancomycin resistance to other virulent bacteria 
including Staphlococcus aureus (S. aureus), giving rise to the dangerous meticillin resistant S. 
aureus (MRSA) (17, 33, 36, 57, 61, 98-100, 107).       
 Pheromone System and Plasmid Transfer 
Potential Enterococcus recipient cells have a unique system of attracting Enterococcus 
donor cells for HGT of genetic material.  This system is known as the “pheromone” system and 
it involves the secretion of peptides by a potential recipient cell that are detected by donor cells 
carrying the conjugative plasmids (26, 35).  Pheromones begin as signal peptides of normal 
lipoproteins that are translated from chromosomal genes (26, 35).  These signal peptides that 
become active pheromones are then cut from the lipoproteins during excretion from the cell.  
Five well studied pheromones are known as cAD1, cPD1, cCF10, cAM373 and cOB1, and they 
exclusively attract plasmids pAD1, pPD1, pCF10, pAM373, and pOB1 (respectively) (26, 35).  
The activation of pAD1 by cAD1 has been well studied and involves the actions of TraA, TraC, 
and TraE1 (26).  TraA normally inhibits the promoter by binding to the nucleic acid sequence 
TTATTTTTATTT (92, 93) which controls the expression of genes iad (inhibitor molecule) traD, 
traE1, sea1, and asa1 (aggregation genes) (26).  When the pheromone cAD1 binds to the 
plasmid-encoded surface protein TraC, it is then chaperoned into the cell by the oligopeptide 
permease system.  The cAD1 then goes on to suppress the inhibitory actions of TraA (26, 35). 
When TraA is suppressed by cAD1, transcription of traE1 upregulates and protein TraE1 is able 
to promote the transcription of the aggregation genes and allow for conjugal binding of the donor 
with the recipient cell and plasmid transfer (26).  Interestingly, once pAD1 has entered the 
recipient cell, the plasmid gene iad is then activated to produce the inhibitor iAD1 which binds 
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to the surface TraC to prevent autoinduction of the cell (26, 35).  Finally, another surface protein, 
TraB moves to suppress production of cAD1 entirely (26, 35). 
 Conclusions 
HGT through conjugation is a relatively straight-forward process where two bacteria 
(donor and recipient) physically join and pass genetic material.  The influence of outside factors 
is, however, multifaceted.  Intriguing past research involving the SOS and pheromone systems, 
as well as the current research contained within this thesis showing the influence of 
catecholamines and antimicrobials, demonstrate that we have only begun to understand these 
most “simple” forms of life.  Future research will continue to define the role of these factors in 
HGT, and in the current AMR crisis.    
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 Abstract 
The ability of pathogenic bacteria to sense and respond to periods of host stress is critical 
to their lifestyle.  Adrenaline and norepinephrine are catecholamines that mediate acute host 
stress in vertebrates and invertebrates.  Catecholamines are also used as environmental cues to 
enhance growth, motility and virulence of bacterial pathogens via specific binding receptors.  
Incidence of multidrug resistant and highly virulent bacterial pathogens is on the rise, and 
majority of the genes for antimicrobial resistance (AMR) and virulence are carried on 
horizontally transferable genetic elements.  Conjugation machinery offers an efficient method for 
acquisition of AMR and virulence genes, which may be responsible for propelling the evolution 
of pathogenic bacteria.  Here we show that norepinephrine (NE) at physiological concentrations 
enhances horizontal gene transfer (HGT) efficiencies of a conjugative plasmid from a clinical 
strain of Salmonella Typhimurium to an E. coli recipient in vitro.  Expressions of plasmid-
encoded transfer (tra) genes necessary for conjugation were also significantly upregulated in the 
presence of NE.  Phentolamine, an α-adrenergic receptor antagonist, negated the effects of NE on 
conjugation more strongly than propranolol, a β-adrenergic receptor antagonist.  This study for 
the first time provides evidence that innate mediators of acute host stress may influence 
evolution and adaptation of bacterial pathogens. 
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 Introduction 
Bacteria display extraordinary variation in their genotypes and phenotypes, considering 
they are single-celled organisms with haploid genomes. The modification, inactivation, or 
differential regulation of the genes has contributed to the genetic diversification of bacteria on an 
evolutionary timescale; however, the significant diversity is difficult to account for  by mutations 
alone [1].  Horizontal gene transfer (HGT) as a major mechanism for bacterial diversity was first 
proposed based on the observation that virulence determinants could be transferred between 
pneumococci in infected mice [2], a phenomenon that was later demonstrated to be mediated by 
the uptake of genetic material, called transformation.  Subsequent identification of gene transfer 
mediated by plasmids, transposons and bacteriophages provided explanation to the current 
picture of gene flux and the importance of mobile genetic elements in bacterial genetic diversity 
[3,4].  Compositional in silico analyses have revealed that considerable proportions of bacterial 
genomes consist of horizontally acquired genes [5] and supports the eco-evo principle that 
organisms coexisting in an ecosystem constantly evolve to adapt to each other, leading to 
bacterial innovation [1].  HGT provides major milestones in microbial evolution, allowing 
bacteria to completely bypass adaptation through the process of random mutation [1,6].  This is 
accomplished through the efficient movement of genetic elements including plasmids, 
transposons, and bacteriophages [3,4].  However, the most efficient method of HGT is 
conjugation, which is mediated by the physical adherence of donor and recipient cells and the 
subsequent transfer of genetic elements into the recipient cell [6,7].  This allows for high 
efficiency transfer of antimicrobial resistance (AMR) and virulence genes from a donor 
bacterium to many recipients, and the spread of these genes among bacteria has considerable 
impact on human and animal health [8].   
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The recent rise in the incidence of illnesses caused by highly virulent and multidrug 
resistant strains of bacterial pathogens is of major concern to human and animal health. While 
recipients of AMR genes survive in environments that contain antibiotics [9-17], recipients of 
virulence genes are better equipped for invasion and spread [18-22].  The World Health 
Organization has referred to AMR as the next pandemic [23], and the Centers for Disease 
Control and Prevention has characterized AMR as one of the world‟s most pressing public health 
problems [24]. AMR can increase the duration of infection, duration of follow-up care, treatment 
outcome, and associated costs. The economic impact of AMR has been estimated to extend 
healthcare costs to over $7 billion annually in the U.S. [25,26] and over €7 billion annually in the 
EU alone [27]. 
Catecholamines are a large group of amine hormones, derived from tyrosine and include 
epinephrine (adrenaline), norepinephrine (NE; noradrenaline) and dopamine. Catecholamines, 
especially adrenaline and NE, are sympathetic neuroendocrine mediators of “fight or flight” 
(acute stress) response of the host. NE-containing sympathetic synapses are distributed 
throughout the body, including the enteric nervous system (ENS) where more than half of the NE 
in the body is synthesized and utilized [28,29].  In the gastrointestinal tract the physiological 
concentration of NE has been shown to be as high as 50 μM [30].  The human gut, especially the 
colon, harbors a dense, mixed population of bacteria (10
11 
-10
12
/g of contents), and the microbial 
ecology of the gut is dependent on health and disease states of the host [31].  The gut flora have 
evolved specific detection systems to sense host mediators of stress and use such mediators as 
environmental cues to alter their growth and virulence.  The first experimental evidence that the 
catecholamines increased bacterial growth was gained using a serum-based (iron-depleted) 
medium [32], and this growth-promoting effect was determined to be due to enhanced iron 
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acquisition and utilization via a catecholate-specific iron transport system with involvement of 
enterobactin and enterochelin pathways [33-36]. Subsequent studies have demonstrated that 
catecholamines can influence production of virulence factors, such as toxins and adhesins, 
biofilm formation, and quorum sensing even in iron-replete conditions [37-40].  For example, E. 
coli O157 responds to catecholamines by increased expression of shiga-toxin [41], exalted 
chemotaxis, and adherence to eukaryotic cells [42,43], enhanced attachment and effacement 
(A/E) lesions [44], attachment to murine cecal mucosa [43], and increased flagella expression 
and motility [45].  In Salmonella, catecholamines have been implicated to enhance motility and 
colonization in the GI tract of pigs [46].  This concept may provide a non immunological 
explanation for increased incidence and severity of infectious diseases among stressed 
individuals.  However, the effects of catecholamines on HGT between bacteria in general, 
especially those in the GI tract, are currently unknown.  
The primary objective of this study was to evaluate the role of NE on the intergeneric 
transfer of conjugative plasmids from Salmonella to E. coli in vitro.  In this study, we used a 
previously described [47] mating pair of bacteria consisting of a donor strain of Salmonella 
Typhimurium that carries a (>100kb) conjugative plasmid encoding multidrug resistance and a 
recipient E. coli. When we measured the overall ratios of transfer efficiencies with and without 
exposure to NE, we observed a significant increase in conjugation with NE treatment.  
Significant upregulation of plasmid transfer (tra) genes was observed in the presence of NE.  
Enhanced conjugative transfer and tra gene expression were inhibited by α and β adrenergic 
receptor antagonists.   
 Materials and Methods 
Bacterial strains and culture media  
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Salmonella Typhimurium strain 5678 [47] was used as donor strains in the majority of 
our experiments.  This strain carries a type A plasmid that is approximately 100 kb in size and is 
transferable by conjugation to recipients including E. coli C600N (a spontaneous nalidixic acid 
resistant mutant of strain C600 [47]; kindly provided by Dr. Paul Fey at University of Nebraska 
Medical Center, Omaha, Nebraska), E. coli MG1655N, and a bioluminescent Citrobacter 
rodentium strain ICC180 [60,61] (Table 1). This plasmid contains a blaCMY-2 gene that encodes 
resistance to a large spectrum of β-lactams including ampicillin, ceftriaxone and cefoxitin, and 
also contains resistance markers for chloramphenicol, streptomycin, sulfisoxazole, trimethoprim-
sulfamethaxozole and tetracycline (Table 1).  A Salmonella Newport 5561 strain that carries a 
similar sized type C plasmid and AMR profile as that of strain 5678 was also used as donor in 
some experiments.  Based on sequence analysis, these plasmids are closely related to the well-
studied plasmid pNF1358, and the organization of the transfer genes is similar to that of IncI 
plasmid R64 [62] (Genbank DQ017661.1).  
 
Motility study 
Motility of Salmonella 5678 and E. coli C600N was determined by stabbing 0.3 OD 
cultures (described below) into standard LB plates overlayed with 0.35% LB agar containing 0, 
5, 50, 100, or 2000 μM of NE.  All plates were incubated overnight at 37ºC before being read.  
Due to slight irregularities in the motility patterns, we measured motility in cm
2
 in an attempt to 
attain a more accurate data reading.  Additional studies were conducted with stabs into standard 
MIO agar (Becton-Dickinson, Franklin Lakes, NJ).   
 
Pulse Field Gel Electrophoresis 
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PFGE was conducted with Salmonella 5678, E. coli C600N and selected transconjugants 
using standard methodologies [63]. The DNA embedded in agarose was digested with XbaI and 
electrophoresed on a CHEF DR-III instrument (Bio-Rad, Richmond, California) using the 
following conditions: initial switching time, 2.2 s; final switching time, 63.8 s; total time, 19 h. 
Salmonella enterica serotype Braenderup H9812 (ATCC# BAA-664) was used as the standard. 
 
Southern Blot  
DNA separated on the PFGE gel was transferred to nitrocellulose or nylon membranes as 
described previously [52]. A DIG labeled blaCMY-2 probe (Roche, Indianapolis, Indiana) was 
created using previously described primers [47,51], and hybridization was detected using 
NBT/BCIP (Roche). 
 
Determination of plasmid copy number per bacteria 
Total DNA from Salmonella grown at 0 and 5 μM of NE at the described time points was 
prepared by boiling the bacteria in Tris-EDTA buffer. Chromosomally-encoded 16S rRNA gene 
(EUB  [64] primers) and tufA1 [65] gene (which encodes an elongation factor for synthesis of 
amino acid chains) were used as housekeeping genes (Table 2). Both EUB and tufA as 
housekeeping genes gave highly similar results, but only results from EUB are shown in this 
study.  The plasmid-encoded blaCMY-2 (β-lactamase), and tnpA (transposase) were used as genes 
of interest. The number of copies of plasmid per bacterial cell (determined by ΔΔCt method [66]) 
was not different when bacteria were grown at 0 or 5 μM of NE; data not shown). 
 
Liquid mating experiments 
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Liquid mating experiments were conducted as previously described with some 
modifications [67].  The initial inocula (Salmonella strain 5678 and E. coli C600N) were grown 
individually for 18 h at 37°C under aerobic conditions with shaking (at 100 rpm).  Overnight 
inocula were diluted 1:10 in fresh prewarmed LB broth free of catecholamines for approximately 
2 h to attain an OD600 of 0.3. Cultures were mixed at the frequently used ratio of 1:5 (donor to 
recipient) to increase the potential mating frequencies by giving the donors more chances to 
donate the plasmid, and grown in static cultures at 37
o
C.  Mixed cultures were grown in 0, 5, 50, 
100, or 2000 μM of NE as previously described [32,34,35,46,68] and reflect the approximate 
concentrations of NE in the host GI tract under stressful conditions, which ranges from 2-50 μM 
[69].  Samples were collected at 0, 2, 4, 6, 8, 12, and 24 h post-mixing and were plated on HE-
agar containing selective antibiotics (50 µg/ml ampicillin for donor, 12 µg/ml nalidixic acid for 
recipient, and 50 µg/ml ampicillin and 12 µg/ml nalidixic acid for transconjugants) [67]. 
Selected transconjugants were replica-plated on to ceftriaxone, cefoxitin, chloramphenicol, 
streptomycin, sulfisoxazole and tetracycline to ensure all the resistance markers encoded on the 
plasmid were transferred.  These transconjugants were checked for the presence of the blaCMY-2 
gene by PCR as previously described [50].  Conjugation efficiencies were determined by 
dividing transconjugant CFUs/mL by CFUs/mL of donor bacteria, as described previously [70]. 
 
Catecholamine response and antagonism assays 
The adrenergic antagonists phentolamine (with equal affinities to α1 and α2 adrenergic 
receptors) at 200 μM concentration [57], or propranolol (with equal affinities to β1 and β2) at 
500 μM concentration [56] was added to the mating mixtures at the same time as NE (0 or 5 μM) 
and samples were collected at 0, 2, 4, 6, and 24 h post-mixing, and the conjugation frequency 
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was determined as described previously [70].  All experiments were repeated from 3 to 5 times 
as independent biological replicates. 
 
Gene expression studies  
Salmonella was grown at 0 or 5 μM concentrations of NE with or without selected 
adrenergic antagonists, and collected at pre-determined time points.   RNA was extracted from 
each bacterial sample using the Trizol  according to the manufacturer‟s instructions (Invitrogen, 
Carlsbad, California), and treated twice with the Turbo DNase kit (Ambion, Austin, Texas).  The 
resulting product was tested for DNA contamination and samples with no threshold fluorescence 
up to cycle 30 were considered to be DNA free.   A 16S ribosomal RNA target (EUB[64]) and 
mRNA from tufA1 gene [45] were used as house-keeping genes to normalize total RNA yields. 
qRT-PCR was performed using SuperScript III Platinum SYBR green One-Step qRT-PCR kit 
(Invitrogen, Carlsbad, California) on a RealPlex PCR machine (Eppendorf, Hauppauge, New 
York). Expression profiles of plasmid- and chromosomally-encoded genes were calculated as 
fold-changes using ΔΔCt method [66].  Cycling conditions for qRT-PCR included RT step for 30 
min at 50°C, followed by a denaturation step at 95°C for 3 min, and 40 cycles of denaturation for 
30 s at 95°C, primer annealing for 30 s at 55°C, and extension for 30 s at 72°C.  On all samples, 
a melt curve analysis was performed in all reactions to confirm amplification of correct product 
size.  All experiments were repeated from 3 to 5 times as independent biological replicates. 
 
Data Analysis 
Mean differences in the conjugation frequency and gene expression levels at various 
concentrations of NE were assessed for wild-type and mutant strains by paired t-tests performed 
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using statistical functions included in GraphPad Prism version 5.00 for Windows (GraphPad Software, San 
Diego, California).  The independent variables were NE concentrations, hours post-mixing, and the 
types and levels of adrenergic antagonists added.  Data is presented as means ± standard error of 
the means (SEM), and differences were considered statistically significant when the probability 
of a type I error was <0.05.  Further analysis was performed using a mixed effects model, with a 
repeated measure over hours analysis in a one-way ANOVA, and "unstructured" as the type of 
variance component.  A Bonferroni test was used for post-hoc analysis. 
 Results 
Effect of NE on Bacterial Growth in LB Media 
Identical to previous reports [32,48,49], NE enhanced the growth of Salmonella and E. 
coli in iron depleted SAPI medium.  However, growth of Salmonella and E. coli was not 
significantly different in the presence of NE when these bacterium were cultured in Luria-
Bertani broth (LB), which was used throughout the study (Figure 1).  LB is iron-replete (total 
iron concentration of 0.951 mg/L; Agilent 7500cx ICP-MS; Kansas State University-Veterinary 
Diagnostic Laboratory).  Adding additional levels of ferric chloride with NE had no effect on 
growth in LB (data not shown), suggesting the effect of NE was not due to 
catecholamine/transferrin interaction [36].   
 
NE increased motility of Salmonella  
Previous studies have reported an increase in the motility of Salmonella in the presence 
of NE in DMEM [46].  Since LB was used throughout the present study we measured motility in 
LB agar.  We observed similar effects with the donor Salmonella strain 5678 with increasing 
concentrations of NE in 0.35% LB agar.  The greatest increase was observed at 50 µM of NE 
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(Figure 2).  Our recipient E. coli strain inherently lacked ability to be motile in LB agar or MIO 
motility medium.  
 
 NE enhanced the ratio of horizontal gene transfer from Salmonella to E. coli 
Previous experiments [32,48,49] showed NE effects in SAPI medium, and while in our 
initial experiments we did see enhancement of conjugation in serum-SAPI, we could not rule out 
if it was due to real enhancement by the NE alone or if it was due to growth enhancement of the 
transconjugants through the NE-transferrin interactions.  LB broth was therefore used in all 
subsequent mating experiments.  Mating in broth was also important in maintaining uniform 
concentrations of catecholamines, and for ease in the collection of representative samples at 
predetermined time points to evaluate conjugative transfer and gene expression trends.  Luria-
Bertani broth (LB) was used in our studies as it is a nutrient-rich medium that supports growth of 
both Salmonella and E. coli. LB alone did not contain any detectable levels of catecholamines 
(ELISA; IBL International, Hamburg, Germany); however, catecholamines added to LB during 
growth and mating studies remained relatively stable with only a 10% to 22% reduction in their 
concentrations after 24 h incubation at 37
o
C under aerobic conditions (data not shown).   
Initial experiments involved incubation of mixed cultures of the donor Salmonella strain 
5678 and the recipient E. coli C600N in LB containing 0, 5, 50, 100, or 2000 μM of NE.  A 
significant increase in the conjugation frequency was shown at 5 μM NE concentration between 
2 to 6 h of mixed incubation (Figure 3). Therefore, further studies were conducted at 5 μM levels 
of NE.  Successful transfer of plasmid was confirmed by subjecting randomly selected 
transconjugants to PCR analysis for blaCMY-2 gene [50],  and pulse field gel electrophoresis 
(PFGE) [47,51,52] followed by Southern blotting and hybridization to a previously described 
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blaCMY-2 probe [47,53].  Additionally, replica-plating in Hektoen enteric agar plates for plasmid 
encoded antimicrobial resistance phenotypes was also performed (data not shown).  Filter mating 
between randomly selected C600N transconjugants as donors and two Salmonella Typhimurium 
strains (LT2 [700720] and 14028) or Citrobacter rodentium ICC 180 as recipients (Table 1), 
followed by PCR analysis for blaCMY-2 in the Salmonella and C. rodentium transconjugants 
confirmed successful transfer of the conjugative plasmid. Replica plating of randomly selected 
C. rodentium and Salmonella transconjugants on Hektoen enteric agar containing various 
antibiotics demonstrated that the plasmid encoded AMR genes were also functional in these 
recipients (data not shown).  
 
Expression of plasmid encoded genes increased in the presence of NE  
There was a significant up-regulation (fold-changes) of tra genes G, I, J, R, and Y during 
the first 6 h of the experiment (Figure 4), which correlated with the time-points when highest 
efficiencies of conjugation was observed (Figure 3).  Up-regulation of chromosomally encoded 
invA (invasin) and luxS genes was modest (less than 2.5-fold; data not shown).   In previous 
studies, the quorum sensing genes in E. coli (qseB/C and qseE/F) that belong to two-component 
signaling pathways have been implicated in interactions with catecholamines [40,54-56].  Levels 
of expression of orthologues of qseB/C and qseE/F genes in Salmonella 5678 (preA/B and 
yfhk/A, respectively) were evaluated in the presence or absence of NE.  Although there was a 
considerable increase in the expression of yfhK (mean fold change of 35.2), statistical analyses 
revealed that they were not significant (p value 0.08; Figure 4).  
 
Catecholamine receptor antagonists inhibited NE-induced conjugation 
41 
 
In previous studies [43,56,57], both α- and β-adrenergic antagonists have been shown to 
inhibit catecholamine-induced growth and virulence in bacteria.  Phentolamine at 500 µM 
concentration negated the increase in conjugation frequencies observed when exposed to NE and 
lowered it to levels not significantly different from that of controls (Figure 5).  Treatments with 
phentolamine alone had no significant effects on conjugation frequencies as compared to the 
controls (Figure 5).    
Treatments with propranolol had delayed inhibitory effects on NE enhanced conjugation 
frequencies.  Such inhibitory effects were not observed until the 4 h time-point, but continued 
through rest of the experimental period (Figure 5).  At the 2 h time-point, conjugation 
frequencies with NE + propranolol treatment was not significantly different from that of 
treatment with NE alone; but NE treatment with or without propranolol had significantly higher 
conjugation frequencies as compared to NE-free controls.  Treatment with propranolol alone did 
not significantly influence conjugative transfer (Figure 5).   
 
Effects of adrenergic antagonists on plasmid gene expression 
RNA was extracted from Salmonella that was treated with 5 µM NE, NE+phentolamine, 
phentolamine alone, NE+propranolol, or propranolol alone at all time-points when mating 
mixtures were plated to determine conjugation frequencies.  The expression of traI, traJ, traR 
and traY genes that had shown significant increases in the presence of NE was negated to levels 
not different from that of NE-free medium in the presence of antagonist (Figure 6).  
Interestingly, the effect of NE –enhanced traI and traJ gene expression was not totally negated 
when the β antagonist was added.   
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 Discussion 
In this study we have presented evidence that conjugative transfer of plasmids from 
clinical isolate of Salmonella enterica serovar Typhimurium (strain 5678) to an E. coli recipient 
strain C600N was enhanced significantly in the presence of NE.   The greatest effects of NE on 
conjugation were observed at the physiologically relevant concentration of 5 µM (during acute 
host-stress), and between 2 to 6 h post-exposure.  Conjugative transfer of this plasmid involves 
complex activation sequence of approximately 30 different transfer (tra) genes for direct cell-to-
cell mating, and we monitored expression of 7 tra genes G, H, I, J, M, R, and Y by qRT-PCR 
analysis.  Significant increases in tra gene expression seen at 2, 4 and 6 h of NE treatment 
correlated with the highest levels of conjugation efficiencies.  The traI gene, which encodes a 
relaxase-helicase and is the central catalytic component of the multiprotein relaxasome complex 
responsible for initiating conjugative DNA transfer, increased 10-fold following exposure to NE.  
Other transfer genes that increased in expression include those that encode TraH, which 
stabilizes the relaxasome structure; TraJ, which recruits the relaxasome complex to the oriT site; 
TraY, which imparts single-stranded DNA character on the oriT site; TraR, which is a LuxR-
type quorum-sensing transcription factor; TraG, which is essential for pili assembly and mating 
pair stabilization; and TraM, which mediates interaction of relaxase to oriT by stimulating 
relaxed DNA formation [58].   
Considerable controversy exists in understanding if α or β receptors are involved in the 
bacterial response to catecholamines.  Sperandio et al., have demonstrated that both α and β 
adrenergic antagonists, phentolamine and propranolol, respectively, caused decreases in 
expression of virulence genes [56].  However, Freestone et al., 2007, suggest that growth and 
virulence were influenced only through α receptors (phentolamine exposure), as this group did 
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not observe any inhibitory effects when propranolol was used [57].  In the present study we 
demonstrate involvement of both α and β receptors, with the stronger inhibition being present 
with the α blocker.  The β blocker had a delayed and incomplete inhibition of NE- enhanced 
effects on conjugative transfer.  Further studies are necessary to understand the true role of the β 
adrenergic receptor in bacterial conjugation. 
Physiological and psychological stresses of the host play an important role in incidence, 
duration, severity and outcome of host diseases, especially those caused by infectious agents. 
The significance of the present study is multifold. Previous studies have demonstrated that intra- 
and inter-species communication among bacteria, such as those mediated by pheromones in 
Salmonella , may influence conjugative transfer of genetic material.  We have used AMR-
carrying plasmids as a model in the present study as they have been implicated in the rise of 
many multidrug resistant bacterial strains, and evaluation of gain of resistance is easier than 
evaluating gain of other phenotypes such as virulence.  Since conjugative plasmids with similar 
backbones carry virulence determinants among pathogenic bacteria, it is fair to infer that such 
plasmids may also be influenced by host stress.  Our studies for the first time implicate the 
involvement of the host hormonal mediators in evolution and adaptation of bacterial pathogens 
in microenvironments where they are in close contact with the host.  Many studies have well 
established the influence of acute stress in animals, as experienced during transportation, 
resulting in increased incidence of infectious diseases [59].  Results from this study suggest that 
host stress may also influence the development and rise of bacterial pathogens that are highly 
virulent and multidrug resistant, and the results showcase the importance of stress management 
to prevent illnesses caused by bacterial infections.   
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 Figures and Tables 
Figure 2.1  Average bacterial counts at 0 to 24 h of incubation (x-axis) of donor and 
recipient, (on left y-axis) and transconjugants (on right y-axis) cultured in LB with 0 or 5 
μM NE. 
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Figure 2.2 Motility of Salmonella 5678 in 0.35% agar with increasing concentrations of NE.  
Motility was measured in cm
2
.  Error bars represent standard error of the means. 
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Figure 2.3 Conjugation frequencies increased when Salmonella 5678 and E. coli C600N 
were co-cultured in the presence of 5 μM NE compared to no-NE control.  Significant (p 
value ≤ 0.05) increases (indicated by an *) were seen at 2, 4, and 6 h. Error bars represent 
standard error of the means. 
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Figure 2.4 Activation (expressed as fold change) of tra and quorum-sensing genes in 
Salmonella 5678 between 2-6 h post-NE treatment compared to no-NE control.   Significant 
increases (p value ≤ 0.05; indicated by an *) were observed in traG, traI, traJ, traR, and 
traY.  Error bars represent standard error of the means. 
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Figure 2.5 Conjugation frequencies between Salmonella 5678 and E. coli C600N in the 
presence of NE with or without phentolamine (alpha adrenergic blocker) or propranolol 
(beta adrenergic blocker).  All treatments were compared to untreated controls at their 
respective hours and significant increases (p value ≤ 0.05) were indicated by an *.  No 
significant difference (indicated by NS) in conjugation efficiency was observed with 5 μM 
NE and 5 μM NE + propranolol at 2 h.  Error bars represent standard error of the means. 
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Figure 2.6 Average tra gene expression (fold change) between 2-6 h in Salmonella 5678 
treated with 5 μM NE with or without phentolamine (α adrenergic blocker) or propranolol 
(β adrenergic blocker).  Figure 6a shows results for traM, 6b for traY, 6c for traI, and 6d for 
traR.  All treatments were compared to untreated controls, and significant (p value ≤ 0.05) 
increases are indicated by an *.  Error bars represent standard error of the means. 
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Table 2.1 List of isolates used in this study.  
 
Table 1:  List of isolates used in this study.    
Strain Species 
AMR 
Phenotype 
Plasmid Type Reference 
5678 Salmonella enterica Typhimurium ACSSuTCroFx A [47] 
5561 Salmonella enterica Newport ACSSuTCroFx C [47] 
C600N E. coli Nal N/A [47] 
MG1655N E. coli Nal N/A [71] 
ICC 180 Citrobacter rodentium luxCDABE Nal, K N/A [60,61] 
14028 S. enterica Typhimurium UKN N/A (ATCC# 14028) 
LT2 S. enterica Typhimurium UKN N/A (ATCC# 700720) 
Abbreviations: A, ampicillin; C, chloramphenicol; S, streptomycin; Su, sulfisoxazole; Sxt, trimethoprim-
sulfamethoxazole; T, tetracycline; K, kanamycin; Cro, ceftriaxone; Fx, cefoxitin, N, nalidixic acid 
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Table 2.2 Complete list of primers used in this study. 
 
 
Table 2: Complete list of primers used in this study. 
Primer 5’ to 3’ Sequence 
Product 
Size 
Reference 
Antimicrobial Resistance    
tnpA F CATCAAGAAGGTGCGTCAAA 87 bp Present Study 
tnpA R TAATTCGTCGCAAAATGCAA   
blaCMY-2 F GACAGCCTCTTTCTCCACA 101 bp [50] 
blaCMY-2 R GAATAGCCTGCTCCTGCATC  (Shortened) 
    
Virulence    
invA F TGCCTACAAGCATGAAATGG 437 bp [72] 
invA R AAACTGGACCACGGTGACAA   
    
Quorum Sensing    
luxF F TTGCAAAAACGATGAACAC 444 bp [73] 
luxF R AAGACTAAATATGCAGTT C   
luxS F GTCGACGCCGCTGATACCGAACCG 178 bp Present Study 
luxS R GTCGACGCGGTGCGCACTAAGTACAA   
preA Sal F AAAGCGGGCCTGAGTAAAAT 175 bp Present Study 
preA Sal R CCGGTTCCTGTTTACCCTTT   
preB Sal F CGACAATGGCTATCTGAAGG 86 bp [46] 
preB Sal R CGGTAATCCCACTCCTGAC   
yfhK RTF CGCGCCATGATCTTCGA 61 bp [54] 
yfhK RTR CCCTTCACCGCCCCTTT   
yfhA RT F CGCCCCGCCATTCTC 58 bp [54] 
yfhA RT R CGTAAGCTGCTGCAAATTACCA   
    
Transfer Genes    
traG F CTGTCCATAACGACGGGTTC 164 bp Present Study 
traG R TCGGATAAAAGCGGAATCAC   
traH F GGACGTGAAGGTTGACTGGT 109 bp Present Study 
traH R GACTGGGAAGGTGATGCAAT   
traI F TTGTCTTCCTTCCTGCCATC 163 bp Present Study 
traI R TGAACGCTTTGTCAGCAATC   
traJ F GCTTTACGACCACCGTCATT 98 bp Present Study 
traJ R CCTGTCATCAGGGATTCGAT   
traM F AATATTCGCGCTCCACATTC 126 bp Present Study 
traM R AACAGCGGGCAAATAATGTC   
traR F TCGACATTGCGAACCATATC 103 bp Present Study 
traR R GCCGGAGCAAACTGACTAAG   
traY F TGCGACGAAACTCAGTATGC 153 bp Present Study 
traY R GGAAGCATGTTCTGGGTGTT   
    
Positive Controls    
EUB F TGGAGCATGTGGTTTAATTCGA 161 bp [64] 
EUB R TGCGGGACTTAACCCAACA   
tufA1 F TGATGACGAAGAGCTGCTGGAACT 146 bp [65] 
tufA1 R CTTTCAGACCAGAACCACGAACGA   
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Chapter 3 - Bimodal Distribution Pattern of Conjugative Gene 
Transfer Ratios pre- and post-MIC 
  Abstract 
The widespread use of antimicrobials in medicine as well as in food production has 
resulted in pathogenic bacteria becoming resistant to the antimicrobials used to treat them.  
Antimicrobial resistance (AMR) can result from horizontal gene transfer (HGT) through 
plasmids and transposons.  The exact influence of the antimicrobial concentration on HGT 
through direct cell-to-cell conjugation is, however, not clearly defined.  The objective of this 
study was to address this deficiency by quantitatively characterizing the efficiencies of 
conjugation in two mating pairs of enteric bacteria during exposure to concentrations above, 
equal to and below the minimum inhibitory concentration (MIC) under in vitro conditions.  The 
first mating pair consisted of a donor E. faecalis INY1010 which transferred a conjugative 
transposon Tn925 to a recipient E. faecalis OG1RF, and the second pair involved the transfer of 
a 100kb conjugative plasmid from Salmonella Typhimurium 5678 to a recipient E. coli C600N. 
Broth mating were performed in the presence of increasing concentrations of tetracycline or 
oxytetracycline, respectively, and compared to antimicrobial-free medium.  Conjugation 
occurred in all concentrations, but efficiencies of transfer were consistently low in 0 MIC and 1 
MIC, with increased activity both above and below 1 MIC.  Expression of plasmid encoded 
transfer (tra) genes was significantly upregulated in response to the lowest and highest MICs 
when Salmonella and E. coli were co-cultured, but were only upregulated in the highest 
concentrations when Salmonella was cultured alone.  A previously described mathematical 
model was fit to these data and the rate constant E that relates the rate of gene transfer to drug 
concentration was determined.  The in vitro data showed highly similar patterns of conjugation 
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efficiencies when compared to the rate constant E. This study provides important insight in 
defining the role of antimicrobial concentration on conjugation efficiencies and may provide 
future insight into better control of AMR. 
 Introduction 
Bacteria are asexual organisms that reproduce by binary fission, resulting in the genetic 
replication of one cell into two daughter cells. This type of reproduction produces genetically 
identical organisms that have equal susceptibilities to environmental pressures, be it 
antimicrobial or otherwise (29).  Over time, systems utilizing transformation, transduction and 
conjugation have evolved to diversify the genome allowing for faster adaptation to 
environmental changes, thereby reducing exclusive dependence of bacteria on random beneficial 
genomic mutations (34, 41).  As a consequence, horizontal transmission of resistance elements is 
considered the predominant mode for the dissemination of bacterial resistance (6) and is 
accomplished through the efficient movement of genetic elements including plasmids, 
transposons, and bacteriophages (40, 41). 
The most efficient method of HGT is through conjugation.  Conjugation is mediated by 
the physical adherence of donor and recipient cells and the subsequent transfer of genetic 
elements into the recipient cell (2, 29).  These genetic elements allow for high efficiency transfer 
of antimicrobial and virulence genes from single resistant donor bacterium to many recipients 
which can in turn donate the resistance genes to more recipients (41).  Horizontal transfer by 
conjugation is not exclusive to bacteria of the same species. This is exemplified by the 
occurrence of vancomycin resistant Enterococcus (VRE) and vancomycin resistant Staplococcus 
aureus (VRSA) in ecosystems where they coexist (11, 12, 20, 24, 35-37, 42).  Conjugative HGT 
has been shown to be not exclusive between bacteria either. Several studies have shown 
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successful transfer of genetic elements by conjugation between bacteria to yeast (18), bacteria to 
plant cells (45), and recently bacteria to mammalian cells (46).  This transfer is important to the 
survival and evolution of many bacterial species (41), and has allowed for high efficiency 
transfer of AMR and virulence genes between bacteria which has had a considerable impact on 
human and animal health (44). 
Gastrointestinal tracts of both humans and animals are a major habitat of Salmonella.    In 
2005, over 36,000 clinical cases of Salmonellosis were reported to the CDC (8).  Of these, 
15,000 resulted in hospitalization and 400 were fatal (17).  In 2007, the number of cases reported 
in a 10 U.S. state survey was 6,790 and the incidence per 100,000 population was 14.92 (7).  
Salmonellosis can also cause severe enteritis, decreasing weight gain and reproductive 
performance in livestock and thereby has a significant economic impact (1).  Recent studies have 
identified plasmid carrying Salmonella strains that contain many different AMR genes that are 
capable of conjugative HGT to recipient strains of E. coli (5, 15). 
The objective of this study was to determine the conjugative transfer efficiencies of 
genetic elements of two pathogenic bacterial mating pairs under in vitro conditions following 
antimicrobial exposure, and to fit these date ot a mathematical model to aid in future AMR 
research (14). 
 Materials and methods 
 
Bacterial strains 
Enterococcus faecalis INY1010 is a clinical isolate that was used as a donor in the first 
set of mating experiments (21).  This strain carries a conjugative transposon Tn925 that highly 
similar to the well-characterized Tn916 (21, 22) that provides resistance to tetracycline (4).  The 
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recipient was Enterococcus faecalis OG1RF which contained chromosomal mutations that 
provided resistance to rifampicin and fusidic acid (31) (Table 1). 
Salmonella Typhimurium strain 5678 (15) was used as the donor strain in the second set 
of mating experiments.  This strain carries a type A plasmid that is approximately 100 kb in size, 
and is transferable by conjugation to the recipient E. coli C600N (a spontaneous nalidixic acid 
resistant mutant of strain C600 (15); kindly provided by Dr. Paul Fey at University of Nebraska 
Medical Center, Omaha, Nebraska). This plasmid contains a blaCMY-2 gene that encodes 
resistance to a large spectrum of β-lactams including ampicillin, ceftriaxone and cefoxitin.  This 
plasmid also contains resistance markers for chloramphenicol, streptomycin, sulfisoxazole, 
trimethoprim-sulfamethaxozole and tetracycline (Table 1).  Based on sequence analysis, this 
plasmid was closely related to the well-studied plasmid pNF1358, and the organization of the 
transfer genes was similar to that of IncI plasmid R64 (23) (Genbank DQ017661.1). 
 
MIC determination 
The minimum inhibitory concentration of tetracycline or oxytetracycline for donor and 
recipient strains was determined using a slight modification of micro-broth dilution method 
recommended by CLSI (30).  Briefly, 10 µL of a 0.5 McFarland bacterial suspension was 
pipetted into 11 mL of Luria-Bertani (LB) broth.  Aliquots of the bacterial suspension (100 μL) 
was added to the wells of a 96-well plate containing 100μL of increasing concentrations of 
tetracycline or oxytetracycline (Sigma, St. Louis, MO) in duplicates, for donor and recipient 
strains. The 96-well plates was placed in an incubated (37
o
C) spectrophotometer (SpectraMax 
190, Molecular Devices, Sunnyvale, CA) set to read absorbance at 600 nm with readings taken 
hourly. The MIC was the lowest concentration at which optical density readings was reduced by 
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60% (25).  The MIC of tetracycline for the E. faecalis INY1010 donor and E. faecalis OG1RF 
recipient strains were 125 µg and 2 µg/ml, respectively.  The MICs of Salmonella 5678 donor 
and E. coli C600N recipient strains for oxytetracycline were determined to be 60,000 and 62.5 
ng/ml, respectively. 
 
Pulse Field Gel Electrophoresis 
PFGE was conducted with Salmonella 5678, E. coli C600N, and selected transconjugants 
using standard methodologies (33). The DNA embedded in agarose was digested with XbaI and 
electrophoresed on a CHEF DR-III instrument (Bio-Rad, Richmond, CA) using the following 
conditions: initial switching time, 2.2 s; final switching time, 63.8 s; total time, 19 h. Salmonella 
enterica serotype Braenderup H9812 (ATCC# BAA-664) was used as the standard (data not 
shown). 
 
Southern Blot 
DNA from the PFGE gel was transferred to nitrocellulose or nylon membranes as 
described previously (38). A DIG labeled blaCMY-2 probe (Roche, Indianapolis, IN) was created 
using previously described primers (5, 15), and hybridization was detected using NBT/BCIP 
(Roche) (data not shown). 
 
Liquid mating experiments 
Broth cultures were used in all mating experiments to maintain uniform concentrations of 
antimicrobials, and for ease in the collection of representative samples at predetermined time 
points to evaluate HGT and gene expression trends.  All Enterococcus matings were performed 
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in static Brain Heart Infusion (BHI) broth and all Salmonella to E. coli matings were conducted 
in static Luria-Bertani (LB) broth.  E. faecalis INY1010 and E. faecalis OG1RF were inoculated 
into separate tubes and grown overnight (12-18 h) at 37
o
C with shaking.  Inocula were mixed at a 
1:1 ratio for a total volume of 100 ml and incubated in 0x, 0.5x, 1x, 2x, 4x, 8x and 16x MIC of 
tetracycline.  Samples were collected at 1, 2, 4, 6, and 8 days post-exposure and plated on 
Tryptic Soy Agar (TSA) plates containing selective antibiotics (30 µg/mL tetracycline for donor, 
50 µg/mL rifampicin for recipient, and 30 µg/mL tetracycline and 50 µg/mL rifampicin for 
transconjugants).  Selected transconjugants were checked for presence of transposon by tetM 
PCR amplification (data not shown). 
Liquid mating experiments between Salmonella and E. coli were conducted as previously 
described with some modifications (26, 32).  The initial inocula (Salmonella strain 5678 and E. 
coli C600N) were grown individually for 18 h at 37°C under aerobic conditions with shaking (at 
100 rpm).  Overnight inocula were diluted 1:10 in fresh prewarmed LB broth free of 
antimicrobials for approximately 2hrs to attain an OD 600 of 0.3. Cultures were mixed at a ratio 
of 1:5 (donor to recipient) oxytetracycline was added to the mixed cultures at 0, 0.25, 0.5, 1, 1.5, 
2, 4, 8, 16, 32, and 64x recipient MIC levels, and incubated at 37
o
C.under aerobic conditions.  
Samples were collected at 0, 2, 4, 6, 8, 10, 12, and 24hrs post-mixing and were plated on HE-
agar containing selective antibiotics (50µg/ml ampicillin for donor, 12 µg/ml nalidixic acid for 
recipient, and 50µg/ml ampicillin and 12µg/ml nalidixic acid for transconjugants) (26). Selected 
transconjugants were replica-plated on to ceftriaxone, cefoxitin, chloramphenicol, streptomycin, 
sulfisoxazole, and tetracycline to ensure all the resistance markers encoded on the plasmid were 
transferred.  These transconjugants were checked for the presence of the blaCMY-2 gene by PCR 
as previously described (50).  HGT ratios were determined by dividing transconjugant CFUs/mL 
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by CFUs/mL of donor bacteria, as described previously (22).  All antimicrobials were purchased 
through Sigma-Aldridge, St. Louis, MO, and all media was purchased through Fisher Scientific, 
St. Louis, MO. 
 
Gene expression studies 
RNA was extracted from Salmonella and E. coli together, or Salmonella alone grown at 0 
through 64X MIC of oxytetracycline using the Trizol (Invitrogen, Carlsbad, CA). The RNA was 
treated with DNase treatment kit (Invitrogen, Carlsbad, CA) to remove residual DNA to acquire 
samples with no threshold fluorescence before cycle 30 in a SYBR Green qPCR reaction.  A 16S 
ribosomal RNA target, EUB (49), was used as a house-keeping gene to normalize total RNA 
yields.  Quantitative RT-PCR was performed on listed primer sets (Table 2) using SuperScript III 
Platinum SYBR green One-Step qRT-PCR kit (Invitrogen, Carlsbad, CA) on a RealPlex PCR 
machine (Eppendorf, Hauppauge, NY). Expression profiles of plasmid and chromosomally 
encoded genes (calculated as fold-changes using ΔΔCt method) are summarized in Figure 2.  A 
melt curve analysis was performed following all PCR to confirm a single amplicon of adequate 
size.   
 
Mathematical Modeling of Mating Pair Data 
The number of bacteria (CFU/mL) from each time point and condition were organized by 
donor, recipient and transconjugant for each concentration and time point.  These files were 
uploaded to a Susceptible-Infected-Recovered (SIR) mathematical model (14) designed in acslX 
modeling platform (AEgis Technologies, Huntsville, AL).  Variables including drug 
concentration, carrying capacity, and starting CFUs/mL were inputted into the model.  Outputs 
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from each run including the E value (rate constant that relates the rate of gene transfer to the drug 
concentration) and standard deviations (how well the in vitro data fit to the model) were 
considered for each run, and the E values and predicted transconjugant CFUs/mL were compared 
by observed value by linear regression analysis (Figure 6;7). 
 
Data Analysis 
Mean differences in the ratio of conjugative frequencies and gene expression levels at 
various concentrations of antibiotics were assessed by paired t-tests performed using statistical 
functions included in GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego, CA).  The 
independent variables were antimicrobial concentrations, hours post-mixing, and the types and 
levels of adrenergic antagonists added.  Data was presented as means ± SEM, and differences 
were considered statistically significant when the probability of a type I error was <0.05.  Further 
analysis was performed using a mixed effects model, with a repeated measure over hours 
analysis in a one-way ANOVA, and "unstructured" as the type of variance component.  A 
Bonferroni test was used for post-hoc analysis. 
 
 Results 
Inhibition of recipient in the presence of antimicrobial 
In the Enterococcus mating pair experiments there was a dose-dependent decrease in the 
CFUs/mL of the OG1RF recipient population as the tetracycline concentrations increased 
(Figure 1a).  This differed from the donor INY1010 population which increased in response to 
antibiotic pressure (Figure 1b).  In the Salmonella to E. coli mating pair, the recipient E. coli 
population also responded in a dose-dependent decrease in CFUs/mL as oxytetracycline 
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concentrations were increased (Figure 1c).  Contrary to the E. faecalis INY1010 donor 
population, the Salmonella population remained relatively consistent in response to increasing 
concentrations of oxytetracycline (Figure 1d). 
 
Bimodal pattern present when conjugative transfer ratios were measured across increasing 
MICs 
Resistance gene transfer occurred in both the Enterococcus (Figure 2) and the Salmonella 
to E. coli (Figure 3) mating pairs.  Resistance gene transfer occurred in the populations exposed 
to all the concentrations of antimicrobials, but the efficiency of transfer varied between antibiotic 
concentrations. In both of these pairs, the resistance gene transfer was consistently low in 
populations exposed to 0x MIC and 1x MIC.  Exposure to sub-inhibitory (0.25x – 0.5x MIC) and 
supra-inhibitory (1.5x – 64x MIC) concentration of antimicrobials had increased numbers of 
transconjugants and higher efficiencies of conjugation, producing a bimodal distribution pattern 
(Figure 2, 3).  The experiments were repeated at least 10 times.  Successful transfer of plasmid 
was confirmed by subjecting randomly selected transconjugants to PCR analysis of blaCMY-2 
gene; pulse field gel electrophoresis (PFGE) (5, 15, 38) followed by Southern blotting and 
hybridization to a blaCMY-2 gene region probe; as well as by replica-plating in Hektoen enteric 
agar plates for plasmid-encoded antimicrobial resistance phenotypes (data not shown).  Filter 
mating between randomly selected C600N transconjugants as donors and Citrobacter rodentium 
ICC180 or two Salmonella Typhimurium strains (LT2 700720 and 14028) as recipients (Table 
1), followed by PCR analysis for blaCMY-2 in the C. rodentium and Salmonella transconjugants, 
and plating in appropriate antimicrobial-containing plates confirmed successful transfer of the 
conjugative plasmid (data not shown). 
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Transfer gene expression when exposed to antimicrobials 
Two plasmid transfer (tra) genes present on the Salmonella plasmid were selected for 
analysis based on their ability to upregulate in the presence of catecholamines, as shown in a 
previous study (32).   There was a significant up-regulation (fold-changes) of plasmid-encoded 
tra genes I and Y in the presence of antimicrobials (Figure 4), which correlated with the sub- and 
supra-MIC concentrations of oxytetracycline and time-points when highest levels of HGT 
occurred (Figure 4).  Interestingly, when Salmonella alone was incubated with the increasing 
concentration of oxytetracycline, the significant upregulation of genes only correlated with the 
post-MIC concentrations.  Additional tra genes J and R were tested and the trend was the same 
(Figure 5).  There was found to be a dose-dependent correlation (as determined by r
2
 values) 
between fold changes and antimicrobial concentrations both pre and post the MIC when 
Salmonella was co-cultured with E. coli and correlation above the MIC when Salmonella was 
cultured alone. 
 
Use of a mathematical model for analysis 
The data acquired during the Salmonella to E. coli mating experiments were fitted to a 
mathematical model (14) and the conjugation efficiencies in increasing concentrations of 
oxytetracycline were determined.  The same bimodal pattern observed in Figure 3 was again 
found when E values (rate constant that relates the rate of gene transfer to the drug 
concentration) were compared by linear regression (deviation was significantly above 0, p value 
>0.001) to observed conjugation ratios (Figure 6).  Predicted vs. observed CFUs/mL of 
transconjugants at all concentrations were also analyzed by linear regression, and all showed 
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significant (p value < 0.001) deviation from zero (Figure 7).  Additional analysis of donors and 
recipient populations by linear regression analysis also demonstrated significant (p value <0.001) 
deviations from zero at all concentrations (data not shown). 
 Discussion 
Perhaps most interesting observation in this study was that there were bimodal effects on 
conjugative transfer efficiency ratios across the increasing concentrations of antimicrobials 
surrounding the 1 MIC level (Figures 2; 3).  A common trend in bacteria is that pre-MIC levels 
of antimicrobials cause an increase in mutation rates as well as increases in the efficiencies of 
HGT of the susceptible recipient bacteria (3, 10, 19).  The pre-MIC side of the bimodal curve 
was expected and was believed to be reflective of this.  For the conjugation increases post-MIC 
we hypothesized that the increase in conjugation was another pre-MIC effect, this time for the 
resistant donor bacteria.  This is supported in the literature with two past studies in Enterococcus.  
In these experiments, pre-incubation in sub-MIC concentrations of tetracycline of a donor E. 
faecalis population containing transposons Tn916 and Tn925 were shown to enhance 
conjugation efficiencies up to 119-fold when the donors they were added to the recipient B. 
thuringiensis bacterial cultures (39, 43). 
Additional support for this hypothesis was gained through the tra gene expression data. 
Conjugative transfer of the Type A plasmid involves complex activation sequence of 
approximately 30 different transfer (tra) genes for direct cell-to-cell mating (16).  We monitored 
expression of two tra genes I and Y by qRT-PCR analysis.   RNA was collected from a mixed 
culture of Salmonella and E. coli and the traI gene (encoding a relaxase-helicase and is the 
central catalytic component of the multiprotein relaxasome complex responsible for beginning 
the conjugative DNA transfer) showed significant upregulation in both the pre- and post- MIC 
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concentrations of oxytetracycline (Figure 4a).  The same bimodal pattern was found for traY, 
which imparts single-stranded DNA character on the oriT site (Figure 4b). 
To support the hypothesis that there was a separate pre-MIC effect of the oxytetracycline 
on the Salmonella donor population, Salmonella was incubated alone and gene expression of traI 
and traY were monitored. The gene expression data indicated a high amount of post-MIC traI 
and traY upregulation when Salmonella was incubated alone with increasing amount of 
oxytetracycline (Figure 5a;b).  Additional transfer genes were quantified including traJ (Figure 
5c), (recruits the relaxasome complex to the oriT site) and traR (a LuxR-type quorum-sensing 
transcription factor; Figure 5d) which both showed the same pattern of increased gene expression 
in the higher concentrations of oxytetracycline.    Based on the gene expression study data, it 
appears that the increase in the HGT in both the pre- and post- MICs may be due to pre-MIC 
effects of both the recipient and the donor. 
In order to determine if the bimodal pattern of AMR acquisition was unique for 
tetracycline treatment, an additional study was performed using the Salmonella to E. coli mating 
pair in the presence of 0, 0.25, 0.5, 1, 2, 4, 8, and 16X MIC of ceftiofur (MIC of ceftiofur for 
Salmonella donor and E. coli C600N was 10,000 and 100 ng/ml, respectively).  Preliminary 
results showed a similar bimodal pattern of AMR acquisition was demonstrated with ceftiofur 
treatment as well (data not shown).    
Dynamics of any system changes as the number of variables are increased.  In the present 
study we considered the each separate bacterial population‟s growth and death, horizontal 
transfer of genetic element between them, the individual time points of the experiment, and the 
influence of increasing concentrations of antimicrobials.  When the susceptible population of E. 
faecalis OG1RF and E. coli C600N were cultured alone, their growth was visibly inhibited in 
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increasing levels of antimicrobials with the smallest inhibitory concentration being the MIC.  
When the recipients were co-cultured with the donor strains (E. faecalis INY1010 or Salmonella 
5678, respectively), inhibition is observed (Figure 1a, 1c), however, recipients are still positively 
identified at the highest MIC concentrations (16x for E. faecalis OG1RF and 64x for E. coli 
C600N) perhaps due to some protective effects by the donor strains.  Some of these potential 
protective effects may be explained by a recent study by Lee et al, 2010 (25).  In this study, 
protective effects from indole were instrumental in increasing the MIC of a susceptible E. coli 
population when they were exposed to antimicrobials. 
There was an interesting growth dynamic with the donor population as well.  In 
Enterococcus, the growth of the donor population increases in response to the increase of 
antimicrobials, or perhaps due to the decrease in the recipient population while the Salmonella 
population remains relatively stable in most antimicrobial concentrations, only showing 
inhibition at 64x MIC.   
The many factors (with varying degrees of knowledge of their true effects) that 
contributed to the results in this study are, in a sense, only a superficial glimpse at the bigger 
picture.  Undoubtedly if we were to change key factors (donor to recipient ratio, carrying 
capacity, efficiency of transfer, etc.) the dynamics of the entire system would change as well.  In 
future studies it may be useful to run experiment of this nature, but the amount of time and 
resources required might be limited.  In order to save resources in future work, we utilized the 
data acquired in the Salmonella to E. coli mating experiments to set up parameters in a 
previously developed SIR computer model (14).  Mathematical models can be defined as 
conceptual models that use mathematical language to represent a particular context. As 
technology and resources become more readily available and user-friendly, mathematical models 
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are being used more frequently to answer complex questions in the biomedical sciences. The 
quantitative nature of mathematical models offers numerous advantages over other conceptual 
models. The use of mathematical language ensures precision in the description of hypotheses and 
assumptions. Also, it facilitates the logical manipulation of statements that can readily be 
updated as our knowledge of the subject increases and evolves. Finally, a mathematical model 
provides quantitative conclusions that can be compared with measurements taken from real life. 
They are particularly useful in cases where a specific numerical outcome is needed such as a 
dosage regimen for drug administration (27, 28).  This model incorporated the SIR format in 
defining the interactions between the donor and recipient strains with the subsequent 
development of transconjugant bacteria (14).  Using these data, the model simulated the same 
bimodal pattern as demonstrated in the in-vitro studies with the conjugation frequency increases 
(measured as E, or transfer efficiency values) pre- and post-MIC (Figure 6).  With this model we 
now have the capability of predicting conjugation efficiencies at a variety of conditions including 
carrying capacity, starting concentrations of antimicrobials, starting populations of donors, 
recipients and transconjugants, hours incubated, and effectiveness of antimicrobials used. 
In this study we provide evidence that the concentration of antimicrobials influences the 
efficiencies of conjugation in an Enterococcus INY1010 to Enterococcus OG1RF and 
Salmonella to E. coli mating pair.  This study for the first time reports significant activity in 
supra-MIC concentration and through gene expression analysis attempts to interpret this 
occurrence.  The mathematical modeling systems developed here for analysis add a valuable tool 
for measuring conjugation frequencies in real-time.  These results demonstrate the complexity of 
the interactions between donor and recipient bacteria as environmental factors are altered. Future 
investigation will further define additional factors affecting conjugative HGT.  
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 Figures and Tables 
Figure 3.1 Growth curves (CFUs/mL) of donor and recipient populations throughout the 
experiments at increasing concentrations of antimicrobials.  Growth of E. faecalis mating 
pair OG1RF (1a) and INY1010 (1b) shows population change over 8 days.  Growth of E. 
coli C600N (1c) and Salmonella 5678 (1d) mating pair shows growth over 24 hours. 
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Figure 3.2 Conjugation efficiencies (measured as log ratios) of conjugative Tn925 between 
E. faecalis strains INY1010 and OG1RF at increasing concentrations of tetracycline.  Each 
bar represents al HGT reads over the course of the 8 day experiment.  An * indicates an 
increase significant at p value <0.05, and ** indicates significant increase at p value <0.01 
compared to 0 MIC. 
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Figure 3.3 Conjugation efficiencies (measured as log ratios) of type A conjugative plasmid 
from Salmonella to E. coli at increasing concentrations of oxytetracycline.  An * indicates 
an increase significant at p value <0.05, ** indicates significant increase at p value <0.01, 
and *** indicates a significant increase at p value <0.001 compared to 0 MIC. 
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Figure 3.4 Gene expression studies for plasmid tra genes traI (3a) and traY (3b) in 
Salmonella co-cultured with E. coli in increasing concentrations of oxytetracycline.  An * 
indicates an increase significant at p value <0.05, ** indicates significant increase at p value 
<0.01, and *** indicates a significant increase at p value <0.001 compared to 0 MIC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
traI SE
0 
M
IC
0.
25
 M
IC
0.
5 
M
IC
1 
M
IC
1.
5 
M
IC
2 
M
IC
4 
M
IC
8 
M
IC
16
 M
IC
32
 M
IC
64
 M
IC
1
10
100
1000
10000
100000
***
**
*
*
*
**
*
*
*
*
Oxytetracycline Concentration
F
o
ld
  
C
h
a
n
g
e
traY SE
0 
M
IC
0.
25
 M
IC
0.
5 
M
IC
1 
M
IC
1.
5 
M
IC
2 
M
IC
4 
M
IC
8 
M
IC
16
 M
IC
32
 M
IC
64
 M
IC
1
10
100
1000
10000
***
***
*
**
*
*
*
**
*
Oxytetracycline Concentration
F
o
ld
  
C
h
a
n
g
e
4a 4b 
86 
 
Figure 3.5 Gene expression studies for plasmid transfer (tra) genes traI (5a), tray (5b), traJ 
(5c), and traR (5d) in Salmonella exposed to increasing concentrations of oxytetracycline.  
An * indicates an increase significant at p value <0.05, ** indicates significant increase at p 
value <0.01, and *** indicates a significant increase at p value <0.001 compared to 0 MIC. 
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Figure 3.6 Linear regression analysis of observed vs. predicted HGT efficiencies.  The 
bimodal pattern is present with 0 and 1 MIC at lower points on the line as compared to all 
other values.  Significant (p value < 0.001) deviation from zero was found. 
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Figure 3.7 Linear regression analysis (7a-k) of observed vs. predicted transconjugants.  (7a) 
is 0MIC, (7b) 0.25 MIC, (7c) 0.5 MIC, (7d) 1 MIC, (7e) 1.5 MIC, (7f) 2 MIC, (7g) 4 MIC, 
(7h) 8 MIC, (7i) 16 MIC, (7j) 32 MIC, and (7k) 64 MIC. Significant (p value < 0.001) 
deviation from zero was found. 
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Table 3.1 List of isolates used in this study.  
Strain Species 
AMR 
Phenotype 
Mobile Element Reference 
INY1010 Enterococcus faecalis T, S, Sp Tn925 (9, 21) 
OG1RF Enterococcus faecalis Rif, Fus N/A (13) 
5678 Salmonella enterica Typhimurium ACSSuTCroFx Type A Plasmid (15) 
C600N E. coli Nal N/A (15) 
ICC 180 Citrobacter rodentium luxCDABE Nal, K N/A (46, 47) 
ATCC 14028 S. enterica Typhimurium UKN N/A (ATCC) 
ATCC 700720 S. enterica Typhimurium UKN N/A (ATCC) 
Abbreviations: A, ampicillin; C, chloramphenicol; Cro, ceftriaxone; Fus, fusidic acid; Fx, cefoxitin; K, kanamycin; N, 
nalidixic acid; S, streptomycin; Sp, Spectinomycin; Su, sulfisoxazole; T, tetracycline; Rif, rifampicin 
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Table 3.2 Complete list of primers used in this study. 
Primer 5’ to 3’ Sequence 
Product 
Size 
Reference 
Antimicrobial Resistance    
blaCMY-2 F GACAGCCTCTTTCTCCACA 101 bp (49) 
blaCMY-2 R GAATAGCCTGCTCCTGCATC  (Shortened) 
Transfer Genes    
traI F TTGTCTTCCTTCCTGCCATC 163 bp (This study) 
traI R TGAACGCTTTGTCAGCAATC   
traJ F GCTTTACGACCACCGTCATT 98 bp (This study) 
traJ R CCTGTCATCAGGGATTCGAT   
traR F TCGACATTGCGAACCATATC 103 bp (This study) 
traR R GCCGGAGCAAACTGACTAAG   
traY F TGCGACGAAACTCAGTATGC 153 bp (This study) 
traY R GGAAGCATGTTCTGGGTGTT   
Positive Controls    
EUB F TGGAGCATGTGGTTTAATTCGA 161 bp (48) 
EUB R TGCGGGACTTAACCCAACA   
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Chapter 4 - The Effects of Stress Hormones and Antibiotics on 
Conjugative Gene Transfer 
 Abstract 
The widespread use of antimicrobials in medicine as well as in food production has 
resulted in pathogenic bacteria becoming resistant to the antimicrobials used to treat them.  
Antimicrobial resistance (AMR) can result from conjugative horizontal gene transfer (HGT) 
through plasmids and transposons.  Adrenaline and norepinephrine are catecholamines that 
mediate acute host stress in vertebrates and invertebrates.  Past research has shown that 
catecholamines can also be used as environmental cues for pathogenic bacteria to enhance 
growth, motility, virulence and increase conjugation frequencies between enteric bacteria.  The 
exact influence of the antimicrobials and catecholamines together on conjugation is, however, 
not clearly defined.  The objective of this study was to address this deficiency by quantitatively 
characterizing the efficiencies of conjugation in a mating pair of Salmonella Typhimurium and 
E. coli C600N during exposure to concentrations above, equal to and below the minimum 
inhibitory concentration (MIC) of oxytetracycline under in vitro conditions with or without 
norepinephrine (NE).  Conjugative HGT occurred in all concentrations of oxytetracycline, but 
efficiencies of transfer were consistently low at 0 MIC and 1 MIC, with increased activities both 
pre- and post- MIC. While the addition of NE enhanced conjugation frequencies at all 
oxytetracycline concentrations, the effects were not cumulative.  Expression of plasmid encoded 
transfer (tra) genes was significantly upregulated in response to the highest concentrations when 
Salmonella was cultured alone, and NE exposure enhanced the fold changes further.  This study 
for the first time provides insights into the effects of oxytetracycline and NE on conjugation, and 
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may provide future insight into better control of AMR in animals and humans whose bacterial 
infections are treated with antimicrobials while experiencing stress. 
 Introduction 
Random mutation has allowed bacteria to adapt to a variety of environmental niches (38, 
48); however, HGT greatly accelerates bacterial evolution (7, 47, 48).  HGT is accomplished 
through the efficient movement of genetic elements including plasmids, transposons, and 
bacteriophages (47, 48).  Conjugative transfer is the most efficient (33).  Conjugation works by a 
host cell physically adhering to a recipient cell, and horizontally transferring genetic elements 
packaged as plasmids or transposons into the cytoplasm for the passage into the recipient cell 
(33). These transposons and plasmids allow for high efficiency transfer of antimicrobial and 
virulence genes from single resistant donor bacterium to many recipients which can in turn 
donate the resistance genes to more recipients (48). 
In a previous study, a significant increase in conjugation was reported in response to 
exposure to catecholamines (35).  Catecholamines are a large group of amine hormones, derived 
from tyrosine, and include epinephrine (adrenaline), norepinephrine (NE; noradrenaline) and 
dopamine. Catecholamines, especially adrenaline and NE, are sympathetic neuroendocrine 
mediators of “fight or flight” (acute stress) response of the host. NE-containing sympathetic 
synapses are distributed throughout the body, with more than half located in the gastrointestinal 
(GI) tract in the enteric nervous system (12, 16).  In the gastrointestinal tract the physiological 
concentration of NE has been shown to be as high as 50μM (1). 
Subsequent studies have demonstrated that catecholamines can influence production of 
virulence factors, such as toxins and adhesins, biofilm formation, and quorum sensing even in 
iron-replete conditions (26-32, 35, 45, 46).  For example, E. coli O157 responds to 
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catecholamines by increased expression of shiga-toxin (51), exalted chemotaxis, and adherence 
to eukaryotic cells (2, 8), enhanced attachment and effacement (A/E) lesions (37), attachment to 
murine cecal mucosa (8), and increased flagella expression and motility (11).  In Salmonella, 
catecholamines have been implicated to enhance motility and colonization in the GI tract of pigs 
(4).   
The development and widespread use of antimicrobials in the last 60 years has resulted in 
many drug resistant strains of bacteria.  Less than inhibitory concentrations (pre-MIC) of 
antimicrobials are thought to play a role in increasing mutation rates as well as increases in the 
efficiencies of HGT of the susceptible recipient bacteria (3, 10, 19).  In two studies, in 
Enterococcus, pre-incubation with pre-MIC concentrations of tetracycline of a donor E. faecalis 
population was shown to enhance transposon HGT up to 119-fold when the donors were added 
to recipient B. thuringiensis bacterial cultures (44, 50).   
The objective of this study was to determine the effects on the conjugative transfer of a 
plasmid from Salmonella Typhimurium to E. coli C600N under in vitro conditions following 
exposure to oxytetracycline and/or NE. 
 
 Materials and methods 
Bacterial strains 
Salmonella Typhimurium strain 5678 (17) was used as the donor strain in all mating 
experiments.  This strain carries a type A plasmid that is approximately 100 kb in size, and is 
transferable by conjugation to the recipient E. coli C600N (a spontaneous nalidixic acid resistant 
mutant of strain C600 (17); kindly provided by Dr. Paul Fey at University of Nebraska Medical 
Center, Omaha, Nebraska). This plasmid contains a blaCMY-2 gene that encodes resistance to a 
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large spectrum of β-lactams including ampicillin, ceftriaxone and cefoxitin; as well as resistance 
markers for chloramphenicol, streptomycin, sulfisoxazole, trimethoprim-sulfamethaxozole and 
tetracycline (Table 1).  Based on sequence analysis, this plasmid is closely related to the well-
studied plasmid pNF1358, and the organization of the transfer genes is similar to that of IncI 
plasmid R64 (22) (Genbank DQ017661.1).  
 
MIC determination   
The MIC of oxytetracycline for donor and recipient strains was determined using a slight 
modification of micro-broth dilution method recommended by CLSI (34).  Briefly, ten 
microliters of a 0.5 McFarland bacterial suspension was pipetted into 11 mL of Luria-Bertani 
(LB) broth.  Aliquots of the bacterial suspension (100 μL) was added to the wells of a 96-well 
plate containing 100μL of increasing concentrations of oxytetracycline (Sigma, St. Louis, MO) 
in duplicates, for donor and recipient strains. The 96-well plate was placed in an incubated 
(37
o
C) spectrophotometer (SpectraMax 190, Molecular Devices, Sunnyvale, CA) set to read 
absorbance at 600 nm with readings taken hourly. The MIC was the lowest concentration at 
which optical density readings was reduced by 60% (24).  The MIC of Salmonella 5678 donor 
and E. coli C600N recipient strains for oxytetracycline was determined to be 60,000 and 62.5 
ng/ml, respectively. 
 
Pulse Field Gel Electrophoresis 
PFGE was conducted with Salmonella 5678, E. coli C600N, and selected transconjugants 
using standard methodologies (36). The DNA embedded in agarose was digested with XbaI and 
electrophoresed on a CHEF DR-III instrument (Bio-Rad, Richmond, CA) using the following 
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conditions: initial switching time, 2.2 s; final switching time, 63.8 s; total time, 19 h. Salmonella 
enterica serotype Braenderup H9812 (ATCC# BAA-664) was used as the standard (data not 
shown). 
 
Southern Blot  
DNA from the PFGE gel was tranfered to nitrocellulose or nylon membranes as 
described previously (42). A DIG labeled blaCMY-2 probe (Roche, Indianapolis, IN) was created 
using previously described primers (6, 17), and hybridization was detected using NBT/BCIP 
(Roche) (data not shown). 
 
Liquid mating experiments 
Broth cultures were used in all mating experiments to maintain uniform concentrations of 
antimicrobials and catecholamines, and for ease in the collection of representative samples at 
predetermined time points to evaluate conjugation frequencies and gene expression trends.  All 
Salmonella to E. coli matings were conducted in static Luria-Bertani (LB) broth.   
Liquid mating experiments between Salmonella and E. coli were conducted as previously 
described with some modifications (25).  The initial inocula (Salmonella strain 5678 and E. coli 
C600N) were grown individually for 18 h at 37°C under aerobic conditions with shaking (at 100 
rpm).  Overnight inocula were diluted 1:10 in fresh prewarmed LB broth free of antimicrobials 
for approximately 2hrs to attain an OD 600 of 0.3. Cultures were mixed at a ratio of 1:5 (donor 
to recipient) oxytetracycline was added to the mixed cultures at 0, 0.25, 0.5, 1, 1.5, 2, 4, 8, 16, 
32, and 64x MIC levels with and without 5μM of NE, and incubated at 37oC under aerobic 
conditions.  Samples were collected at 0, 2, 4, 6, 8, 10, 12, and 24hrs post-mixing and were 
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plated on HE-agar containing selective antibiotics (50µg/ml ampicillin for donor; 12 µg/ml 
nalidixic acid for recipient; and 50µg/ml ampicillin and 12µg/ml nalidixic acid for 
transconjugants) (25). Selected transconjugants were replica-plated on to ceftriaxone, cefoxitin, 
chloramphenicol, streptomycin, sulfisoxazole, and tetracycline to ensure all the resistance 
markers encoded on the plasmid were transferred.  These transconjugants were checked for the 
presence of the blaCMY-2 gene by PCR as previously described (55).  HGT ratios were determined 
by dividing CFUs/mL of transconjugant by CFUs/mL of donor bacteria, as described previously 
(21). 
 
Gene expression studies  
RNA was extracted from Salmonella and E. coli together, or Salmonella alone grown at 0 
through 64X MIC of oxytetracycline using the Trizol (Invitrogen, Carlsbad, CA) and was treated 
with DNase treatment kit (Invitrogen, Carlsbad, CA) to remove residual DNA to acquire samples 
with no threshold fluorescence before cycle 30.  A 16S ribosomal RNA target EUB (54) was 
used as a house-keeping gene to normalize total RNA yields. Quantitative RT-PCR was 
performed on listed primer sets (Table 2) using SuperScript III Platinum SYBR green One-Step 
qRT-PCR kit (Invitrogen, Carlsbad, CA) on a RealPlex PCR machine (Eppendorf, Hauppauge, 
NY). Expression profiles of plasmid and chromosomally encoded genes (calculated as fold-
changes using ΔΔCt method) are summarized in Figure 2.  A melt curve analysis was performed 
following all PCRs to confirm a single amplicon of adequate size. 
 
Data Analysis 
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Mean differences in the ratio of HGT and gene expression levels at various 
concentrations of NE were assessed for wild-type and mutant strains by paired t-tests performed 
using statistical functions included in GraphPad Prism version 5.00 for Windows (GraphPad 
Software, San Diego, CA).  The independent variables were oxytetracycline concentrations (with 
or without NE), hours post-mixing, and the types and levels of adrenergic antagonists added.  
Data is presented as means ± SEM, and differences were considered statistically significant when 
the probability of a type I error was <0.05.  Further analysis was performed using a mixed effects 
model, with a repeated measure over hours analysis in a one-way ANOVA, and "unstructured" 
as the type of variance component.  A Bonferroni test was used for post-hoc analysis. 
 Results 
Effects of NE and oxytetracycline on donor and recipient growth 
There was a dose-dependent decrease in the CFUs/mL of the drug-susceptible E. coli 
population as the concentration of oxytetracycline increased (Figure 1a).  The addition of 5μM of 
NE to the antimicrobials did not significantly enhance or suppress the effects of the 
oxytetracycline.  The drug-resistant Salmonella donor growth did not show any significant 
inhibition by the oxytetracycline or any enhancement with the addition of the 5μM NE (Figure 
1b). 
 
NE and oxytetracycline enhance HGT, but effects are not compiled 
Transfer of the conjugative plasmid occurred in all concentrations of oxytetracycline 
tested, both with and without NE.  As was shown in a previous study (unpublished data), a 
bimodal pattern emerged with the highest transfer efficiencies being observed below (0.25x – 
0.5x MIC) and above (1.5x – 64x MIC) 1 MIC (Figure 2a).  The addition of 5μM NE to each of 
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the concentration of oxytetracycline only increased HGT efficiencies significantly at 0 MIC.  A 
similar bimodal pattern was seen in transconjugant CFUs/mL with increases in population again 
below and above 1 MIC (Figure 2b).  The number of transconjugants was greater at 0 MIC with 
5μM NE (Figure 2b).  Successful transfer of plasmid was confirmed by subjecting randomly 
selected transconjugants to PCR analysis for blaCMY-2 gene (55),  and pulse field gel 
electrophoresis (PFGE) (6, 17, 42) followed by Southern blotting and hybridization to a 
previously described blaCMY-2 probe (5, 17).  Additionally, replica-plating in Hectoen enteric 
agar plates for plasmid encoded antimicrobial resistance phenotypes was also performed (data 
not shown).  Filter mating between randomly selected C600N transconjugants as donors and two 
Salmonella Typhimurium strains (LT2 700720 and 14028) or Citrobacter rodentium ICC 180 as 
recipients (Table 1), followed by PCR analysis for blaCMY-2 in the Salmonella and C. rodentium 
transconjugants confirmed successful transfer of the conjugative plasmid. Replica plating of 
randomly selected C. rodentium and Salmonella transconjugants on Hectoen enteric agar 
containing various antibiotics demonstrated that the plasmid-encoded AMR genes were also 
functional in these recipients (data not shown).  
 
Transfer gene expression 
The plasmid transfer (tra) genes present on the Salmonella 5678 type A plasmid were 
selected for gene expression analysis to upregulate in the presence of NE and oxytetracycline.  
Salmonella incubated alone with oxytetracycline upregulated tra gene expression when exposed 
to concentrations of oxytetracycline above the MIC of E. coli (8x – 64x MIC) (Figures 3a;3b).  
Interestingly, the addition of 5μM NE to increasing concentrations of oxytetracycline resulted in 
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the upregulation of the tra genes significantly above the fold changes caused by oxytetracycline 
alone in both traI and traY (Figure 3a;3b). 
 Discussion 
In this study we have presented evidence that the conjugative transfer of a plasmid from a 
clinical strain of Salmonella to a recipient E. coli was significantly affected by the addition of 
oxytetracycline and/or 5 μM NE.  Past studies showed significant increases in HGT when NE or 
oxytetracycline was added to the Salmonella to E. coli mating pair (unpublished data).  It was, 
however, unknown if the combination of NE and oxytetracycline would cause additive effects to 
conjugation efficiencies.  In the present study, we report that this particular mating pair had a 
limit to the enhancement of conjugal transfer efficiencies that was reached by the addition of NE 
or oxytetracycline, and this limit was not exceeded with the addition of the combination of the 
two (Figure 2a). 
A divergent result was found in the gene expression portion of this study.  Conjugative 
transfer of the type A plasmid involves a complex activation sequence of approximately 30 
different transfer (tra) genes for direct cell-to-cell mating (18).  We monitored expression of two 
tra genes I and Y by qRT-PCR analysis based on their abilities to respond to NE and 
oxytetracycline in past studies (Chapters 2; 3).  The traI (encoding a relaxase-helicase and is the 
central catalytic component of the multiprotein relaxasome complex responsible for beginning 
the conjugative DNA transfer) and the traY (which imparts single-strand DNA character to the 
oriT site) genes were monitored.  While maximizing limits were reached when HGT efficiencies 
were measured, gene expression studies showed a cumulative increase in tra gene expression 
when NE was added to increasing concentrations of oxytetracycline.  This may suggest that there 
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is a bottleneck-type effect between conjugative signals and actual conjugation at a critical, but 
unknown control point.    
 This study is relevant to human and animal health as stress and antimicrobial use often 
occurs in the same environment.  In wards including the ER, OR and ICU, stress levels are 
extremely high for patients with life-threatening afflictions, and to prevent infection, a wide 
variety of antimicrobials are used to inhibit bacterial infection.  In food animal health, the feedlot 
setting where small pens with multiple animals create stress, and antibiotics which serve as 
prophylactics and growth enhancers are mixed into the feed in less than inhibitory doses (9, 15).    
Perhaps due to this deadly combination we have witnessed the rise of vancomycin resistant 
Enterococcus (VRE) and vancomycin resistant Staplococcus aureus (VRSA) (13, 14, 20, 23, 39-
41, 49). 
This study for the first time attempts to determine the effects of catecholamines and 
antimicrobials on HGT.  While the combination of oxytetracycline and NE did not have a 
cumulative effect on HGT efficiencies, there was an intriguing enhancement of tra gene 
upregulation responsible for the transfer of the plasmid.  These results demonstrate complexity of 
the interactions between bacteria undergoing conjugative HGT as environmental factors are 
altered.  In the case of the present study, it was not sufficient to monitor bacterial actions on Petri 
dishes.  Only through gene expression analysis were we able to begin to define the complete 
picture.  Future investigation will further enhance our knowledge of how multiple elements 
contribute to efficiencies of conjugative HGT.   
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 Figures and Tables 
 
Figure 4.1 Growth averages (CFUs/mL) of mixed donor and recipient populations 
throughout the experiments with increasing concentrations of antimicrobials (x-axis) with 
and without 5μM of NE. Average growth of Salmonella 5678 (1a) and E. coli C600N (1b) 
are shown. 
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Figure 4.2 Conjugative transfer efficiencies (measured as log ratios) of type A conjugative 
plasmid from Salmonella to E. coli at increasing concentrations of oxytetracycline either 
with NE (black bar) or without NE (white bar) (2a).  Transconjugant numbers (CFUs/mL) 
in the presence of increasing concentration of oxytetracycline either with (black bar) or 
without NE (white bar) (2b).  An * indicates an increase significant at p value <0.05, ** 
indicates significant increase at p value <0.01, and *** indicates a significant increase at p 
value <0.001 compared to 0 MIC. 
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Figure 4.3 Gene expression studies for plasmid transfer (tra) genes traI (3a), and traY (3b) 
in Salmonella exposed to increasing concentrations of oxytetracycline with NE (black bar) 
or without NE (white bar).  An * indicates an increase significant at p value <0.05, ** 
indicates significant increase at p value <0.01, and *** indicates a significant increase at p 
value <0.001 compared to 0 MIC. 
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Table 4.1 List of isolates used in this study.    
Strain Species 
AMR 
Phenotype 
Plasmid Type Reference 
5678 Salmonella enterica Typhimurium ACSSuTCroFx A (17) 
5561 Salmonella enterica Newport ACSSuTCroFx C (17) 
C600N E. coli Nal N/A (17) 
MG1655N E. coli Nal N/A (38) 
ICC 180 Citrobacter rodentium luxCDABE Nal, K N/A (46, 47) 
14028 S. enterica Typhimurium UKN N/A (ATCC# 14028) 
LT2 S. enterica Typhimurium UKN N/A (ATCC# 700720) 
Abbreviations: A, ampicillin; C, chloramphenicol; S, streptomycin; Su, sulfisoxazole; T, tetracycline; K, 
kanamycin; Cro, ceftriaxone; Fx, cefoxitin, N, nalidixic acid 
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Table 4.2 Complete list of primers used in this study. 
Primer 5’ to 3’ Sequence 
Product 
Size 
Reference 
Antimicrobial 
Resistance 
   
blaCMY-2 F GACAGCCTCTTTCTCCACA 101 bp (49) 
blaCMY-2 R GAATAGCCTGCTCCTGCATC  (Modified) 
Transfer Genes    
traI F TTGTCTTCCTTCCTGCCATC 163 bp (This study) 
traI R TGAACGCTTTGTCAGCAATC   
traY F TGCGACGAAACTCAGTATGC 153 bp (This study) 
traY R GGAAGCATGTTCTGGGTGTT   
Positive Controls    
EUB F TGGAGCATGTGGTTTAATTCGA 161 bp (48) 
EUB R TGCGGGACTTAACCCAACA   
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 Abstract 
Successful printing and hybridization is essential for efficient and reliable data 
acquisition in a spotted microarray experiments. In this study we demonstrated that printing a 
25mer (printed 25mer) with a standard 70mer probe in each spot followed by the use of a 
fluorescently labeled 25mer complement in the hybridization mixture ensures monitoring overall 
printing quality of the chip.  This system can also be used as a control to evaluate adequate 
hybridization, washing, and alignment of spots to position the tracking grids during scanning.  A 
print correction value incorporated in data analysis enhances consistency and reliability of 
results.    
 Introduction 
Spotted microarrays are reliable, efficient, and relatively inexpensive tool used in 
diagnosis of infectious diseases in laboratories (Chittur, 2004, Ojha and Kostrzynska, 2008).  
The customizable feature of spotted array makes it a very important technique in molecular 
analysis, especially in the field of pathogenic microbiology where preprinted arrays (such as 
Affymetrix) are unavailable or can be very expensive.  The importance of uniformity in printing 
of oligonucleotide on glass slides is an essential step to attaining usable and accurate data.  In 
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order to assess quality of spotted array printing, fluorescently labeled oligomers (3-6mers) 
(SpotQC, IDTDNA, Coralville, IA), and SYBR Green II, which binds to ssDNA, have been used 
(Battaglia et al., 2000, Gupta et al., 2007, Tran et al., 2002).  While these strategies do allow for 
visualization and assessment of the overall printing, sacrificing a chip for this type of analysis 
can be expensive, and the chip used may not be representative of the entire series that was 
printed.  Additionally, poor printing of even a limited number of oligos on the untested slides 
could potentially lead to important genes being false negatives.   
Some methods have been developed to address this problem, including the addition of a 
fluorescein label to each printed 70mer probe (Hessner et al., 2003), or by co-printing a labeled 
70mer probe with each standard 70mer (Hessner et al., 2004).  While they are beneficial for print 
checking on every chip, they do not address the important aspect of its use as control to 
normalize variations associated with hybridization.   
Hybridization controls are important for use in microarray experiments,  but the currently 
available systems, such as external RNA controls, ArrayControl™ (Ambion, Austin, TX) or 
ToxArray
TM
 involve multiple probes and complex algorithms, and are expensive to set up and 
perform (van Bakel and Holstege, 2004, Yauk et al., 2006).  In another study, a 40mer control 
was printed alongside the standard 40mer probe.  A complement for the co-printed 40mer was 
used to evaluate hybridization efficiency (Zhao et al., 2006).  The effects of such probe-
complement system on the binding of fluorescently labeled sample DNA to the standard 40mer 
or its ability to correct for variations due to printing was not described.  In this study, our goal 
was to identify an inexpensive hybridization system that would serve as a reliable printing and 
hybridization controls that can be used on every chip without affecting the efficiency of 
hybridization of the probes.  We describe the use of a unique 25mer oligonucleotide (printed 
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25mer) that is printed in the same spot as the standard 70mer.  The hybridization mixture 
contains fluorescently labeled sample DNA along with the fluorescently labeled 25mer 
complement (25mer complement) that allows for easy and consistent visualization of spots 
containing the printed 25mer. This system is subtle enough to prevent inhibition of binding of 
fluorescently labeled sample DNA to printed oligos and is specific and flexible enough to be 
used at a wide range of hybridization temperatures. Additionally, it has allowed for development 
of an analysis method called Print Correction Value for normalization in a diagnostic microarray.  
 Materials and Methods  
2.1 Development of 25mer probe  
A 25 oligomer sequence was chosen by first generating an arbitrary sequence of 25 
nucleotides that at the time of its selection had no matching sequences on a BLAST search.  If 
any matches were identified, the entire sequence was reshuffled until an appropriate sequence 
was determined.  Possible candidate oligos were checked for secondary structures and self-
dimers using the OligoAnalyzer 3.0 software (IDT, Integrated DNA Technologies, IA).  Single 
nucleotides were changed and analyzed until the sequence 5‟-
GGATGCTAGATCGTGTGCTCTCGCC-3‟ was found.  A complementary sequence 5‟-
GGCGAGAGCACACGATCTAGCATCC-3‟ was then synthesized (IDT) with either a 5‟ Cy3 
or Cy5 dye attachment.  
Modifications to 25mer sequence was carried out by incorporating degenerate nucleotides 
(A,T,G,or C represented by N; IDT) in different positions in the printed 25mer sequence.  
Overall intensities were monitored for each of these sequence modifications, and compared to 
the control 25mer. 
2.2 Microarray chip printing  
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25mer primers with sequence modifications (Table 1) were created and printed in 
replicates of ten on UltraGap slides (Corning Inc., Corning, NY).  Two fields containing the 
oligos, at 35 M concentrations were printed using a Genetix QArray2 System slide printer 
(Genetix, New Milton, UK).  The fluorescent hybridization signals from the array were 
visualized using a GenePix 4000B slide reader (Molecular Devices, Sunnyvale, CA) and 
matched to the GenePix Array List (GAL) file previously created by the microarray slide printer.  
The 70mer primers; Salmonella-specific gene invA (Chiu and Ou, 1996) and the positive control 
EUB targeting the 16S ribosomal RNA gene for all eubacteria (Yang et al., 2002) were printed 
alone or in combination with each of the modified 25mer primers.  
2.3 DNA labeling 
Genomic DNA from Salmonella enterica DT104 was directly labeled with the BioPrime 
Plus Array CGH Genomic Labeling System (Invitrogen, Carlsbad, CA), with slight 
modifications.  After random primer incorporation, 1.5L of 1mM Cy3 or Cy5-dCTP 
(Amersham, Piscataway, NJ) was spiked in to increase overall fluorescence signal.  Dye 
incorporation and amplification was checked by the microarray feature on a Nanodrop ND-1000 
spectrophotometer (Nanodrop-Thermo Fisher Scientific, Wilmington, DE). 
2.4 Hybridization 
After labeling, the genomic DNA was mixed with a 2X Hybridization Solution 
(GeniSphere, Hatfield, PA) and 1L of 1nM stock of either Cy3 or Cy5-labeled 25mer was 
added to the mixture.  The mixture (total volume of 30L) was heated to 80ºC for 5 minutes and 
then added onto the prepared chips.  The functional temperature range of the 25mer complement 
was determined by overnight hybridization to printed slides in water baths or incubators at 
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temperatures 42ºC, 47ºC, 53ºC, 59ºC, and 65ºC.  This test was performed three times, and colors 
of Cy dyes switched each time.  
2.5 Sample scoring 
To determine if the signals were positive, a previously described method by Frye et. al 
was employed (Frye et al., 2006).  The average of the median fluorescence signal for each spot 
was divided by average of the median fluorescence emitted by all spots on the chip to acquire a 
ratio.  This value was called the relative signal intensity, and a threshold of 2.0 or above was 
considered positive.   
2.6 Statistical analyses   
Unpaired t-tests were performed using statistical functions included in Microsoft Excel 
(Microsoft Corp., Seattle, WA) and GraphPad Prism version 5.00 for Windows (GraphPad 
Software, San Diego, CA).  A p-value of < 0.05 was considered significant. 
 Results 
3.1 Changes in affinity with increasing temperature 
At low temperatures, the control 25mer produced the highest relative signal intensity, but 
as temperatures increased, there was a net decrease in relative signal intensities (Figure 1).  The 
exceptions to this trend were oligos 11 and 5 which had NNN tag on the 3‟ end and a single N on 
the 5‟ end, respectively (Table 1).  As the hybridization temperature increased (42°C to 65°C), 
the relative intensities of these oligos began to increase, probably due to a relaxation of 
secondary structures on the chips (Table 2), as determined by using AutoDimer v1 software 
(http://www.cstl.nist.gov/div831/strbase/AutoDimerHomepage/AutoDimerProgramHomepage.ht
m) (Vallone and Butler, 2004).   
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The 25mer complement was able to bind to the printed 25mers up to hybridization 
temperatures of 59ºC.  Even at a hybridization temperature of 65ºC there was still fluorescent 
signal present; however, lower temperatures ranging between 42ºC and 53ºC were optimal.  At 
no temperature did the 25mer complement bind to spots that had only 70mers (Figure 1). 
3.2 Changes in affinity with increasing modifications 
Affinity of binding was determined by different sequence modifications of the 25mer 
complement.  As the number of modifications to the printed 25mer increased (Table 1), there 
was an overall reduction in their relative signal intensities (Figure 1).  This was exemplified in 
modified probes 13, 14, 15, 16, 17, and 19 (in which Ns were added into the middle of the 
printed 25mer), where there were rapid reduction in relative signal intensities as the number of 
Ns increased (Table 1 and Table 2).   
3.3 Co-detection assay 
Co-detection assays using 25mer complement and fluorescently labeled Salmonella 
enterica DNA were performed to determine the effects of the 25mer on the hybridization of the 
bacterial DNA.  The labeled 25mer complement was able to hybridize to the printed 25mer, and 
the labeled genomic DNA was able to hybridize to Salmonella-specific probes. The most optimal 
temperature range for these reactions was between 42ºC and 47 ºC, where no statistically 
significant differences in fluorescence signal were observed between the 25mer + 70mer and the 
70mer alone.  As temperature increased, there was statistically significant reduction in relative 
signal intensities of the 25mer + 70mer spots compared to the 70mer spots alone.  Interestingly 
for invA, printing 25mer + 70mer actually had better relative signal intensities compared to 
70mer at 47 ºC (Figure 1).   
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Oligo probes numbers 18 and 20 which had fluorescence intensities similar to that of the 
unmodified 25mer in the affinity assays (Table 2), were shown to inhibit the overall 
hybridization functions of the 70mer (data not shown), when co-printed with 70mer.  Thus, the 
original, unmodified printed 25mer was shown to be the best for use in co-detection assays.  In 
other words a combination of a printed 25-mer and its exact complement had optimal 
hybridization kinetics for use in this control system.   
The optimal temperature for use of the printed 25mer was determined to range from 42ºC 
to 47ºC.  However, it should be noted that we performed labeling of the genomic DNA only 
using BioPrime Plus Array CGH Genomic Labeling System, and use of another kit or alternate 
(SDS-based) hybridization buffers would possibly yield increased functionality at higher 
hybridization temperatures.  
3.4 Print correction value   
In order to correct for possible printing variations (over-printing or under-printing) with 
spotted array, this 25mer probe-complement system can be used to normalize the signals from 
the 70mer by a Print Correction Value (PCV). The PCV can be defined as the ratio of the mean 
of the median 25mer signals of a particular spot, and the mean of median 25mer signal of all 
spots on the chip.  The 70mer value (numerator) will then be divided by this PCV (denominator) 
on that spot to adjust printing variation (Figure 2).  
PCV = 25mer value / mean or median net 25mer values  
Corrected value of 70mer  = 70mer value / PCV  
This method is based on the assumption that printing variation is normally distributed and 
should be tested for each study using frequency distribution charts.  If the assumption were found 
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to be not true, subpopulations and/or outliers should be identified and these values should be 
accounted for by using a non-parametric summary statistic (e.g., median) as an estimate of the 
PCV.  This PCV method has been used in microarrays in our laboratory and has provided us with 
additional confidence in the data acquired in our experiments (data not shown). 
3.5 BLAST results 
When the 25mer was originally designed (fall 2006), there were no similarity to any 
sequence deposited in GenBank.  However, our 25mer sequence has recently shown some 
limited homologies to a few recently submitted sequences on a blastn search using the megablast 
option for highly similar sequences.  Depending on the host system (bacterial, Drosophila, 
mouse, human, etc.), it would be relatively simple to identify a new 25mer that has no sequence 
homology to any genes that they will likely encounter in that system, for its use as a printing and 
hybridization control. 
 Discussion 
4.1 Use in diagnostic arrays 
Our 25mer system is ideal for incorporation in the newly developing field of diagnostic 
microarray (Chandler et al., 2006, Dankbar et al., 2007, Frye, et al., 2006, Kostic et al., 2007, Li 
et al., 2006, Perreten et al., 2005, Strommenger et al., 2007, Tembe et al., 2007, Tomioka et al., 
2005, Volokhov et al., 2002, Yu et al., 2004) as it is useful in nearly all steps of a DNA 
microarray experiments (Figure 3).  This system will eliminate false negative readings due to 
lack of printing of the oligos, ensuring that a negative in this test is a true negative.  The 25mer is 
not only useful for determination of printing and its variations; it is also useful for checking 
overall hybridization results of an array.  Any type of technical mishaps during hybridization 
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steps including air bubbles, shifted cover slips, unequal distribution of hybridization mix, 
improper buffer concentrations, improper hybridization temperatures etc., can be easily 
visualized and accommodated when analysis of the data is performed.   
This system will allow the user to detect and optimize slide washing procedures.  Often 
times, when new microarray protocols are being developed, determining the appropriate washing 
conditions (stringency and duration) can be challenging, time consuming and expensive; 
especially if chips are lost in the work-up process.  Being able to visualize the quality of each 
printed spot after washing provides us greater knowledge on the molecular kinetics of 
hybridization that occurs between printed probes and labeled targets, and will allow for 
optimization of the washing temperatures.   
In routine scanning of spotted array slides, fluorescent spots representing the positive 
controls are essential to align tracking files.  The use of the 25mer in printed spots makes this 
alignment of the tracking files simple and easy as each and every printed spot is visualized and 
detected by the software, allowing for less time spent positioning the tracking grids.  Finally, 
incorporation of the 25mer allows for increased confidence in the data acquired by allowing for 
easy identification of problem spots due to hybridization problems, and by use of a print control 
calculation to account for any printing issues.  This control system can be adapted easily in a 
three-color microarray by using complementary probes that have different fluorescence emission 
wavelength compared to that of the samples.   
The only steps which it will not be of benefit would be during the initial design and 
synthesis of the 70mer oligos.  Caution will have to be taken in these stages to ensure that the 
25mer used will not cross-react with any of the 70mers designed or with any of the labeled 
sample DNA (see above).  The 25mer system will not eliminate false prints (switched oligos), 
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cross reactions, or lack of hybridization due to incorrect probe design.   
4.2 Conclusions 
We have presented in this study a 25mer control system that is easy and inexpensive to 
use, and provides consistent results in spotted microarray.  The ability to check every microarray 
chip for printing and hybridization efficiency allows for greater confidence and enhances 
reliability in the obtained results.      
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 Figures and Tables 
 
Figure A.1 Box plot of representative trial (T3) of co-detection experiment.  The p-values 
ofeach 70mer with and without 25mer are listed above each box plot.  For invA 47°C 
(marked with *) the addition of the printed 25mer caused a significant increase in 70mer 
fluorescence signal, though this was not generally typical at this temperature. 
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Figure A.2 Appearance of 25mer on microarray chip as detected by GenePix 4000B two 
color scanner. Figures A.2a and A.2d show labeled DNA bound to 70mer oligos (Cy 5 and 
Cy3 respectively).  A.2b and A.2e show two-color ratio scan of labeled oligos. Figures A.2c 
and 296 nd A.2f show hybridization of labeled 25mer (Cy 3 and Cy 5 respectively) to its 
printed 25mer target. Variations in printing that is present in A.2c and A.2f can be 
corrected by the Print Correction Value option that the 25mer offers. 
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Figure A.3 Flow chart of microarray work flow showing which steps are benefited by the 
addition of the 25mer printing and hybridization system. 
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Table A.1 Complete list of all oligos with modifications used in this study.  Column marked 
rank indicates the oligos producing the most fluorescent signal at 42°C. 
 
Probe Name Probe Sequence Rank 
Printed 25mer GGATG CTAGA TCGTG TGCTC TCGCC 1 
oligo 1 NGATG NTAGA TCGTG TGCTC TCGCC 6 
oligo 2 NGATG NTAGA NCGTG TGCTC TCGCC 17 
oligo 3 NGATG NTAGA NCGTG NGCTC TCGCC 19 
oligo 4 NGATG NTAGA NCGTG NGCTC NCGCC 22 
oligo 5 NGATG CTAGA TCGTG TGCTC TCGCC 2 
oligo 6 GGATG NTAGA TCGTG TGCTC TCGCC 13 
oligo 7 GGATG CTAGA NCGTG TGCTC TCGCC 11 
oligo 8 GGATG CTAGA TCGTG NGCTC TCGCC 12 
oligo 9 GGATG CTAGA TCGTG TGCTC NCGCC 5 
oligo 10 GGATG CTAGA TCGTG TGCTC TCGCN 14 
oligo 11 GGATG CTAGA TCGTG TGCTC TCGCCNNN 9 
oligo 12 NNNGGATG CTAGA TCGTG TGCTC TCGCC 7 
oligo 13 GGATG CTAGA TCGNNNTG TGCTC TCGCC 4 
oligo 14 GGATG CTAGA TCNTG TGCTC TCGCC 16 
oligo 15 GGATG CTAGA TCNNG TGCTC TCGCC 15 
oligo 16 GGATG CTAGA TNNNG TGCTC TCGCC 20 
oligo 17 GGATG CTAGA TNNNN TGCTC TCGCC 10 
oligo 18 NNNNN CTAGA TCGTG TGCTC TCGCC 3 
oligo 19 GGATG CTAGA NNNNN TGCTC TCGCC 21 
oligo 20 GGATG CTAGA TCGTG TGCTC NNNNN 8 
oligo 21 NNNNN CTAGA NNNNN TGCTC TCGCC 23 
oligo 22 GGATG CTAGA NNNNN TGCTC NNNNN 24 
oligo 23 NNNNN CTAGA NNNNN TGCTC NNNNN 26 
oligo 24 NNNNN NNNNN NNNNN NNNNN NNNNN 25 
oligo 26 NNNNN CTAGA TCGTG TGCTC NNNNN 18 
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Table A.2 Results of each probe and each trial (T1, T2, T3) by temperature.  Black 
rectangles indicate positives and white rectangles indicate negatives.  No hybridization 
occurred for T1 at 65°C, so data was not analyzed. 
 
  
T1 
42°C 
T 2 
42°C 
T 3 
42°C T1 47°C T2 47°C T3 47°C T1 53°C T2 53°C T3 53°C T1 59°C T2 59°C T3 59°C T1 65°C 
T3 
65°C 
25mer                 
25mer EUB                  
25mer invA                
EUB only                             
invA only                             
oligo 1                 
oligo 1 EUB                  
oligo 1 invA                     
oligo 2                  
oligo 2 EUB                         
oligo 2 invA                        
oligo 3                        
oligo 3 EUB                          
oligo 3 invA                            
oligo 4                            
oligo 4 EUB                            
oligo 4 invA                            
oligo 5                 
oligo 5 EUB                  
oligo 5 invA                    
oligo 6                 
oligo 6 EUB                     
oligo 6 invA                  
oligo 7                
oligo 7 EUB                   
oligo 7 invA                      
oligo 8                 
oligo 8 EUB                  
oligo 8 invA                    
oligo 9                 
oligo 9 EUB                     
oligo 9 invA                     
oligo 10                
oligo 10 EUB                     
oligo 10 invA                   
oligo 11                
oligo 11 EUB                 
oligo 11 invA                   
oligo 12                 
oligo 12 EUB                
oligo 12 invA                  
oligo 13                       
oligo 13 EUB                             
oligo 13 invA                           
oligo 14                 
oligo 14 EUB                    
oligo 14 invA                   
oligo 15                    
oligo 15 EUB                    
oligo 15 invA                            
oligo 16                          
oligo 16 EUB                            
oligo 16 invA                            
oligo 17                      
oligo 17 EUB                             
oligo 17 invA                             
oligo 18                  
oligo 18 EUB                    
oligo 18 invA                  
oligo 19                            
oligo 19 EUB                            
oligo 19 invA                             
oligo 20                     
oligo 20 EUB                        
oligo 20 invA                        
oligo 21                            
oligo 21 EUB                             
oligo 21 invA                            
oligo 22                             
oligo 22 EUB                             
oligo 22 invA                           
oligo 23                             
oligo 23 EUB                            
oligo 23 invA                             
oligo 24                             
oligo 24 EUB                             
oligo 24 invA                             
oligo 26                           
oligo 26 EUB                             
oligo 26 invA                            
buffer                             
none                             
131 
 
 
Appendix B - Diagnostic Microarray for Human and Animal 
Bacterial Diseases and Their Virulence and Antimicrobial 
Resistance Genes 
Greg Peterson 
1
, Jianfa Bai
1
, T.G. Nagaraja 
1
 and Sanjeev Narayanan 
1 
Accepted for publication in Journal of Microbiological Methods 80:223-230, 2009 
Department of Diagnostic Medicine / Pathobiology, Kansas State University 
College of Veterinary Medicine, Manhattan, KS 66502 
1
 
 
 Abstract 
Rapid diagnosis and treatment of disease is often based on the identification and 
characterization of causative agents derived from phenotypic characteristics.  Current methods 
can be laborious and time-consuming, often requiring many skilled personnel and a large amount 
of lab space.  The objective of our study was to develop a spotted microarray for rapid 
identification and characterization of bacterial pathogens and their antimicrobial resistance 
genes.  Our spotted microarray consists of 489 70mer probes that detect 40 bacterial pathogens 
of medical, veterinary and zoonotic importance (including 15 NIAID Category A, B and C 
pathogens); associated genes that encode resistance for antimicrobial and metal resistance; and 
DNA elements that are important for horizontal gene transfer among bacteria.  High specificity 
and reliability of the microarray was achieved for bacterial pathogens of animal and human 
importance by validating MDR pathogenic bacteria as pure cultures or by following their 
inoculation in complex and highly organic sample matrices, such as soil and manure.   
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 Introduction 
Laboratory diagnoses of bacterial diseases continue to be predominantly cultivation-
based methods, including isolation, identification and antimicrobial susceptibility 
determinations.  Molecular methods, such as PCR, have enhanced detection abilities and have 
replaced traditional methodologies for many infections (Versalovic & Lupski 2002; Sabat et al. 
2006).  However, the limitations of PCR include expense and human hours involved in 
developing and optimizing each assay, especially those that are specialized, such as multiplex-
PCR, Real Time PCR, etc.  Although high throughput PCR amplification and fluorescence-based 
detection systems have improved the number of target genes detectable (Brenan et al. 2005; 
Lucero & Spurgeon 2007), the number of genes detected in parallel is considerably less 
compared to microarray methodologies.   
DNA microarrays, which work on nucleic acid hybridization principles, are widely used 
and have multiplex capability to detect hundreds of thousands of genes in a single experiment 
(Bryant et al. 2004).  Spotted DNA microarray platforms are cost-effective, flexible and easy to 
use in any laboratory with basic facilities and equipment (Chittur 2004).   
Most species of pathogenic bacteria have strains that vary in their disease-causing 
abilities (virulence).  Such variations have been associated with virulence factors that provide a 
selective advantage to bacteria‟s parasitic lifestyle compared to less virulent strains belonging to 
the same species.  Therefore, an approach that focuses on detecting genes that encode these 
virulence factors is essential to identify and characterize bacterial pathogens.  Many of these 
genes are carried on horizontally transferable genetic elements, such as pathogenicity islands, 
lysogenic phages, plasmids, etc (Galan & Curtiss 1989; Chiu & Ou 1996; Paton & Paton 1998; 
Plunkett et al. 1999).  Screening bacterial strains for such genetic elements can provide 
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understanding on the mode of acquisition of the virulence factors by that particular strain and can 
establish a clonal relationship between isolates.   
Antimicrobial resistance is considered to be the cause of the next pandemic, and with the 
horizontal transfer of multidrug resistant (MDR) plasmids and transposons being a factor, 
potentially deadly strains are on the rise (Phillips et al. 2004).  The significance of MDR bacteria 
is exemplified by vancomycin-resistant Enterococcus (VRE), which can not only withstand 
treatments with the most powerful antimicrobials but also has shown the ability to horizontally 
transfer the resistance genes to other species of bacteria (CDC 2002; Ray et al. 2003; NNIS 
2004).  
Intraspecies and interspecies horizontal transfer of genetic elements packaged as plasmids 
or transposons is an integral part of survival and evolution for many bacterial species and is often 
accomplished through bacterial conjugation (Thomas & Nielsen 2005).  Horizontal transfer of 
virulence and antimicrobial resistance genes between bacteria has had a considerable impact on 
human and animal health and on medical practices (van den Eede et al. 2004) as demonstrated 
by the occurrence of VRE and methicillin resistant Staphylococcus aureus in ecosystems where 
they cohabitate with other pathogens (Hiramatsu 1998; Rice 2001; CDC 2002; Khan et al. 2002; 
DeLisle & Perl 2003; Ray et al. 2003; Rosenberg et al. 2004; Rice 2006; Tiwari & Sen 2006).  
Another significant group of genes that is horizontally transferred is the group that encodes metal 
resistance.  Since these genes are frequently present in close proximity to the antimicrobial 
resistance (AMR) genes, selection for metal resistance may select for AMR genes and vice versa 
(Hasman & Aarestrup 2002; Hasman 2005; Hasman et al. 2006).   
The objective of this study was to develop a spotted microarray that is capable of 
identifying pathogenic bacterial species based on their virulence factors and characterizing them 
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based on the presence of antimicrobial resistance genes, DNA segments essential for horizontal 
transfer of genetic material and genes for metal resistance.  The objective included validation of 
the array using MDR pathogenic bacteria as pure cultures and following their inoculation into 
complex and highly organic sample matrices like soil and manure.   
 
 Materials and Methods 
2.1.  70mer oligo development and selection   
Conserved regions (300 to 400 bp) of the genes that encode virulence factors, 
antimicrobial resistance and metal resistance were identified by reviewing current literature 
available at PubMed (www.ncbi.nlm.nih.gov).  One or more oligonucleotide probes 
(approximately 70 bp; 70mers) were identified for each gene using Picky 2.0 (size: 65-75mer 
with 40-60% GC content; Iowa State University, Ames, IA) and Oligowiz 2.1.0 (size: 70mer, 
with default settings; CBS, Lyngby, Denmark); and a consensus probes were selected for 
printing.  The specificity of the selected sequences was confirmed by a blastn search 
(www.ncbi.nlm.nih.gov) in the GenBank database.  Positive hybridization controls, based on 16S 
rRNA sequences (EUB (Yang et al. 2002), Frye 1, 2, and 3 [personal communication, Dr. 
Jonathan Frye]) 23S rRNA, and the beta subunit of RNA polymerase (rpoB (Aliyu et al. 2004)) 
were also synthesized and printed.  Negative controls including H2O only, hybridization buffer 
only and a 25 bp DNA probe without homology to any listing in GenBank were also printed 
(Peterson et al. 2009).  Probes were synthesized by Invitrogen (Invitrogen Co., Carlsbad, CA) 
and Operon Biotechnologies (Operon, Huntsville, AL).  A total of 113 virulence genes from 43 
pathogenic bacteria, 227 AMR genes conferring resistance to 30 antimicrobials, 99 genes that 
encode resistance from 20 metals, 31 horizontally transferable elements and 7 positive control 
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oligos were chosen for this study.  The entire list of the genes and their 70mer probe sequences is 
provided in Table 1 (supplemental).   
2. 2.  Microarray oligomer printing   
A complete array containing 489 70mer oligos was printed at a concentration of 35µM in 
replicates of 3, 10 or 16.  Two identical fields were printed on each Ultra Gap slide (Corning, 
Lowell, MA) using a Genetix QArray2 System slide printer (Genetix, Hampshire, UK) 
crosslinked in a UV Stratalinker 2400 (Stratagene, La Jolla, CA) at 600μJ, and stored in the dark 
at room temperature until used. 
2.3.  Bacterial cultures   
DNA was isolated from the following bacterial strains: Enterococcus faecalis V583 
PMV158GFP (Dr. Lynn Hancock, Kansas State University, gfp, asc10, asa1, ermBCT, and vanB 
positive), Enterococcus faecium R2-Tx5034 (Dr. Ludek Zurek, Kansas State University, esp, 
ermBCT, and vanA positive), Escherichia coli  O157:H7 (ATCC 43894; eae, stx1, and stx2 
positive), E. coli O157 Neo 5-13-005 (clinical isolate with  a plasmid  containing aphA1 gene 
that encodes for neomycin resistance), Salmonella Typhimurium DT104 (ATCC 700408; invA 
and spvC positive, sopE negative), Salmonella Munster (T. G Nagaraja, Kansas State University, 
invA and sopE positive) and Fusobacterium necrophorum subspecies necrophorum strain A25 
(T. G Nagaraja, lktA, and HAEM positive).   
2.4.  DNA isolation   
Pure cultures of Salmonella Typhimurium DT104, Enterococcus faecalis V583 
PMV158GFP,  and E. coli O157:H7 were grown overnight at 37
o
C in 5 ml of TSB culture 
media, and F. necrophorum A25 were grown overnight at 37
o
C in 5 ml of pre-reduced 
anaerobically sterilized brain-heart infusion broth (PRAS-BHI).  DNA was extracted using a 
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DNeasy Blood & Tissue kit (Qiagen, Valencia, CA).   
2.5  DNA extraction from environmental samples 
DNA from bacteria-spiked manure and soil samples was isolated using a FastDNA Spin 
kit for Soil (MP Biomedicals, Solon, OH) and further purified using Geneclean Turbo kit (MP 
Biomedicals).  This stepwise procedure was selected for DNA isolation from soil because it 
provided consistently higher yields and quality of DNA as shown by Nanodrop ND-1000 
spectrophotometer (Nanodrop, Wilmington, DE) than all other kits used in our studies, including 
PowerSoil DNA kit (Mo Bio, Carlsbad, CA), UltraClean Fecal DNA kit (Mo Bio), Qiagen 
RNA/DNA Mini Kit (Qiagen, Valencia, CA), and QIAamp DNA Stool Mini kit (Qiagen, 
Valencia, CA).   
A protocol that combined the FastDNA Spin kit for soil (MP Biomedicals) followed by 
purification using Geneclean Turbo kit (MP Biomedicals) was effective in extracting adequate 
amounts of  DNA from flies (personal communication, Dr. Ludek Zurek), soil and cattle manure 
as well as water and fecal samples from dogs and cats (Narayanan, et al., unpublished data).  The 
labeling and hybridization protocols are optimized in such a way that the same protocol could be 
used on all samples (pure cultures or complex matrices).  Therefore, no modifications were 
necessary to perform microarray analysis of bacteria from soil and cattle manure, as well as from 
water and fecal samples from dogs and cats.   
2.6.  Environmental samples   
Manure samples were surface-grabbed from feedlot cattle pens and mixed to represent 
many animals in individual pens.  The soil samples at depths of 15.2 cm were collected from a 
corn field near the feedlot.  Salmonella Typhimurium DT104 was added to manure and soil at 
concentrations of 10
10
, 10
8
, 10
6
, 10
4
, and 0 (i.e. unspiked) CFUs/g.  Total DNA from these 
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samples was isolated, fluorescent labeled and used for hybridizing microarray chips (see below).  
A second series of spiking experiments was conducted using Enterococcus faecalis strain V583 
PMV158GFP at concentrations of 10
10
, 10
9
, 10
8
, 10
7
, 10
6
, 10
5
, and 10
4
 CFUs/gram in manure 
and soil samples.   
2.7.  Bacterial isolation from environmental samples    
The viability of the bacteria spiked into manure and soil samples was assessed by 
suspending 250 mg of each environmental sample in 2.5 ml of PBS.  Serial dilutions of this 
suspension were plated on Brilliant Green agar (BD, Franklin Lakes, NJ) containing 10μg/ml 
tetracycline and 10μg/ml ampicillin (both antibiotics from Sigma, MO) was used for Salmonella 
Typhimurium DT104.  Salmonella isolates from plates were confirmed using a Salmonella Poly 
O antigen sera agglutination test (Oxoid Inc., Ontario, Canada).   
M-Enterococcus agar (BD, Franklin Lakes, NJ) with 10 μg/ml vancomycin (Sigma, St. 
Louis, MO) was used as a selective medium for Enterococcus faecalis V583 PMV158GFP.  The 
identity of the strain was confirmed by their green fluorescence under UV light when grown on 
TSA plates.  
2.8.  Enrichment of environmental samples  
Single colonies of E. coli O157 (ATCC 43890, 4055397, 4064932, or 4027993) were 
grown on TSA plates overnight at 37C, and was inoculated in 10mL of TSB and incubated 
overnight in a shaking airbath (37C, 150 rpm). 1ml of the overnight cultures were mixed with 
10ml of fresh TSB and incubated for an additional 6 hours to allow the bacteria to attain log 
phase growth.  The bacterial suspensions were centrifuged at 5000 x g for 10 minutes, and the 
pellets were resuspended in 1ml TSB.  Serial dilutions were made in TSB and 200µl of the 
diluted bacterial suspensions were mixed with 1g of autoclaved cattle feces.  The final 
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concentrations of E. coli, as determined by plating, were 10
9
, 10
8
, 10
7
, 10
6
, 10
5
, 10
4
, 10
3
, 10
2
 and 
10
1 
CFUs/g.  Unspiked manure was again used as a negative control.  Enrichment of fecal 
samples was carried out in Gram Negative (GN) (Greenquist et al. 2005; Jacob et al. 2008a) 
which contained Cefixime (0.5µg/ml) (Dynal, Lake Success, NY), Cefsulodin (10µg/ml) (Sigma, 
St. Louis, MO), and Vancomycin (8µg/ml) (Sigma, St. Louis, MO).  After incubation (37C, 150 
rpm), DNA was extracted from 250µl of the solution using the FastDNA Spin kit for soil (MP 
Biomedicals) followed by purification using Geneclean Turbo kit (MP Biomedicals) as described 
above.  Presence of the bacteria was determined by a positive signal of a microarray probe or a 
PCR specific for the O antigen-specific polymerase of E. coli O157 (O157 wzy) (Table 1; Table 
1 Supplemental).  The unspiked manure sample failed to show the presence of this gene even 
after enrichment. 
2.9.  DNA labeling and hybridization   
DNA from all sources was labeled directly using the BioPrime Plus Array CGH Genomic 
Labeling System (Invitrogen Co., Carlsbad, CA) per the manufacturer‟s protocol with slight 
modifications.  After random primer incorporation, an additional 1.5 μl of 1 mM Cy3 or 1 mM 
Cy5-dCTP (Amersham, Piscataway, NJ) was added to the labeling mixture to improve dye 
incorporation and amplification.  For each sample, the overall labeling efficiency was determined 
with the Microarray Feature on Nanodrop ND-1000 spectrophotometer, and only samples that 
had a labeling efficiency of 1 pmol/μl were used for hybridization.   
The microarray chips were prehybridized in blocking solution (0.1% BSA, 5X SSC, 1% 
SDS) at 42
o
C for 1 hour with shaking, and then spun at 2,200 x g in a minicentrifuge (Fisher 
Scientific) to dry.  The labeled DNA was mixed with an equal volume 2X hybridization solution 
(2% SDS, 30X SSC, 50% Formamide) or 2X Hybridization Solution #7 (Genisphere Inc., 
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Hatfield, PA) and the mixture was added onto the chips.  The labeled DNA mixture was 
hybridized overnight at 42
o
C, and the chips were then washed for 10 min in each of the 
following wash buffers: 10X SSC + 0.2% sarkosyl, 10X SSC, and 0.2X SSC.  Lastly, the slides 
were dipped quickly in water, spun dry at 2,200 x g and visualized on a GenePix 4000B slide 
reader (Molecular Devices, Sunnyvale, CA).  The spotted probes that printed irregularly 
provided no signals, had inconsistent hybridization, or exhibited nonspecific binding were 
excluded from further consideration. 
2.10.  Spiked Primer DNA Labeling   
In an attempt to increase the detection limit of our microarray, specific primers were 
added to random primers used in fluorescent labeling reactions (Figure 3).  The primers were 
designed in two ways: either as "inside" primers, which were reverse complements of the last 18-
25 nucleotides in the 3‟ end of the 70mer, or as "outside" primers (18-25 bp), which were reverse 
complements of a region that is 5 nucleotides downstream to the 70mer probe (Figure 3). The 
gene targets chosen for this experiment included invA, intl1 (Salmonella specific), sopE (a 
Salmonella marker, but not present in the strain used), asc10 (Enterococcus specific, negative 
control for Salmonella experiments) and EUB (positive control for all eubacteria).  In total, 3 nM 
of the specific primers were spiked into the labeling mix both with and without random 
hexamers.   
2.11.  Data analyses   
The fluorescent hybridization signals from the array were visualized using a GenePix 
4000B slide reader (Molecular Devices, Sunnyvale, CA) and matched to the GenePix Array List 
(GAL) file previously created by the microarray slide printer.  A GenePix Report (GPR) file was 
generated measuring the overall intensities.  The fluorescence signal from each probe set was 
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averaged and used for further analyses.  Data analysis was performed using the TIGR 
MultiExperiment Viewer (TMEV) program (TIGR, Rockville, MD) with one-color setting.  
Additional data analyses were performed using a previously developed relative pathogen signal 
(RPS) ratio method (Tomioka et al. 2005).  Briefly, the averaged signal intensities for each probe 
were divided by signal intensities of positive control spots to gain an RPS ratio, and the values 
over 0.25 were considered positive and values below 0.25 were considered negative.  Since EUB 
and Frye 3 produced the most consistent results they were considered for further analysis.  The 
detection limit of a test is defined as is the lowest concentration of an analyte that can be detected 
in a given matrix (Morrison et al. 1979; Ripp 1996).  The lowest concentration of E. coli O157 
(measured in CFUs/g) that still gave an RPS ratio above the threshold in manure was considered 
to be the detection limit of the microarray.  
 Results 
3.1.  Specificity of microarray analysis   
Total DNA from pure cultures of strains of Salmonella Typhimurium DT104, F. 
necrophorum A25, Enterococcus faecalis V583 PMV158GFP, and E. coli O157:H7 were used to 
evaluate the specificity of the chip.  The chip was capable of detecting antimicrobial resistance 
genes, as well as distinguishing bacterial species based on species-specific virulence genes 
(Figure 1).  
Microarray detected virulence genes eae, stx1 and stx2 from E. coli O157:H7 DNA; lktA 
and HAEM (hemagglutinin) from F. necrophorum DNA; asa1 and asc10 from Enterococcus 
DNA , and invA from Salmonella DNA.  Salmonella DNA also hybridized with known markers 
for DT104; tetG, tetR, sul1, flo, and aadA2, and Enterococcus DNA was further identified by the 
presence of ermB, ermBCT and vanB genes. Minimal non-specific hybridizations infrequently 
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occurred, as was shown by total DNA from F. necrophorum hybridizing with the hemA probe for 
C. parvum (Figure 1).  
Specificity of the platform was determined to be high for the array as it was capable of 
differentiating two clonally related species of Enterococcus (Figure 2).  DNA from E. faecium 
R2-Tx5034 hybridized with probes for esp, msrC, pbp5, and vanA and was compared to E. 
faecalis V583 PMV158GFP used in the first study.  Both Salmonella  were positive for ermB 
and ermBCT, but the gene for vanB and gfp was only detected in E. faecalis V583 PMV158GFP 
(Lakticova et al. 2006).  PCR was again performed for confirmation on selected genes (Table 1) 
(data not shown).  Each of these genes corresponded with known genetic markers for the strain 
and was confirmed by PCR analysis or as reported in previous literature (Table 1) (data not 
shown).   
Our microarray analysis confirmed a previous report that msrC was present only in E. 
faecium resistant to methicillin (Portillo et al. 2000) and pbp5 was present in E. faecium resistant 
to penicillin (Fontana et al. 1983).  When Salmonella Typhimurium DT104 and Salmonella 
Muenster were compared, both strains were positive for invA. However, the virulence gene sopE 
was present only in Salmonella Muenster.  These results were also confirmed using PCR assays 
(data not shown).  When E. coli O157:H7 ATCC 43894 was compared against E. coli O157 Neo 
5-13-005 (a clinical isolate that has a plasmid with neomycin resistance), genes stx1 and stx2 
were detected only in ATCC 43894, whereas aphA1 for neomycin resistance was present only in 
E. coli O157 Neo 5-13-005 (data not shown).  
3.2.  Microarray of environmental samples   
In order to determine the detection limit of the microarray platform, Enterococcus 
faecalis V583 PMV158GFP and Salmonella enterica DT104 were serially diluted and mixed 
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into manure and soil to obtain concentrations from 10
10
 to 10
1
 CFU/g.  As expected, the positive 
control EUB probe for 16s rRNA was detectable at all dilutions, confirming adequate labeling 
and hybridization.  The highest detection limit for species-specific genes, virulence factors or 
antimicrobial resistance genes was 10
9 
CFUs/gram for cattle manure or soil.  To improve the 
detection limit of this array, a variety of methods was evaluated with mixed results.  Indirect 
labeling and a Templiphi amplification kit (Amersham Biosciences, Piscataway, NJ) previously 
reported to be effective for increasing the detection limit (Wu et al. 2006), did not significantly 
improve the overall detection limit of the array.  Additional experiments were conducted using 
specific primers that bound inside and outside of the 70mer sequence spiked along with the 
random hexamers in the hybridization mix to enhance specific labeling of the DNA.  The inside 
primers mixed in with random hexamers consistently provided improvements to the detection 
limit (10
8
 CFU/g of Salmonella in cattle manure) as compared to random hexamer alone (no 
detectable signal) or random hexamers mixed in with outside primers (10
9
 CFUs/g, data not 
shown) (Figure 3; Figure 4; Table 2).  The efficiency of labeling was poor when the inside and 
outside primers were used without random primers in the labeling mixture (data not shown).  It is 
interesting to note that the 18-25 nucleotides in the 3‟ end of the 70mer did not impact the 
binding of the sample DNA.  The detection limit was greatly improved to from 10
9
 to 10
3
 
following enrichment in GN broth (Figure 4; Table 2).   
  Discussion 
The spotted  microarray developed in this study contained 489 oligomers, including a 
total of 113 virulence genes, 227 AMR genes, 99 metal resistance genes, 31 transferable 
elements and 7 positive control oligos. This encompasses a total of 43 bacterial species and 
resistance for 30 different antimicrobial agents.  This microarray will add to the growing list of 
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microarrays used to aid in the diagnosis and characterization of disease-causing bacteria 
(Volokhov et al. 2002; Yu et al. 2004; Perreten et al. 2005; Tomioka et al. 2005; Chandler et al. 
2006; Frye et al. 2006; Li et al. 2006; Dankbar et al. 2007; Kostic et al. 2007; Strommenger et 
al. 2007; Tembe et al. 2007).   
The ability to rapidly and specifically identify and characterize bacterial pathogens is 
important to human and animal health.  In our array, we designed oligomer probes to identify 
both veterinary and zoonotic human bacterial pathogens, which include many categories of select 
agents belonging to Category A, B and C as listed by NIAID, 
(http://www3.niaid.nih.gov/topics/emerging/list.htm) by targeting genes that encode known or 
putative virulence factors.  This approach that focuses on detecting genes that encode these 
virulence factors is essential to identify and characterize virulent bacterial pathogens.  
High specificity of our microarray was confirmed by the ability to differentiate between 
aerobic and anaerobic bacteria, and between gram-negative and gram-positive bacteria, including 
Salmonella Typhimurium DT104, F. necrophorum A25 Enterococcus faecalis V583 
PMV158GFP, and E. coli O157:H7.   It could also differentiate between two strains of 
Enterococcus (E. faecium R2-Tx5034 and E. faecalis V583 PMV158GFP), two strains of E. coli 
(O157 ATCC 43894, and O157 Neo 5-13-005) and two strains of Salmonella enterica 
(Typhimurium DT104 and Muenster).  The specificity of our system proved to be very high, as 
probes corresponding to species-specific virulence genes distinguished the four species of 
bacteria and even between strains within species, some of which differ by as little as one gene 
(Figures 1 and 2).  Probes corresponding to AMR, metal resistance and horizontally transferable 
genetic elements further characterized the bacterial strains and corresponded to known genetic 
markers of each of the tested bacteria.    
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Based on the ability of this microarray to accurately characterize bacterial strains, this 
technology could be standardized for use in routine diagnosis in human or animal hospitals.  This 
“diagnostic lab on a chip” approach can be optimized to achieve a fool proof, versatile, high 
throughput, low-cost system for use in field setting, and could provide an important primary step 
in the diagnosis of disease as it is able to identify many virulence genes in a single test.  With the 
rapid results that diagnostic microarrays such as this can provide, it may allow for more specific 
antimicrobial treatments to begin earlier and would aid greatly in source tracking as well as 
fingerprinting of any strain of bacteria. Spotted microarrays have an extra advantage of being 
easily customizable by allowing printing of probes to detect additional genes without having to 
refabricate the entire chip.   
Rapid identification of causative agents of natural and maliciously introduced infectious 
disease outbreaks is pivotal in immediate treatment and control strategies.  In such a situation, it 
is crucial to identify all pathogens involved in the outbreak, their total virulence profile and their 
overall antimicrobial susceptibilities.  Since future bioterrorism threats could involve a mixture 
of agents, new or uncommon variants of known agents, or a single highly transmissible agent 
with multiple virulence and AMR genes (Phillips et al. 2004; Tomioka et al. 2005), we designed 
probes to detect genes encoding virulence factors.  This gene-centered rather than pathogen-
centered approach was the basic criterion for selection of probes to detect Group I (emerging), 
Group II (re-emerging), and Group III (agents with bioterrorism potential belonging to categories 
A-C) bacterial pathogens, antimicrobial resistance genes, metal resistance genes and horizontally 
transferable elements.   
Many studies that use traditional bacteriology and PCR assays are laborious, time-
consuming and are focused on phenotype characterization that limit the number of species, 
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subspecies or serotypes of the pathogen that can be identified (Ziebell et al. 2002; Inglis et al. 
2006; Kim et al. 2006; Bolton et al. 2007; Kerouanton et al. 2007; Jacob et al. 2008a; Jacob et 
al. 2008b).  With a spotted microarray, the genetic analysis of many bacterial species in various 
types of samples can be performed in one rapid test allowing for a global view of all species 
existent in a microcosm (Porwollik et al. 2003; Yu et al. 2004; Wu et al. 2005; Frye et al. 2006; 
Ballmer et al. 2007; Han et al. 2007; Malorny et al. 2007; Strommenger et al. 2007).  Although 
microarrays in the past were designed to determine relative gene expression profiles, recent 
arrays like the one in the present study have focused on using this powerful technology for 
identification and characterization of pathogens (Chandler et al. 2006; Ballmer et al. 2007; 
Bonhomme et al. 2007; Ojha & Kostrzynska 2008).  For example, this technology has been used 
in high throughput detection of methicillin-resistant Staphylococcus in hospitals (Strommenger et 
al. 2007) and in the identification of antimicrobial resistance genes (Perreten et al. 2005; Frye et 
al. 2006).  Additional studies have included arrays that detect bioterrorism agents in blood 
samples (Tomioka et al. 2005) and those that detect pathogenic strains of Shigella and E. coli in 
fecal samples (Li et al. 2006). 
Detection limits in complex matrices such as manure and soil are complicated by the 
presence of other competing DNA, inhibitors of labeling reactions (tannins, silica, etc.) and low 
yields of DNA (Gentry et al. 2006; Schadt  CW 2006).  Previous attempts to improve detection 
limits including using the Templiphi amplification kit (Amersham Biosciences, Piscataway, NJ) 
yielded marginal improvements (Wu et al. 2001; Wu et al. 2005; Wu et al. 2006).  The detection 
limit of our microarray was marginally improved by the inside primer technique to 10
8
 
CFUs/gram, which is consistent with detection limits reported in previous studies (Schadt  CW 
2006).  However, this technique may not be applicable for large arrays because of increased 
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probability of producing heterodimers, as well as increased cost.  When the fecal samples were 
enriched with the GN broth, the detection limit improved to 10
3
 CFUs/g.  At this detection level, 
the array will be able to characterize most enteric bacteria, as studies have shown that infectious 
doses of enteric bacteria, such as Salmonella, is 10
3 
CFUs/gram (Blaser & Newman 1982).   
 Conclusion 
We have developed a microarray chip that is capable of identifying and characterizing 
bacterial pathogens that can cause human, animal and zoonotic diseases including 15 NIAID 
Category A, B and C bacterial pathogens.  This array was developed and validated for four 
different bacterial species that carry resistance for multiple AMR, metal resistance and 
horizontally transferable elements.  Although the detection limit of the current array limits its use 
in the presence of large amounts of contaminating DNA, it can be used with confidence in pure 
and enriched cultures.   
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 Tables and Figures 
 
Figure B.1 Microarray gene profile of total DNA from four different pathogenic species of 
bacteria:  A, DNA from Salmonella Typhimurium DT104 (ATCC 700408); B, E. coli 
O157:H7 (ATTC 43894); C, Enterococcus faecalis V583 PMV158GFP; and D, 
Fusobacterium necrophorum subspecies necrophorum strain A25. 
Genes A B C D   Genes A B C D   Genes A B C D 
E. coli           Chloramphenicol           Copper/Silver         
Q933           flo          int         
H7 new           Erythromycin           cusA         
stx 1 2           erm(B)           cusB         
stx1           ermBCT           cusC         
Stx1b           Fluoroquinolones           cusF         
stx2           parC           cusS         
O157 wzy           Lincomycin           Copper/Zinc/Cadmium         
stx2 2           lin(A)2           copABCD         
stx2 3           Sulfanilamide           Iron         
EHEC hlyA           sul1           pmrA         
SZ eae           Tetracycline           pmrB         
Szeae 3           tetC           Nickel         
fliC H7           tetD           ncrC         
mdfA           tetG           Tellurite         
tuf           tetK           terC 2         
Enterococcus sp.           tetL           tehA         
asa1           tetM           tehB         
asc10           tetY           terC         
gfp           tet(R)           Zinc         
Fusobacterium sp.           Aminoglycosides           ybgR         
haem 2           aadE           zraP         
lktA           aadA1           zraR         
haem           aadA1b           Class I Integrons         
rpoB           aadA2           intl 1         
rpoB 2           aph2-ia           Plasmids         
Salmonella sp.           Glycopeptides           incQ         
intl1 2           vanB2           colE1         
salinvAp           vanH           pBR322         
salinvAp 2           Quat. Ammonium           pAD1         
intl-1 l2 l3           qac           pUC19         
S. aureofaciens           Arsenic           Transposons         
tcr           arsR           trans         
E. faecalis           Chromate           Positive Control         
erfA           cysA           EUB         
E. faecium           Cobalt/Nickel           Frye 2         
orf16           cnrB           Frye 3         
Lactococcus sp.           cnrT           rpoB         
mdtA           yohM           Negative Control         
B. anthracis           Copper           H20         
lef           copA          Buffer         
Cryptosporidium sp.           cueO               
hemA           cutA               
Enterobacteriaceae           cutF               
rrnB           dipZ               
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Figure B.2 Microarray gene profile of total DNA from two enterococcal strains: A, DNA 
from Enterococcus faecalis V583 PMV158GFP; and B, Enterococcus faecium R2-Tx5034.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Genes A B  Genes A B 
E. faecalis    Aminoglycosides   
asa1    aadE2   
asc10    aac6-ie   
gfp    aac6-ii   
orf44    aph2-ia   
erfA    aph3-iii   
E. faecium    Glycopeptides   
orf16    vanA   
esp    vanB2   
Lactococcus sp.    vanH   
mdtA    vanR   
Salmonella sp.    vanX   
inti-1 l2 l3    vanY a   
S. pneumoniae     vanY b   
orf45    Arsenic   
Streptococcus B    arsR   
msrC    Cobalt/Nickel   
Streptococcus sp.    cnrB   
mreA    cnrT   
Erythromycin    Copper/Silver   
erm(B)    cusA   
ermR    Copper/Zinc/Cadmium   
ermBCT    copABCD   
Methicillin    Tellurite   
msrC    terC 2   
Penicillin    Insertional Elements   
mecA2    IS1182   
pbp5    IS150   
Vancomycin    Plasmids   
vanA    orf46hirt   
vanB    incQ   
Tetracycline    pAD1   
tetC    Transposons   
tetL    res   
tetK    trans   
tetU    trans-1   
tetM    Positive Controls   
tetY    EUB   
tet(R)    Frye 3   
Vancomycin    Negative Controls   
vanZ    H20   
Aminoglycosides    Buffer   
aadE       
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Figure B.3 Schematic alignment of inside and outside primers used in this study. A >>> 
symbol indicate the position of the original probe in relation to the primers. 
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Figure B.4 The detection limit (CFUs/g) following the inside primer technique and 
enrichment protocol. 
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Table B.1 Complete list of primers used for PCR confirmation of 70mer oligos. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene Forward Primer 5' to 3' Reverse Primer 5' to 3' 
Product 
Size 
Reference 
asa1 GCACGCTATTACGAACTATGA TAAGAAAGAACATCACCACGA 375 (Vankerckhoven et al., 2004) 
asc10 GGTAGTGCAACGCCTAATAC TTCAGCTCCTACTGTTGGTT 171 This study 
ermB GAATCCTTCTTCAACAATCA ACTGAACATTCGTGTCACTT 175 (Jacob et al., 2008a) 
ermBCT GAAATTGGAACAGGTAAAGG TTTACTTTTGGTTTAGGATG 404 (Jost et al., 2004) 
esp AGATTTCATCTTTGATTCTTGG AATTGATTCTTTAGCATCTGG 510 (Vankerckhoven et al., 2004) 
EUB TGGAGCATGTGGTTTAATTCGA TGCGGGACTTAACCCAACA 161 (Yang et al., 2002) 
gfp CAATGCTTTTCAAGATACCC GTGTCCAAGAATGTTTCCAT 213 This study 
haem CATTGGGTTGGATAACGACTCCTAC CAATTCTTTGTCTAAGATGGAAGCGG 310 (Tadepalli et al., 2007) 
Intl 1 GTTCGGTCAAGGTTCTG GCCAACTTTCAGCACATG 923 (Zhang et al., 2004) 
invA TGCCTACAAGCATGAAATGG AAACTGGACCACGGTGACAA 500 (Guerra et al., 2000) 
lktA AAATGGTGAAAGAATGACAA TGCATAATTTCCTACTCCTG 194 (Tadepalli et al., 2007) 
O157rfb CGGACATCCATGTGATATGG TTGCCTATGTACAGCTAATCC 259 (Paton & Paton, 1998a) 
rpoB TACGTATGCCTCACGGATCA CTCTCGAAACAACCCCTTTG 183 
(Narongwanichgarn et al., 
2003) 
stx1 ACACTGGATGATCTCAGTGG CTGAATCCCCCTCCATTATG 614 (Gannon et al., 1992) 
stx2 CCATGACAACGGACAGCAGTT CCTGTCAACTGAGCAGCACTTTG 779 (Gannon et al., 1992) 
tufA1 TGATGACGAAGAGCTGCTGGAACT CTTTCAGACCAGAACCACGAACGA 146 (de Sablet et al., 2008) 
vanA CATGAATAGAATAAAAGTTGCAATA CCCCTTTAACGCTAATACGATCAA 1030 (Kariyama et al., 2000) 
vanB GTGACAAACCGGAGGCGAGGA CCGCCATCCTCCTGCAAAAAA 433 (Kariyama et al., 2000) 
161 
 
Table B.2 Results from sensitivity improvement experiments.  Inside primers and outside 
primers with and without random hexamers results are not noted as they did not produce 
measureable levels of fluorescence.  Values are listed as CFUs/g. 
      
  Manure 
Spiked 
Primers in 
Manure 
Soil 
Bacteria Genes Unenriched Enriched 
Inside 
Primers with 
Hexamers 
Unenriched 
S. enterica 
Typhimurium 
DT104 
invA 1010 - 10
8 1010 
 EUB Unspiked - Unspiked 104 
      
E. faecalis V583 
PMV158 GPF 
asa1 109 - - - 
 asc10 109 - - - 
 GFP 109 - - - 
 vanB 1010 - - - 
 EUB Unspiked - - - 
      
E. coli O157 48390 O157 wzy 1010 103 - - 
 EUB Unspiked Unspiked - - 
      
E. coli O157   
4055397 
O157 wzy 1010 104 - - 
 EUB Unspiked Unspiked - - 
      
E. coli O157 
4064932 
O157 wzy 1010 105 - - 
 EUB Unspiked Unspiked - - 
      
E. coli O157 
4027993 
O157 wzy 1010 105 - - 
 EUB Unspiked Unspiked - - 
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Table B.3 Complete list of 70mer oligos designed using Picky 2.0 and Oligowiz 2.0 printed 
and used in this study.  Oligos with a *  were derived from 26-33mer probes origionally 
created by Perreten et al., 2005.  Oligos with a ** were previously published by Frye et al., 
2006. 
 
                                                                                            Virulence Genes NCBI accession no 
A. baumannii     
 aar3 CATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGGGGCGGAGAAGAAG AY038837 
B. anthracis    
 cya ACTATTTGCTATATCCTCCTCACAGGCTATAGAAGTAAATGCTATGAATGAACATTACACTGAGAGTGA DQ889680 
 lef AGTGGTCCCGTCTTTATCCCCCTTGTACAGGGGGCGGGCGGTCATGGTGAT M29081 
 pX01 AGGGGTTGATGATTCATATTTAAAAAACGCATATAAGCAAATACTTAATTGGTCAAGCGATGGAGTTTCT AE017336 
 pX02 AGCCTTGATAGTGCGAGAAGACATATGAAAAACATAAAAATTGTAAGAATATTGAAACATGATGAGGCAA AE017335 
B. pseudomallei    
 BpeAB-oprB TCCTTGCGCATCGCGGGGCTCGTGCGCAGCATGTCGAAGCAGCCGTCGACGAGTTTTTCCGCATGCCGTT CP000572 
Brucella sp.    
 brucella FB4U AGCGAGGAAAGCCGCATGTTCCTGGTCAAGCAGGGGCATCATTCGATGATTTGCCGCCTGGAGCT CP000709 
 VirB  AGCCCGACTCGACCTGCACGATTGCTGCCATAGTCTGAGGTGCAACAGTCGGTGCGCATTGTTGCGAGG AF141604 
Campylobacter  
sp.    
 racR CGGCTAGAGGTGACTTAAGCGATAAAGTTGTGGGGCTTCAAATCGGTGCTGATGATTATTTACCAAAGCCT AF053960  
 VirB11 AGTCTCAGGTGGAACAGGAAGTGGAAAAACTAGCTTTTTAAATTCTTTAATGGGTGAAATTGATCCAAAT CP000550 
C. difficile    
 ToxA CCAATACAAGCCCTGTAGAAAAAAATTTACATTTTGTATGGATAGGTGGAGAAGTCAGTGATATTGCTCT X51797 
 ToxB ATGGAGAGTCATTCAACTTATATGAACAAGAGTTGGTAGAAAGGTGGAATTTAGCTGCTGCTTCTGACA X53138 
C. glutamicum    
 ImrB ACCTCTCCGGCAGCTGCGAAGCTGCCTAGGGAGGTCGTTGTTGTTCTTTCGATCCTCGTGGTTTCCGCGA AF237667   
C. botulinum    
 bont/A ACTGATCTTGGAAGAATGTTGTTAACATCAATAGTAAGGGGAATACCATTTTGGGGTGGAAGTACAATAG CP000727 
 botulinum nt AGCTTTGGACATGAAGTTTTGAATCTTACGCGAAATGGTTATGGCTCTACTC CP000727 
C. perfringens    
 catDP AGCAGATTATGAAAGTGATACGCAACGGTATGGAAACAATCATAGAATGGAAGGAAAGCCAAATGCTCCGGAAAACAT U15027 
 cpe AGGAGATGGTTGGATATTAGGGGAACCCTCAGTAGTTTCAAGTCAAATTCTTAATCCTAATGAAACAGGTACCT CP000312  
 cpa ACAAGCTACATTCTATCTTGGAGAGGCTATGCACTATTTTGGAGATATAGATACTCCATATCATCCTGCTAATGT EU839838 
 cpb AAAGCGAATATGCTGAATCATCTACAATAGAATATGTCCAACCTGATTTTTCTACTATACAGACAGATCAT EU839838 
 cpb2 ACACCATCATTTAGAACTCAAGTTTGTACATGGGATGATGAACTAGCACAAGCAATTGGGGGAGTTTATCCACA EU085384  
 ext ATCTTGTAAAAAGTTTAGCAATCGCATCAGCGGTGATATCCATCTATTCAATAGTTAATATTGTTTCACCAACT AY858558   
Cryptosporidium sp.   
 DNAJ AGCGAAGATGACCTTTTTGATTTGTTTATGAAGGAGGTTAATGAAGCAAACAGTAAAAGCACTAACCAAGGA XM_625506 
 hemA ATTCTTTCACTCCTACAAATTCTGGTTCTTTGGAACTTTTCCAATTTGAAAGAAGAGATAGTCCTGT U18120 
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E. coli    
 ereA3 ATGCCATCGTCTGTGTTACAAGCGCCGGCAAGGACAGCCTGGTTGCCC AY183453 
 EHEC hlyA ATAAGACGGATGTTGGTAAACTAACAATTGATGCAACAGGAGCATCAAAACCTGGTGAGTATATAGTTC X94129 
 fliC H7 TCAAAACGTGATGCGTTAGCTGCCACCCTTCATGCTGATGTGGGTAAATCTGTTAATGGTTCTTACACCA AM228905 
 flicC H11 TTAATATCGATGGCGCGCAGAAAGCAACTGGCAGTGACCTGATTTCTAAATTTAAAGCGACAGGTACT AY973413 
 H11 new TGGGAATGGTGTATATTCTGCAGAAATTGATGGTAAGTCAGTGACATTTACTGTGACAGATGCTGACAAA AY337465 
 H7 new ATGCTGCATTCGATAAATTAGGGAATGGCGATAAAGTCACAGTTGGCGGCGTAGATTATACTTACAACGC AF228488 
 invE AGCATTTTTTCATCTATGGAGCTCTCACATCAGAGCTCCACAAGAATATTATTCTTTTATCCAA AF386526  
 ipaH ACCGCCTTTCCGATACCGTCTCTGCCAGCAATACCTCCGGATTCCGTGAACAGGTCGCTGCATGGCTGGA DQ132807 
 LT AGCGGCGCAACATTTCAGGTCGAAGTCCCGGGCAGTCAACATATAGACTCCCAAAAAAAAGCCAT                CP000795                
 O157 wzy GTCAAAGGATAACCGTAATCCTAAAATAAAAAGAATAATAGGGTATTTTTTATTGGTAGGGGTTGTATGC AY647261 
 Q21 ATGCCTCGTTGTTTATGATTTACCCGATTCTGGATAGTGCGTTTAAAAACCGGAAACGTGTAGAGAAAAT AJ605767 
 Q933 AGCGTGAATTGCCGGGAGGGAGAACCTCTGTATTTTATCAGCGAAAAAATAGTTTACGATCGTAAAAATC AF548457 
 ST Sta CCGTTTAACTAATCTCAAATATCCGTGAAACAACATGACGGGAGGTAACATGAAAAAGCTAATGTTGGCAA AJ555214 
 Stb AGCCAAGGAAAGTTGTAAAAAAGGTTTTTTAGGGGTTAGAGATGGTACTGCTGGAGCATGCTTTGGCGC AY028790 
 stx 1 2 ACCTTTACAGTTAAAGTGGGAGATAAAGAATTATTTACTAACAGATGGAATCTTCAGTCTCTTCTTCTCA AY135685 
 stx1 ACGCAGTCTGTGGCAAGAGCGATGTTACGGTTTGTTACTGTGACAGCTGAAGCTTTACGTTTTCGGCA EF685162 
 Stx1 GATCTCAGTGGGCGTTCTTATGTAATGACTGCTGAAGATGTTGATCTTACATTGAACTGGGGAAGGTTGA EF079675 
 STX1 AGTGGAACCTCACTGACGCAGTCTGTGGCAAGAGCGATGTTACGGTTTGTTACTGTGACAGCTGAAGCT       EF685162       
 
STX-1 FAM 
IBQ-1 CACTGACGCAGTCTGTGGCAAGAGCGATGTTACGGTTTGTTACTGTGACAGCTGAAGCTTTACGTTTTCGGCA     EF685162      
 stx2 ACGCCGGGAGACGTGGACCTCACTCTGAACTGGGGGCGAATCAGCAATGTGCTTCCGGAGTATCGGGGAG AF525041 
 StX2 TCAGATTTTACACATATATCAGTGCCCGGTGTGACAACGGTTTCCATGACAACGGACAGCAGTTATACCA EF079674 
 stx2 2 AGTACCTGTGAATCAGGCTCCGGATTTGCTGAAGTGCAGTTTAATAATGACTGAGGCATAACCTGATTC AM230664 
 stx2 3 CTCTTGAACATATATCTCAGGGGACCACATCGGTGTCTGTTATTAACCACACCCCACCGGGCAGTTATTT AB168111 
 stx2 3 CTCTTGAACATATATCTCAGGGGACCACATCGGTGTCTGTTATTAACCACACCCCACCGGGCAGTTATTT EF079674 
 
STX-2 FAM 
IBQ-1 ACGCCGGGAGACGTGGACCTCACTCTGAACTGGGGGCGAATCAGCAATGTGCTTCCGGAGTATCGGGGA         EU086525        
 Stx2e TGCTCAGCTGACAGGGATGACTGTAACAATCATATCTAATACCTGCAGTTCAGGCTCAGGCTTTGCCCAGG DQ449665 
 SZ eae ACCAGCGCCGGGATCCCATCGTTTCGTCTAAATATATCCATAATCATTTTATTTAGAGGGAGGGAGGGGGGA BA000007 
 SZ eae 2 AACCTAATAACACAAAACCCTCTTCCTGGGGTTAATGTTAATACTCCAAATGTCTATGCGGTTTGTGTAGAA EF079676 
 Szeae 3 TGAGCAGTATTATGGTGATAATGTTGCTTTGTTTAATTCTGATAAGCTGCAGTCGAATCCTGGTGCGGC EF079676 
 Tuf ACTTCCCGGGCGACGACACTCCGATCGTTCGTGGTTCTGCTCTGAAAGCGCTGGAAGGCGACGCAGAGT CP000800 
 Tuf 2 GTTCGAATCTGAAGTGTACATTCTGTCCAAAGATGAAGGCGGCCGTCATACTCCGTTCTTCAAAGGCTAC X57091 
E. maxima    
 ww2 CAATTAATGGATTTGAAGCTCTTTAGAAGGGTGGATGTCCTCTTGCATGAAGAGGTTTGTGAGCGCGCGC AY779455 
Enterbacteriaceae    
 rrnB AGCGGGTGAAAAGCCCGCTCGCCGGAAGACCAAGGGTTCCTGTCCAACGTTAATCGGGGCAGGGTGAGT V00331 
Enterobacter sp    
 nrpA GATAATCATCAGGCTGTACTTATTTGGACATTTCAACTGCTTGAAAGGGAACCAGCCTTAAATGAATTAG 
                   
DQ264843                 
 nrpB AATACGCTGACAAGTATGTATTATGACCGTGCTATACGTATCGAATTGCCAGTCGCTGATAAGTTATGTA 
                     
DQ264843                 
Enterococcus sp.    
 Asa1  GCATGAATGATGTCTTGGACACGACCCATGATCGTTTCACAGGAAAATGGCACGCTATTACGAACTATGA X62656  
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 Asa1 2 CGCTCCTCTTTTATATATAGAGAGGCTACCCAGCAATGATAACTAGGTAGCCACAGACATAAAATT X17214 
 Asa1 Hirt GGGGCATGAATGATGTCTTGGACACGACCCATGATCGTTTCACAGGAAAATGGCACGCTATTACGAACTATGACCT X62656  
 cyt ATTGTTGCATCAGCAGGAAATGAGTCGCGTGATATAAGCACTGGTAATGAAAAACATATACCAGGAGGAC AF454824 
 asc10 ACGCAACCAGGATCAACGACAGTGCACCCCGATAACCCCGATCCGCAGTTAGGTAGTGCAACGCCTAATACGGC   AY855841    
 esp ATGTTGACACAACAGTTAAGGGGAAAGTATTCATCCACGAGTTAGCGGGAACAGGTCACAAAGCGCAACT    AF034779     
 esp 2 AAAAGATACAGTAAAAGTTCCAGTAGAAGTAACAGACAATCGCTCTGACGCTGATAAATATGAGCCAACA AF034779 
 gelE TCAGAGTAACTTCTTCACCAACTGGTGACCCCGTATCATTGGTTTATAAAGTGAACGCTACAGATGGAACAAT D85393 
 GFP TGTTCAATGCTTTTCAAGATACCCAGATCATATGAAACGGCATGACTTTTTCAAGAGTGCCATGCCCGAAGGT AF286456 
 GFP 2 TGGATGAACTATACAAATAAGCTTAATTAGCTGAGCTTGGACTCCTGTTGATAGATCCAGTAATGACCTC            DQ493885         
F. tularensis       
 oppD GCGCAACATCCGTATACAAAAGTCCTTCTAAATGCTATTCCTATTGCAGATCCACAACTAACTAGGTAACG CP000803  
 RD5 GAAGAGCAAGAGCAATATGAAACTGTAAAAACTCAAGCGGAGAAAGAAGCAGAGCAAAAATACCAACCTC CP000608  
 RD7 ATGCAATTGCTCAAGGTTCATCGGAGAGAAGTGTGACATTTGCTGTAAAAGCAGAGGATGAAGTTCGAGGT CP000608   
Fusobacterium sp.    
 HAEM ATGGAATGTTTATTCTGGTTCATTGGGTTGGATAACGACTCCTACTTTGGATCCAGGAACGGGAAAAGT AF529887 
 HAEM 2 AAAGAATCCAAGCAACCGCTTCCATCTTAGACAAAGAATTGAAATATCTCAAGAAAGAATGGGAT AF529887 
 lktA ACAGCAAAACGTTATAGTTCTGTTGCAATTGGAAATGCCGCAGTCGGAGTGGCTGCAAAAGGAGCTGGA DQ672338 
 rpoB 2 GGGGAAAAAGCGAGAGATGTTCGAGACAGTTCTCTACGTATGCCTCACGGATCAAAAGGAACGGTTGTGGA AF527637  
Listeria sp.    
 actA ACCGCCAACTGCATTACGATTAACCCCGACATAATATTTGCAGCGACAGATAGCGAAGATTCCAGTCTGA EF661572  
 iap AGCAACTATCGCGGCTACAGCTGGGATTGCGGTAACAGCATTTGCTGCGCCAACAATCGCATCCGCAAGC AY072791 
 inlA ACATCAGTCCCCTAGCAGGTTTAACCGCACTCACTAACTTAGAGCTTAATGAAAATCAGCTGGAAGATATTAGC AB276427 
 inlB ACGGGGCGAAAGTACAAGCGGAGACTATCACCGTGCCAACGCCAATCAAGCAAATTTTTCCAGATGATGC DQ302480 
 hlyA1 ACCACGGAGATGCAGTGACAAATGTGCCGCCAAGAAAAGGTTATAAAGATGGAAATGAATATATCGTTGT DQ844159   
 inlD AACAAAACAGCATTACGTATCTTAGTAACTCTGGCTGTAGTAATGGCAATTAGCTTTTGGGTAGGGACGA DQ347810  
M. elsdenii    
 phy ACGCCGGGCGAAATCGACGCCTTCCTGGCTTTCGTCCGTACCTTGCCAGCTGACGCCTGGCTGCACGACC DQ257441 
N. meningitidis    
 terC 2 CCCGATTTCCGTTTCACTGTCGGTCGTGTTCGGCGCGTTGGGTGCATCGATACTGACCTCGTTAATTTAT AL157959 
P. aeruginosa    
 mexC/D TCCAGATCGATCCGGCACCGCTGAAGGCTGCGGTGTCGCGCGCCGAGGGTGAGCTGGCGCGGAACCGCGC U57969 
 nfxB ACCTCACCCACCGCGAGCTGCTGGTATTCCTGGTATTCCAGTACCGCCCGGACTTCCTCGACCCGCACGG AY180395 
Rickettsia sp.    
 tsa686 ACAACTGGCCTGCCATTTGGTGGTACATTAGCTGCTGGTATGACAATTGCTCCAGGTTTTAGAGCAGAGC U80635 
Salmonella sp.    
 fliC GTCGCTGATATTGCCACTGGCGCGACGGATGTTAATGCTGCTACCTTACAATCAAGCAAAAATGT AY864776 
 IntI-1 L2 L3 AAACCTTGCGCTCGTTCGCCAGCCAGGACAGAAATGCCTCGACTTCGCTGCTGCCCAAGGTTGCCGGGT EU006711  
 Intl1 AAAACCGCCACTGCGCCGTTACCACCGCTGCGTTCGGTCAAGGTTCTGGACCAGTTGCGTGAGCGCAT EU052800 
 SalInvAP ACCTACCTATCTGGTTGATTTCCTGATCGCACTGAATATCGTACTGGCGATATTGGTGTTTATGGGGTCG DQ644633 
 SalInvAP 2 TTATTGATTGCACATAAAGATCTTGTCCTCCTTACGTCTGTCGATGTCCGTCGATTTATTAAGAAA U43273 
 
Salmonella 
InvA ACAGGATACCTATAGTGCTGCTTTCTCTACTTAACAGTGCTCGTTTACGACCTGAATTACTGATTCTGGT AE008832 
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 sopE AAAACCGCCACTGCGCCGTTACCACCGCTGCGTTCGGTCAAGGTTCTGGACCAGTTGCGTGAGCGCAT AY168875 
 sopE 2 GGTCTTTACTCGCACTACCTCTAATATCTATATCATTGAGCGTTTGAAGCATAAAATCTTTAACG AY167930 
S. aureofaciens    
 tcr ACGGCGAACAGTTCGGTGGTGATGTCACTCAAGGTCTCGGCCGCGGGGGAGAGATCGGTCATGGGGGCAG D38215 
S. fradiae    
 tcl ACGGCCGAGAACAGGGGCTTTCGCATGCGTACATCACCTTCCTCCCAGCTTTCCCTGCACGGTGTCACCA M57437 
S. rimosus       
 otrB ATGCCGTTCTACGGCAAGCTGTCCGACATCTACGGGCGCAAGCCCATGTACCTGATCTCCATCGTGGTGT AF061335 
S. suis    
 mrp TGGGGCAGCAAGCGTTTTGCTTGGTGTGTCGTTAGTTTTAGGTGCTGGTGCACAGGTTGTTAAGGCTGATGA CP000408   
S. aureus    
 can ACAGTACCATTAACTGTTAAAGGTGAACAGGTGGGTCAAGCAGTTATTACACCAGACGGTGCAACAAT M81736 
 FnBPA CGGAACAAAACAATACTACAGTAGAGGAAAGTGGGAGTTCAGCTACTGAAAGTAAAGCAAGCGAAACACA X62992 
 vga ACGTGGTGAAGATGTCTCGGGTACAATTGAAGGACGGGTATTGTGGA M90056 
S. agalactiae    
 bca ATGGGGATGTTTCTCAGTTGCAGAGTACAGGAAGGGCTAGTCTTACCTATAATATATTTGGTGAAGATGG M97256 
 bac AGTAGCTAGTGTAGCGGTACGTAGTTTGTTCATGGGAAGCGTTGCTCATGCAAGTGAGCTTGTAAAGGACGA X58470 
 cyl AGCCAACGAAGCCACTGTCTCTAACTATAAAGAATCATATGGTGTTGTTTTGCGTAATGCTGATGGAGAAAGGCT CP000114     
 sec ACACCCAACGTTTTAGCAGAGAGTCAACCAGACCCTATGCCAGATGATTTGCACAAATCAAGTGAGTTTA AP009324   
S. equi    
 fnz AGGTGCAACATTATTGTTTGGTTTAGGTCATAATGAGGCCAAAGCCGAGGAGAATTCAGTACAAGACGT Y17116 
 SeM TGCCGGTGCAGCATCAGTATTAGTTGCAACAAGTGTGTTGGGAGGGACAACTGTAAAAGCGAACTCTGAGGT AF012927  
S. pneumoniae    
 Hyal1 AGTCATTGAGGCTAAGGATGGGGCTATCACTATCTCAAGCCCTGAGAAATTAAGGGCAGCGGTTCACCGTATGGT CP000410 
 Nana AGCTCAAGAAGGGGCAAGTGAGCAACCTCTGGCAAATGAAACTCAACTTTCGGGGGAGAGCTCAACCCTAACT CP000410 
 ply CCGACTTCTTATCTAGCCAGACGGCGACGCAATGTCTCAGAAGAATTGTACGAGGAAATTTTGGATCACT X52474 
 orf45 ACCGGTACGCTTATATAGAAGATATCGCCGTATGTAAGGATTTCAGGGGGCAAGGCATAGGCAGCGCGCT AM490850 
S. pyogenes    
 scp CTGGTCAAGGGTATAGAAACCGTACTGATTGCGGTTATAGTCAGGTTTTTCTTTGTGTAACATAGGAGAACCT CP000261  
Streptococcus G    
 Protein G AGGAAGCAACCCATTCTTCACAGCAGCTGCGCTTGCAGTAATGGCTGGGGCGGGTGCTTTGGCGGTCGCT X06173 
S. zooepidemicus    
 zag GCGGACATTACAGGAGCAGCCTTGTTGGAGGCTAAAGAAGCTGCTATCAATGAACTAAAGCAGTATGGCA U25852 
V. cholerae    
 eltor AGGCTAGGTGGGCCAGGCGACGGTTGTCCTGGTTCAAGTGCGTAGGCTTGAGAGTTAGGTAAATCCGGCT AE003852 
Y. pestis    
 yfeA ATGTCCCGTCTGCCGTCGTGACCGCAGGTATTACACCCCTGCCTATCCGAGAAGGCCCCTATAGCGGCAT YPU50597 
Species Specific AMR 
C. difficile    
 catD ATGTATCTATGATACCGTGGTCAACCTTCGATGGCTTTAATCTGAATTTGCAGAAAGGATATGAT X15100 
 cme TGGCTCATCACTTGTACAAATGGCAATGATATGGTATGTCACACTTCAGACATCATCAGGTGTATGGGTA AY362981 
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Corynebacterium sp.   
 cmr TCGTCCCATTCCGCCAACAAGGCCGCGTATTTGGACTAGCCATGGCAGTGGAAATGGCAGCCAACCCGCT CGU43535 
 lmrB ACCTCTCCGGCAGCTGCGAAGCTGCCTAGGGAGGTCGTTGTTGTTCTTTCGATCCTCGTGGTTTCCGCGA AF237667 
E. coli    
 mdfA ACTTGCTGTTAGCGCGTCTGACCTCGCGCCGCACCGTACGTTCGCTGATTATTATGGGCGGCTGGCCGAT Y08743 
E. faecalis    
 aad9 CAGCAAGAAATGGTACCGTGGAATCATCCTCCCAAACAAGAATTTATTTATGGAGAATGGTTACAAGAGCT M69221 
 erfA TGTGTGTTTGGTTTTATTTTGATTGAATTAGGCTTGCCGACCATTTTAGCACGAATGATTGACAAAGGAA AE016830 
 erfB ACGGCTAATTTCTGTCGTCGGTAATCCAGTCAAATAAGGCAACGCTGCATTAAAGGCAACGGT AE016830   
 orf44 CCGAGGATTTGTGGGAGAAACTTTTGTCCACCTACCGGATGGATTCCTATGAAAACATATGGGAAGCAT X92945 
E. faecium    
 emtA AGGTGGTTCATTCACGGCTTTTTTGTGTTCTTAAAACGGCGTTCAAAAAAGTGGAGGCGTAAGTATGACT AF403298 
 inuB * CATCCAACTGGTTGTTTGACGTAGCTCCGTACTTGATGCTTTATAAAAATGAGTACGGAACAGAGGTAGT AJ238249 
 orf16 ATGCCATCAATTGTTCAGGGCGGTATCCGGTGAGGTGGCGGAAAGGCTTCATTATGCCTATCCGGAGTAT AM490850 
 pbp5 AGCACGGCAAAAATCGAACAGGCGCTTATATTGCCGGCGCAGTGATCTTAATAGCAGCTGCGGGTGGCGG X92687 
Lactococcus sp.    
 mdtA TGGCGGCACGATTGTCCACGCGGGTTGGGTTGAAGTTCTATTTGCTGCTGCGATGCTGATTGGCTCTTTTGCTGT X92946  
 mdtA 2 * ACCGCTCAGATGCCAACAGTCCAATCTATTATGCCCACAATGGTACCAGAAGACGAAATTACTCGAGTCAACGG X92946 
M. elsdenii    
 tetOW ATGGGGCCATCTTGGTGATCTCCGCGAAAGATGGCGTGCAGGCCCAGACCCGTATTCTGTTCCATGCCCT AY485126 
S. aureus    
 inuA * ACTCATTGGTTAGATGGAGGCTGGGGCGTAGATGTATTAACTGGAAAACAACAAAGAGAACACAGAGA J03947 
 NorA AGGACCAGGGATTGGTGGATTTATGGCAGAAGTTTCACATCGTATGCCATTTTACTTTGCAGGAGCAT  D90119 
Strep. B    
 flo ACTTGGGTTTAAATGAAGCACTTGAGCGTTCTTGTAATGTTTTGAGTGGTGGGGAAAGAACGAAATTATCG M81802 
 msr(SA) AGTGAAAAACAAAGATTGTCCCAAGCCAGTAAAGCTAAACGAAATCAAGCGCAACAAATGGCACAAGCATC AB013298 
 msrC AGGGTTTGCTCAGGAAACTCTGACGAAACCGTTGTGTACGTTAAGTGGGGGAGAAGCGACTCGTTTGACG AY004350 
 msrD mel CCGTAGCATTGGAACAGCTTTTCACACCCCGGCTCTCAATGCGGTTACGCCACTTTTAGTACCAGAAGAACAGCT AF227521 
 orf5 AGCTGCAGAATACGAACAATTTATTGCGGAACGTGCTCGATTGGAAAGGGCTGCGGAGGAAAAGCGAAAACAGGCT AF227520 
 vgb AGGGCGAATAACTCCTCTGGGGGAAATTACCGAATTCAAAATTCCAACGCCAAACGCTCGACCTCATGCA M20129 
Streptococcus sp.    
 mreA ACCTGTGGCATGGTAGTACATGGAGATGCTAGAGGACGAACTATAGGGTTCCCAACTGCTAATCTAGCT U92073 
Antimicrobial Resistace 
Bleomycin    
 ble ** ATGGATTCGCAGTTCTAATGTGTAATGAGGTTCGGATTCATCTATGGGAGGCAAGTGATGAAGGCTGGCG D86934 
Chloramphenicol    
 cat ** CGACATGAAGAGTTCAGGACCGCATTAGATGAAAACGGACAGGTAGGCGTTTTTTCAGAAATGCTGCCTT M35190 
 cat ACCAGTTGCTCTGCAACTTCATCATTCTGTATGTGATGGTTACCATGCTTCACTATTTAT X92945 
 cat4 ** CCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGAAATTCCGTATGGCAATGAAAGACGGTGA AJ401050 
 cat-86 * AGCAAAAGCAGCAACCTATTTCCGAAACCTCATATGCCAGAAAACATGTTCAATATTTCAAGTCTACCGTGG K00544 
 catB * AGATTGAAATGGCTAGGTCACGGAAAAAAGCCTTCTAAAATAGAATTACGAAAATTTTTAGGAGGCCCGA M93113 
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 catDP1 * AGCAGATTATGAAAGTGATACGCAACGGTATGGAAACAATCATAGAATGGAAGGAAAGCCAAATGCTCCGGAAAACAT U15027 
 cat-DPS ATGTATCTATGATACCGTGGTCAACCTTCGATGGCTTTAATCTGAATTTGCAGAAAGGATATGAT X15100 
 cat-LM * ATGAAATGTTTCCTAAAAAACCAATACCTGAAAACACAGTTCCTATTTCGATGATTCCTTGGATTGATTT X68412 
 catP ** TGGCAATTCAAGTTCATCACGCAGTATGTGACGGATTTCACATTTGCCGTTTTGTAAACGAATTGCAGGA L02937 
 catP * GTGTTTAGAACAGGAATTAATAGTGAGAATAAATTAGGCTATTGGGATAAGTTAAATCCTTTGTATACAG M64281 
 catQ * ACTGCAAATATAGAGATAACTGGTTTACTGCGTGAAATTAAACTTAAGGGCCTGAAACTGTACCCTACGCT m55620 
 catS * ACAGAGACATTTTCCAACCTTTGGACACCATACATACCAGATTTTGAAGCATTTTCTATGGCGTATGCGA X74948 
 cat-TC * AGGGTGATAAACTCAAATACAGCTTTTAGAACTGGTTACAATAGCGACGGAGAGTTAGGTTATTGGG U75299 
 cfr * ATGGGAATGGGTGAAGCTCTAGCCAACCGTCAAGTATTTGATGCTCTTGATTCGTTTACGGATCCTAAT AJ249217 
 flo ** GATATTCATTACTTTGGCTATACTGGCGATGCTCGCACTCCTAAATGCGGGTTTCAGGTGGCACGAAACC AF252885 
Erythromycin     
 ere(A) ** CGCAATTGGCCGAAATTATCCAGCTCATCGATCACCTCATGAAACCGCACGTTGATATGTTGACTCACTT A15069 
 ere(A2) ** CCGGTGCTCATGAACTTGAGCGATTTTCGGATACCCTGACCTTTTCTTTGTATGGCTCAGTGCTGATTTG AF512546 
 ere(B) ** GCAGGGCGATATGGGTGCAAAAGACAAATACATGGCAGATTCTGTGCTGTGGCATTTAAAAAACCCACAA A15097 
 erm(A) ** AAGTGGGTAAACCGTGAATATCGTGTTCTTTTCACTAAAAACCAATTCCGACAGGCTTTGAAGCATGCAA D86934 
 erm(B) ** ACAAGCGTACCTTGGATATTCACCGAACACTAGGGTTGCTCTTGCACACTCAAGTCTCGATTCAGCAATT AJ243541 
 ermC ** TTTGAAATCGGCTCAGGAAAAGGCCATTTTACCCTTGAATTAGTAAAGAGGTGTAATTTCGTAACTGCCA NC001386 
 erm(F) ** GATTTGAAACTTGTCTATGAGGTAGGTCCTGAAAGTTTCTTGCCACCGCCAACTGTCAAATCAGCCCTGT U30830 
 erm(G) ** TTTGAAATAGGTGCAGGGAAAGGTCATTTTACTGCTGAATTGGTAAAGAGATGTAATTTTGTTACGGCGA M15332 
 erm(TR) ** AGAGGGGATTTGCTAAAAGGTTGCAAAATACCCAACGAGCTTTAGGTTTGCTGTTAATGGTGGAAATGGA AF002716 
 ermA * TGGGTAAACCGTGAATATCGTGTTCTTTTCACTAAAAACCAATTCCGACAGGCTTTGAAGCATGCAAATGTCAC X03216 
 ermB * ACCGTTTACGAAATTGGAACAGGTAAAGGGCATTTAACGACGAAACTGGCTAAAATAAGTAAACAGGTAACG Y00116 
 ErmBCT ACCGATACCGTTTACGAAATTGGAACAGGTAAAGGGCATTTAACGACGAAACTGGCTAAAATAAGTAAAC EF525477 
 ermC ATCGGCTCAGGAAAAGGCCATTTTACCCTTGAATTAGTAAAGAGGTGTAATTTCGTAACTGCCAT V01278 
 ermC * ATCGGCTCAGGAAAAGGCCATTTTACCCTTGAATTAGTAAAGAGGTGTAATTTCGTAACTGCCAT J01755 
 ermC CGTCTAATAGCCGGTTAAGTAATAGCCGGTTAAGTGGTCAAACTTTGGGAAAATCTCAACCCGCATTAAG X82664 
 ermD * TGCGTTTCGGGGACTTGCCGAATACGCGCTAAAGGAGCCGAATATCCCTCTCTGTGTTGCTTTACGCGGA M29832 
 ermF * ATGTTCAAGTTGTCGGTTGTGATTTTAGGAATTTTGCAGTTCCGAAATTTCCTTTCAAAGTGGTGT M14730 
 ermG * CCTAGGTATTATTTCCATCCAAAACCTAAAGTGGATAGCGCATTAATTGTATTAAAAAGAAAGCCAGC M15332 
 ermQ * CACCAACTGATATGTGGCTAGTTATGGAGAAAGGTTCCGCAAAAAGATTTATGGGAATACCTAGAGAGAG L22689 
 ermT * AGATTGGTTCAGGGAAAGGTCATTTCTCGTTTGAATTAGCTAAAAGGTGTAATTATGTAACCGCCAT M64090 
 ermX * ACCTCCTCGGCGGCGGTCGAAGTGGTCCATGATGATTTCCTTAACTTCCGGTTACCCGCCACTCCCTGCGT M36726 
 ermY * ATTGGTTCAGGAAAAGGGCATTTCACACTAGAACTGGTTCAAAAATGTAATTATGTAACAGTTATCGAGA AB014481 
Fluroquinilones    
 parC TGTCGCAGATGGGCTGGGTACGCAGCGCTAAAGGCCATGATATCGACGCGCCGGGCCTGAATTATAA  M58408 
Lincomycin    
 car(A) ACTTCACTCACCCAGATCAGGAGGACTCCTGCGTGTCGACAGCGCAACTAGCTCTGCATGACATCACCAAGC M80346 
 lin(A) ACCCTTAACAATCCCAAAACTTGTCGAATGGTCGGCTTAATAGCTCACGCTATGCCGACATTCGTCTGCA M14039 
 lmr(A) ACCGCGGATTACCGGTTCCCTATTCCCTATTCCCAGGTAATGCACCGGATATCGAGGGCCGTGGCGGCACGT X59926 
 lsaB orf3 CCTCATGGAAGTTGAACTTTGACCGACAGCAGGGACATGAACAAGCAACAAATGAACGCTTGCAGAAGGA AJ579365 
Methicillin    
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 ccrA AGAAAAGTTGGCACAAGGCATCATTGATGCAGAAACGTTCAGAGAACAAACGCAATCATTACGTC DQ483067 
 ccrB GTGAAAAACGTCGTAAAGGGCTGAATGATAAACCAGTGATAGCTGAAGGTAAGCATTCCCCCATT DQ483075 
Oleandomycin    
 ole(B) TGGGCCGCTCCCTTTTGGCCACACTGCCTCTTTTTCTCCGAATGGCGGATCACCCATGCAGAACGCACACCGT L36601 
 oleC ACTGCTCGCCATGATGGGCATGAACATGGCCCAGGGCGTGGGAACCGGCTTCAACCAGGACTTCAACTCCGGT L06249 
PCN-binding prot 
2    
 pbp4  ACCGGTACGCTTATATAGAAGATATCGCCGTATGTAAGGATTTCAGGGGGCAAGGCATAGGCAGCGCGCT AM490850 
 mecA * AATTGGCAAATCCGGTACTGCAGAACTCAAAATGAAACAAGGAGAAACTGGCAGACAAATTGGGTGGTTT AB096217 
 mecA ** AATTGGCAAATCCGGTACTGCAGAACTCAAAATGAAACAAGGAGAAACTGGCAGACAAATTGGGTGGTTT AY271717 
 mecA-2 AGCTCCAACATGAAGATGGCTATCGTGTCACAATCGTTGACGATAATAGCAATACAATCGCACATACA AB266532 
 penA ** ACTTATCCGACGTTGGATGGCGAGAACGTCTTATAGTGACTCTGTCAACTGCCACACTCAACCTATCTCG L02928 
Pristinamycin    
 vgaB TGGAGCAAGCTATAAAGCTAAAAGAGAATAAGGCGCAAGGAATGATTAAGCCCCCTTCAAAAACAATGGGAACAT U82085 
Rifampin    
 arr-3 ** ATAATTACAAGCAGGTGCAAGGACCGTTCTATCATGGAACCAAAGCCAATTTGGCGATTGGTGACTTGCT AY038837 
Spiramycin    
 srm(B) ACCACCTCACCCCGGTGCTGGTGGAGGAGTTGGAGCAGGCACTCGCGGACTACCGCGGCGCCGTCGTGGT X63451 
Streptogramin A    
 satA CGGTGCCATAGAAATAGAAATGCAACTTGTTCCAGGCTTTACTCCTCGTGCTTGCGGAACATTCCGAAGCCAGCA L12033 
 satG ACGTGTGGTTTGGGCAAAATGTGACCGTCCTACCAGGCGTAAAAATAGGTGACGGTGCCATTATCGGAGCA AF139725 
 vat ATGCCTGGGGTGAAAATTGGGGACGGGGCAATCATTGCTGCAGAAGCTGTTGTCACAAAGAATGTTGCT L07778 
 vatB TGTGTGGATTGGTCAGAATGTTACTGTTATGCCAGGAATTCAAATAGGAGATGGAGCAATTGTTGCTGCG U19459 
 vatB 2 * TGGTCAGAATGTTACTGTTATGCCAGGAATTCAAATAGGAGATGGAGCAATTGTTGCTGCGAATTCAGT U19459 
 vatC * ACACGGAAATTGGGAACGATGTTTGGATTGGACGAGATGTGACAATTATGCCCGGTGTAAAAATAGGAAACGGGGC AF015628 
Streptogramins    
 
sat(G) vat(E-8) 
** ACTGACTGATTTGCCGTTGAAAGGTGATACTGTAGTCGGAAATGACGTGTGGTTTGGGCAAAATGTGACC AY043213 
 vga(A) CGGGTACAATTGAAGGACGGGTATTGTGGAAAGCAAAAAGTTTTAGTATTCGCGGAGGAGACAAGATGGC M90056 
Streptothricin    
 sat4 * TTGGAACCGGTACGCTTATATAGAAGATATCGCCGTATGTAAGGATTTCAGGGGGCAAGGCATAGGCAGC AF516335 
Sulfanilamide    
 sul1 ** CTACCTGAACGATATCCAAGGATTTCCTGACCCTGCGCTCTATCCCGATATTGCTGAGGCGGACTGCAGG AY458224 
 sulII ** GAATAAATCGCTCATCATTTTCGGCATCGTCAACATAACCTCGGACAGTTTCTCCGATGGAGGCCGGTAT NC005324 
Tetracycline    
 otrA AGGCGACCACGAATCCGGCAGGAAAGGTCCGCATCACGACGCTAAGGAATCCGAACCCCCTCCA X53401 
 otrC ACATCGCCATGTCGGTCGGCTCCGGCGTCAACGACGACTTCAACAAGGGGGTGATGGACCGCTTCCGCACCAT AY509111 
 tcr ACGGCGAACAGTTCGGTGGTGATGTCACTCAAGGTCTCGGCCGCGGGGGAGAGATCGGTCATGGGGGCAG D38215 
 tet30 CTGCCGGAAAGCCGAAAGGCCGGTCCGGGCAAGTTTGCGTTCAAGGAACTTAACCCGTTGGCGCCATTGGT AF090987 
 tet31 CCTTGCAGGGCTAGGGTTAATGCATATTATCTTTCAGGCTTTTGTCGCAGGATATATCGCATCTCGCTGGA AJ250203 
 tet32 AGGTTTCCCTGTCGCCAAAGATAACCATGACCGATATTTCTGATTTGGACAAATGGGATATGATTATTTCCGGA AJ295238 
 tet33 ATTGGGCAGGCTCCAGGTGCGACCTGGGTGCTGTTTACTGAACACCGCCTCGACTGGAGTCCCGTCGAAGT AJ420072 
 tet34 ACGACGAAGATTGCGATACCAACGCTGACCTGAGTTTTCACGCATTTCATCGAGCAACGCACGATTGGTTGGCA AB061440 
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 tet35 AGCTAACTACGCGTTCTGGCAGGATGCCATTTTAGACTTCGACAGCCACGACAGAATCGCACAAACGA AF353562 
 tet36 CAGCAGAGGTCAGTTCCTACACACAAGGCTTGGGCGTTTTTGTTACTCGATTTTCGGGTTATCGACCTACCA AJ514254 
 tet37 AGACTGATCCAGGCTTGGTTATCTGCTACGGAACGATGTATGGGAACACAGAGGATCGCACACCGTCGAT AF540889 
 tet38 ACGACAGTAAGTTGGCAAGCGACATTAGCCGGTTTAGTAATTGGTATTGGCGCTGTAGTATACGCT AY825285 
 tet39 ATGGCTGCTGCTCCTTCTCTATTGTGGCTATATATTGGTCGTATTTTTGCGGGAATTACAGGTGCCAACATGGCTGT AY743590 
 tetA TGCCGGCCGCGCTTTGGGTCATTTTCGGCGAGGATCGCTTTCACTGGGACGCGACCACGATCGGCATTT AF534183 
 tet(A) ** CAGCCTGACCTCGATCGTCGGACCCCTCCTCTTCACGGCGATCTATGCGGCTTCTATAACAACGTGGAAC AJ634602 
 tetAP * ATTGTATGGGGATTAGGGTCTACTTTTATCAGTGGCTCGCTTGAAGCTTGGATTGCAGAAGAAGAGAAGA L20800 
 tetB TGCCGATACCACCTCAGCTTCTCAACGCGTGAAGTGGTTCGGTTGGTTAGGGGCAAGTTTTGGGCTTGGT AB084246 
 tetBP ATGGAGCAATACTAGTTATATCAGGAGTAGAGGGGATTCAGTCACAAACAAGAATATTATTTGACACA L20800 
 tetC * TGCATGCACCATTCCTTGCGGCGGCGGTGCTCAACGGCCTCAACCTACTACTGGGCTGCTTCCTAATGCAGGAGT AY171578 
 tetD ACTCGGGGCGATGCATGCACTGTTTCAGGCGGTGGTTGCCGGGGCGCTGGCAAAACGGCTGAGTGAGAAAACCA L06798 
 tetE ATGCCTGTCTTGCCGGCGTTATTACGGGAGTTTGTTGGAAAGGCTAATGTTGCAGAGAACTACGGTGT Y19116 
 tetG ATTGCCGGGCCAGCACTTGGTGGCATGCTCGGTGGTATTTCTGCTCATGCTCCGTTTATCGCCGCTGCCCT AF133139 
 tetH GGCGCATCATTGCGGGGATCACAGGCGCAACAGGTGCCGTATGTGCATCAGCGATGAGTGATGTGACTCCCGC Y15510 
 tetJ ACGGGACTTGGCTTCTACAGGGTGGTTTCAATCTATTCTTGCTGAAGCCATGGCCATCACGGGAAAAGCAT AF038993 
 tetK ACTACTCCTGGAATTACAAACTGGGTAAACACTGCATATATGTTAACTTTTTCGATAGGAACAGCAGTA S67449 
 tetK 2 * ATTTTTGGTAGGTTAGTACAAGGAGTAGGATCTGCTGCATTCCCTTCACTGATTATGGTGGTTGTAGCTAGA M16217 
 tetL * ACCACCTGCGAGTACAAACTGGGTGAACACAGCCTTTATGTTAACCTTTTCCATTGGAACAGCT M11036 
 tetM ATCCCCTCCCTCTGCTGCAAACGACTGTTGAACCGAGCAAACCTCAACAAAGGGAAATGTTACTTGATGCACT X04388 
 tetM 2 CCGCACCCTCTACTACAAACAACTGTTGAACCGAGTAAACCTGAACAGAGAGAAATGTTGCTTGATGCCC AP009324   
 tetO AGGCACAACAAGGACAGATACAATGAATTTGGAGCGTCAAAGGGGAATCACTATCCAGACAGCAGTGACA M18896 
 tet(O) ** GAAAAGCAGAATATACCATCCACATAGAAGTCCCGCCAAATCCTTTCTGGGCTTCTGTCGGGTTGTCCAT M18896 
 tetO 2 AGCGTCAAAGGGGAATCACTATCCAGACAGCAGTGACATCTTTTCAGTGGGAGGATGTAAAAGTCAACAT M18896 
 tetQ CCGCAAAGGAAGGCATACAAGCGCAAACAAAGTTGCTGTTCAATACTTTACAAAAACTGCAAATCCCGAC Z21523 
 tet(R) ** ATGTTTATCAGTGATAAAGTGTCAAGCATGACAAAGTTGCAGCCGAATACAGTGATCCGTGCCGCCCTGG AJ634602 
 tetS * CGGTATCTTAGCACATGTTGATGCAGGAAAAACTACTTTGACAGAAAGCTTACTATACAGTAGCGGAGCAAT L09756 
 tetT * ACCTGGGCACATGGATTTCATAGCCGAAGTTGAGCGAACTCTGAAAGTGTTAGATGGAGCTAT L42544 
 tetU * ACGTGGCAAAGCAACGGATTGGCATGCGATGGTTCAGGAAAGCTTAGATAGTTTTGCAAGCCCGCAT U01917 
 tetV AGTTCTACCCGGTGGTGGTGTCGACGCTGATCTACATCGTGACCACGATGGCCTCGGGCAACCCCATGCT AF030344 
 tetW 2 ACCGGGGAGCGTCGAAAAAGGGACAACGAGGACGGACACCATGTTTTTGGAGCGGCAGCGTGGGAT DQ294299 
 tetW * TGCCCATGTAGACGCTGGAAAGACGACCTTGACGGAGAGCCTGCTATATGCCAGCGGAGCCAT AJ222769 
 tetX CTTGCCCTAAAAGATTGATTGGAATTTATTCAGGACTGCCTATCACTTAGATAGAAGTCCAAGGTCTGCT M37699 
 tetY ACCGGCACTCTTTCAAAGCGACTGGGTGACCGCGGTGTGTTGCTGCTTGGAATGGGCGCTGATATGTGCGGGT AF070999 
 tetZ * AGCAAACCGCAGAGGTCGGCAATGCGAGCGTTCCTGAACGCGACCGGGAATTCGATTTCGGCCTGACAGCACT AF121000 
Trimethoprim    
 dfr1 ** AGCCGGAAGGTGATGTTTACTTTCCTGAAATCCCCAGCAATTTTAGGCCAGTTTTTACCCAAGACTTCGC AJ400733 
 dfrA1 ** TTATCTCTCCTCCCGTCGTAACAGCAAAGCTGCATACCGGTTTCTGGGTAAAATCCTCAACAACGTGAAG AJ628353 
 dhfrI ** CAGTTTTGATTATGGGTAGAAAAACTTTTGCCTCACTGCCTAAAGTGCTGCCCGGACGACTTCATGTGGT X57730 
Tylosin    
 tlcC ACGGCCGAGAACAGGGGCTTTCGCATGCGTACATCACCTTCCTCCCAGCTTTCCCTGCACGGTGTCACCA M57437 
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Vancomycin    
 VanB * ACCGGAGGCGAGGACGCTTACCTACCCTGTCTTTGTGAAGCCGGCACGGTCAGGTTCGTCCTTTGGCGT U00456 
 vanC * AGGCAATTCACCGGAATACACCGTTTCTTTAGCTTCAGCAACTAGCGCAATCGAAGCACTCCAATCATCT AF162694 
 vanC2  CACCGTTTCTTTAGCTTCAGCAACTAGCGCAATCGAAGCACTCCAATCATCTCCCTATGACTACGACCTC L29638 
 vanD4-5 AGCCCTGCCGGGACTGGGAGAACTATGCGGGATACCCGGCTGTGATTTCTCCGGACAGAAGGATCCATGGC AF277571 
 vanZ ACAAATACTGTTGGAGGCTTTCTTGGACTGAAATTATATGGTTTAAGCAATAAGCATATGAATCA M97297 
Virginiamycin    
 vgbA ACAGAGTACCCACTACCGACACCAGATGCAAAAGTCATGTGTTTAACTATATCCTCAGATGGGGAAGT M20129 
 vgbB AGGTGGCTTTACAGAATATCCATTGCCACAGCCGGATTCTGGTCCTTACGGAATAACGGAAGGTCTAAATGGCG AF015628 
Miscellaneous AMR 
Acetyltransferase    
 vatA ACCATCGGATGGATGGATCAACATATCCTTTTCATCTATTCAGGATGGGTTGGGAGAAGTATATGCCTTCCT L07778 
 vatD CGGGGATGGTGCAATAGTAGCTGCTAATTCTGTTGTTGTAAAAGATATAGCGCCATACATGTTAGCTGGAG L12033 
 vatE TCGGAAATGACGTGTGGTTTGGGCAAAATGTGACCGTCCTACCAGGCGTAAAAATAGGTGACGGTGCCAT AF139725 
Aminoglycosides    
 aadB TACTTTTACTATGCCGATGAAGTACCACCAGTGGACTGGCCTACAAAGCACATAGAGTCCTACAGGCTCG AY204504 
 aac(3)-Id ATTAAAAAACTCAAGGCTATAGGCGCAGCGCGTGGAGCTTATGTGATTTACGTCCAAGCTGATAAAGGCG AY458224 
 aac(3)-III CCTCATGACTGAGCATGACCTTGCGATGCTCTATGAGTGGCTAAATCGATCTCATATCGTCGAGTGGTGG X13542 
 aac(6)-Ib* AAGTCGCCTGGAAAACGGCATCAGAATACGATTCAAACGGCATTCTCGATTGCTTTGCTATCGAAGGAAA AY103455 
 AAC6-Ie CCAAAAACTGATGAGATAGTCTATGGTATGGATCAATTTATAGGAGAGCCAAATTATTGGAGTAAAGGAATTGG M18086 
 AAC6-Ii ACAGCTCGGCAGAAGAAGTAGAAGAAATGATGAATCCAGAACGAATCGCGGTAGCAGCGGTAGACCAAGAT L12710 
 AAC6-Im AGCGAGTTTCCTTTCGCCCGATGAATGAGGATGATTTAGTTCTAATGTTAAAATGGCTGACAGATGACCG AF337947 
 aacC1 CCGCAGTGGCTCTCTATACAAAGTTGGGCATACGGGAAGAAGTGATGCACTTTGATATCGACCCAAGTAC U04610 
 aadA1 TCATATCGTTTTAACCCTGGCGCGTATCTGGTACACCCTTTCTACCGGGAGATTTACCTCTAAGGATGCG NC003198 
 aadA1b AGGTATCTTCGAGCCAGCCACGATCGACATTGATCTGGCTATCTTGCTGACAAAAGCAAGAGAACATAGC AJ62853 
 aadA2* AAAACGCCTACCTGCCCAGTATCAGCCCGTCTTACTTGAAGCTAAGCAAGCTTATCTGGGACAAAAAGAA AY263741 
 aadA7 GATCTCTTCAGCTCAGTCCCAGAAAGCGATCTATTCAAGGCACTGGCCGATACTCTGAAGCTATGGAACT AY458224 
 aadE AGCCACAGCCGCCAGAGAACATGATGGATATTCCGGGGATGGCGGATGAAATGCGACGCCCAATGATGCT CP000408 
 aadE 2 GAAGCATTATTTCTATGCCATCAATTGTTCAGGGCGGTATCCGGTGAGGTGGCGGAAAGGCTTCATTATG AF516335 
 aadK AGTGGCTCGAAATCTTTGGGAAGCGCATTATGATGCAAAAACCAGAAGATATGGAGCTTTTTCCTCCCGA M26879 
 ANT4-Ia GGGGATGATGTTAAGGCTATTGGTGTTTATGGCTCTCTTGGTCGTCAGACTGATGGGCCCTATTCGGA PB0110CG 
 ANT6-Ia AGCGCAAGGGAGTATGATGATTGCTGCAATGAATTTTGGAATGTAACACCTTATGTTATTAAAGGATTGTGCCGT AF516335 
 ANT9-Ia AGGAGTGAAGTTGTCCCTTGGCAATATCCTCCAAAAAGAGAATTTATATACGGTGAGTGGCTCAGGGGT X02588 
 aph TTCTTGAGCTTCTCGGGCAGACGGAACTAACCGTCAACAAAATCGGATATTCCGGAGATCACGTCTATCA X03364 
 APH2-Ia ACTATGTCAGAAGAAGAACAAAATTTGTTAAAACGAGATATTGCCAGTTTTTTAAGACAAATGCACGGT M18086 
 APH2-Ib AGGATGCCCTTGCATATGATGAAGCGACGTTTTTGAAAGAGTTACATTCCATAGAGATTGATTGTTCTGT AF207840 
 APH2-Ic AGCATACAATCCGTCGAGTCGCTTGGTGAGGGCTTTAGGAATTACGCGATCCTCGTCAATGGAGATTGGGT U51479 
 APH2-Id CCATTCCGGAGGTGGTTTTTACAGGAATGCCATCAGAAACGTACCAAATGTCTTTCGCAGGT AF016483 
 aph3’’ TTTTTGGTGAATCGCATTCTGACTGGTTGCCTGTCAGAGGCGGAGAATCTGGTGATTTTGTTTTTCGACG AYO55428 
 APH3-III ATGCTATGGCTGGAAGGAAAGCTGCCTGTTCCAAAGGTCGTGCACTTTGAACGGCATGATGGCTGGAGCA M36771 
 APH3-Iva ACCGTCAACAAAATCGGATATTCCGGAGATCACGTCTATCACGTGAAAGAGTACAGGGGCACCCCCGCAT X03364 
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 aph6  TCATTGCCAGACGGGACTCCTGCAATCGTCAAGGGATTGAAACCTATAGAAGACATTGCTGATGAACTGC AYO55429 
 aphA-3 CAGGCTCTTTCACTCCATCGACATATCGGATTGTCCCTATACGAATAGCTTAGACAGCCGCTTAGCCGAA AF516335 
 aphAI TGCTCGAGGCCGCGATTAAATTCCAACCTGGATGCTGATTTATATGGGTATAGATGGGCTCGCGATAATG U13633 
Beta-lactams    
 bla1 GCGATTGATACTGGTACAAATCAAACAATCGCTTATCGACCTAACGAAAGGTTTGCCTTTGCATCAACT AF367983 
 ampC CACTATTTGAGCTCGGATCTGTAAGTAAAACTTTCACAGGTGTGCTGGGTGCGGTTTCTGTGGCGAAAAA AJ237702 
 ampR CTGGCCGGATTCTATGACAGCCATCCGCATATTGATCTGCATATCTCCACCCATAACAATCATGTGGACC AJ237702 
 bla2 AGCAGTTCCTTCGAACGGTTTAATCCTTAATACTTCTAAAGGATTAGTACTTGTCGATTCTTCTTGGGAT  AF367984 
 blaCMY-2 ATATCGCCAATAACCACCCAGTCACGCAGCAAACGCTGTTTGAGCTAGGATCGGTTAGTAAGACGTTTAA X91840 
 blaCTX-M-1 TTGCCGAATTAGAGCGGCAGTCGGGAGGAAGACTGGGTGTGGCATTGATTAACACAGCAGATAATTCGCA DQ663489 
 blaCTX-M-12 AGACTGGGTGTGGCATTGATTAACACAGCGGATAATTCGCAAATACTTTATCGTGCTGATGAGCGCTTCG AF305837 
 blaFOX-2 AATGACAAGATGCAAACTTACTATCGGAGCTGGTCACCGGTTTATCCGGCGGGGACCCATCGCCAGTATT Y10282 
 blaIMP-2 ATTGGTTTGTGGAGCGCGGCTATAAAATCAAAGGCACTATTTCCTCACATTTCCATAGCGACAGCACAGG AJ243491 
 blaKPC-3 CATCCGTTACGGCAAAAATGCGCTGGTTCCGTGGTCACCCATCTCGGAAAAATATCTGACAACAGGCATG AF395881 
 blaOXA-2 GCAGGCCACAATCAAGACCAAGATTTGCGATCAGCAATGCGGAATTCTACTGTTTGGGTGTATGAGCTAT M95287 
 blaOXA-26 GTTACTCCACAGGTAGGTTGGTTGACTGGTTGGGTGGAGCAAGCTAATGGAAAAAAAATCCCCTTTTCGC AF201287 
 blaOXA-27 GGCGAGAAAAGGTCATTTACCGCTTGGGAAAAAGACATGACACTAGGAGAAGCCATGAAGCTTTCTGCAG AF201828 
 blaOXA-2b AGCAATAAAGAGGTGGTAAATAAAAGGCTGGAGATTAACGCAGCCGATTTGGTGGTCTGGAGCCCGATTA AY303807 
 blaOXA-61 ATGATGGAAAAACTTGGGCGAGTAACGACTTTTCAAGGGCTATGGAGACTTTCTCTCCCGCTTCCACTTT AY587956 
 blaOXA-9 TCCGTGCTCGTCTTTTAAACTTCCATTGGCAATCATGGGGTTTGATAGTGGAATCTTGCAGTCGCCAAAA M55547 
 blaOXY-K1 GCACCACCAATGATATTGCGGTTATCTGGCCGGAAGATCACGCTCCGCTGATATTAGTCACCTACTTTAC AF473577 
 blaPER-2 TTATGGAAATGGATGGTTGAAACCACCACAGGACCACAGCGGTTAAAAGGCTTGTTACCTGCTGGTACTA X93314 
 blaPSE-1 TGTGGAGTGAGCATCAAGCCCCAATTATTGTGAGCATCTATCTAGCTCAAACACAGGCTTCAATGGCAGA AB126603 
 blaROB-1 TATTATTGCTGACATTAACGGCTTGTTCGCCCAATTCTGTTCATTCGGTAACGTCTAATCCGCAGCCTGC AFO22114 
 blaSHV-37 CTTGAGCAAATTAAACTAAGCGAAAGCCAGCTGTCGGGCCGCGTAGGCATGATAGAAATGGATCTGGCCA AF317502 
 blaSME-1 GATGAGCGGTTCCCTTTATGCAGTTCATTTAAAGGTTTTTTGGCGGCTGCTGTTTTAGAGAGGGTGCAAC Z28968 
 blaSME-2 TTAGGTTAGATCGCTGGGAACTGGAACTTAACACTGCAATCCCAGGAGATAAACGTGACACTTCAACGCC AF275256 
 blaTEM TTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGAT AJ634602 
 blaVIM-2 TTATTGGTCTATTTGACCGCGTCTATCATGGCTATTGCGAGTCCGCTCGCTTTTTCCGTAGATTCTAGCG AF369871 
 blaZ AGTGGTCAAGCAATAACATATGCTTCTAGAAATGATGTTGCTTTTGTTTATCCTAAGGGCCAATCTGAACCTAT M60253 
 mecI TGCAAGTGCGAATAATATAATAGAAGAAATACAAATGCAAAAGGACTGGAGTCCAAAAACCATTCGTACA D86934 
Dihydrofolate reductase   
 dfrA ATTGTCGCTCACGATAAACAAAGAGTCATTGGGTACCAAAATCAATTACCTTGGCACTTACCAAATGAT AF051916 
 dfrD AGGTAGAAAGAACCTTCAATCAATCGGAAGGGCTTTACCTGACAGAAGAAATATTATTTTGACTAGAGA Z50141 
Efflux pumps    
 cmeA TTTAGGTGTTGTGCTTTTACTCGCTGCTTGCAGCAAAGAAGAAGCACCAAAAATACAAATGCCGCCTCAA AR466820 
 cmeB TTGCCAATGATTTTCGCAACAGGAGCAGGAAGTGCTTCAAGACACTCTTTAGGAACAGGGCTTATTGGTG AR466820 
 cmeC AAAATTTGATGGTAGCGCAAGCGGAAGTCGTGCAAAAACAGCTATAAATGCTCCAAGCAATCGAACTGGG AR466821 
 cmeR ACTCAAATAGAACACCATCACAAAAAGTTTTAGCCAGACAAGAAAAAATCAAAGCAGTGGCCTTAGAGCT AR466820 
 mef ATTTTGGGACCTGCCATTGGTGTGCTAGTGGATCGTCATGATAGGAAGAAGATAATGATTGGTGCCGAT u70055 
 mef(A/E) CGATTTTGGGACCTGCCATTGGTGTGCTAGTGGATCGTCATGATAGGAAGAAGATAATGATTGGTGCCGA AY319932 
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 msr(A) CACCACGGAAATCGCTAACGCCACACCGTTTTATTATGCCGAAGATGACCACCAGCAATATCTGCATAAA NC_002655 
Glycopeptides    
 vanA AAAACCTTGCGCGGAATGGGAAAACGACAATTGCTATTCAGCTGTACTCTCGCCGGATAAAAAAATGCAC AF516335 
 vanB2 AAAAGTCGCAATCATCTTCGGCGGTTGCTCGGAGGAACATGATGTGTCGGTAAAATCCGCAATAGAAATT AY145441 
 vanD TTTACTTCCTACAGCCGTTATCCCCGCATGATGACAGCAGCCGGTTTTACGCTTACTGAAATACTGGATC AY489045 
 vanE TGGTTGTGGTATTTTAGGAAATGAACAATTGGTCGTTGGAGAATGTGACCAAATCAGTCTTGTGGATGGC AF430807 
 vanG AATTGGCAGGAATACCTGTTGTTGGCTGCGATACACTCTCATCAGCTCTTTGTATGGATAAGGACAGGGC AF253562 
 vanH GAATCCAACGCCAAATCCGCGCCTTTCAATCAATGTATCAGTGTGGGACATAAATCAGAGATTTCCGCCT AF516335 
 vanR ATCATGCTTCCCGGCACAAGCGGCCTTACTATCTGTCAAAAAATAAGGGACAAGCACACCTATCCGATTA AF516335 
 vanX TACCGTCCTAATCGTGCTGTAAACTGTTTTATGCAATGGGCTGCACAGCCGGAAAATAACCTGACAAAGG AF516335 
 vanY TTGATGAGCAAAGTGTGCTTTACCAAGAAATGGGGGCTGAGTATGCCTTACCAGCAGGTTATAGTGAGCA AF516335 
Lincosamides    
 linB TGAAACATAGTATAACCTCGAACTTTGATTCATCCAACTGGTTGTTTGACGTAGCTCCGTACTTGATGCT AJ238249 
Macrolides    
 mph(A) CCGACATGGGCTCAAGCTCCATGGCCCGCTGACTGTCAATGAGCTTGGGCTCGACTATAGGATCGTGATC AY522923 
 mphB AGCCGCAGCGCTTGATCTTGTAGTACACACACCAGAAGAAGCAAGAATGTCAATGAAGCAGCGTATGGATGCAG D85892 
 mphBM ACGTCACAGGTCTCATAGACTGGACTGAAGCAACCCACTCCGACCCATCAATGGACTTTATGGGACACCATCGT AB013298 
 mphK ACTGTACGCACTTGCAGCCCGACATGGGCTCAAGCTCCATGGCCCGCTGACTGTCAATGAGCTTGGGCT U36578 
O-nucleotidyltransferases   
 lnuA ACTCATTGGTTAGATGGAGGCTGGGGCGTAGATGTATTAACTGGAAAACAACAAAGAGAACACAGAGA J03947 
 lnuB CATCCAACTGGTTGTTTGACGTAGCTCCGTACTTGATGCTTTATAAAAATGAGTACGGAACAGAGGTAGT AJ238249 
Quat. Ammonium    
 qac GCAATAGTTGGCGAAGTAATCGCAACATCCGCATTAAAATCTAGCGAGGGCTTTACTAAGCTTGCCCCTT AY458224 
Metal Resistance 
Aluminum    
 BnALMT1 AAGGACTAAATCGAGGAGTGGCAACATTAGTAGCAGGAGGACTAGCACTTGGAGCTCATCAGCTAGCA 110082270 
 BnALMT 2 TAGATACGAGTTGCGTACATGGGGTCGGGATGATGCTAGAACATTCATTGGGTGTTCGTATACTTCAGAT AB194301 
 ybaX CAGTAGCCTGACGCGTGACAGCATTCCGGTGCCTGATTATGAACCTGAAGCCGATGGTATCCCGAATACG U00096 
Arsenic    
 arsB GGCGTCATGACGGCGTTTCTGTCTTCGATCATGAACAACATGCCCACCGTGCTCATCGGGCTGCTGTCC 71553748 
 arsC GGCGCACCGCCGGACATCGTCATCACCGTTTGCGACGCCGCCGCGGGGGAAGCCTGCCCGCTGTATCTCG CP000438 
 arsD TCGAAGTGTTTGACCCATCGCTGTGTTGCAGCACCGGCGTCTGCGGCGTGGATGTTGACCAAGCCTTGGT DQ057986 
 arsH CAGTTGCGCGTGCTGGGTCGCTGGATGCGCATGTTCACCATCCCCAACCAGTCCTCGGTTCCCAAGGCCT CP000438 
 arsR ACCGCCTGAACCCTGCGCTGCCGGCCTGGATCCACGAAGTCCTGCAAGTGACCCTGCGGGCCAACGGCGA CP000438 
Cadmium    
 cadA TGTTAAAAAGATTCCAGGCGTTCAGGACGCAAAAGTAAACTTTGGCGCTTCTAAAATTGATGTATATGGA AB179623        
 cadD TGAGATGTTTTATGATTCAAAATGTCGTTACTTCAATAATCCTGTATTCTGGGACAGCCGTAGACTTACT AL157959 
 cadD2 TTGGAAAAATATAGCAGATGGTTTGTTGCTGTTGTTTATTTAGGATTGGGGGTATATATCCTGATTGAAA AL157959 
 cadD3 GGTGCTGACAATATTGGTGTCTTTGTTCCATATTTTACTACCTTAAATTTAGTGAATTTGATAGTGGCTT AL157959  
 cadD4 TTTAGTGAATTTGATAGTGGCTTTACTTACCTTTCTAGTCATGATTTATCTCTTGGTTTTTTCTGCCCAA AL157959     
 colR CGCACCCTGCAGGTGGCTGACCTGAGCTACGACCTCGATACCCTCGAGGTAACCCGCCAGGGTCGTCTGC AM279159 
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 colS TGGCGCGACACCATCGAACAGAAAGGCCTCACCCTGTATTTCGATGGCCGCGTGAGCGCTAGCCCTGTGC AM279160 
Chromate    
 cysA CATGCGCGGCTGTATAACGGCGACGAGCGTATCGAAACCCGCGATGAGGAACTTGCTCTCGCACAAAGCG U00096 
Cobalt/Nickel    
 cnrA GTGGAGCCGGACACGGGGAAGATGGCAGCATACGGAGTTTCCTACGCGGACCTAGCCCGGGCGCTCGAAG AJ276513 
 cnrB TCCCAGTGTCGGAGAAGTCCCCCGCATCTACACAGGCCCCGGAAGCACAGAAGCCACAATCCGCCCCAGT AJ276513 
 cnrC TGGCGTCAGTGCGGGCGTCCGCCGCTATGGCTGGACCAATTCCAGTGGCTATGTGGTTGGGGTCACGGCC AJ276513 
 cnrH CGTCCAGGACACCTTTGTTGCCGCCTGGCACGCCCTGGATGACTTCGATCCCGACAGGCCATTTCGCGCC AJ276513 
 cnrT TCCTGCTTGCGTTTGCGATCTGGCCTGAGGTGCCAGGCTTCGCATTCTGGGCGGCTTTGGCTTTGATGGC AJ276513 
 cnrX GCTGTTCCACTAGATGCCAACGAGCGCGAGATTCTTGAGTTGAAAGAAGATGCCTTTGCGCAGCGTCGGC AJ276513 
 cnrY TGCAGCCTTGGTCGCGTTTGCGGCAATCAATCGCGTGGCGACCATCATGTTGGAAAAGCCTGCCCCGACG AJ276513 
 ncrA AGGCTTCATTCATCGCCCTGACTGTTGTGGCAACATTGTCGCTGGTCACCGCCGTACTTATCTGGCGTCC DQ517331 
 ncrB TTTTATAAACAGCGACCACAGACGCATCAAAACTCAAGCTCTGCACCACAGAGCTTTTACTATCAAAATC                CP000241              
 yohM GGATGCCCATGCACGAGCCCATGCCAATGACATTAAACGACGCTTTGATGGTAGAGAGGTCACCAACTGG U00096 
Copper    
 copA GCCGCGATCCGAGCCGCACGATAGAGCTGCACCTGACCGGCCACATGGAGAAATTCGCCTGGTCGTTCAA AY321492 
 copB TGGAATCGCACTTACGGCAACACCGCCGACTACGCCCGCGAAGAAGACGAGGATCGCAGTGAGGCGCGCC AY321492 
 copC TGGTCACGCAATTCTCCGGGGCCAAACTGGTAATGACCGAAATGGGTGGCAGGGCCCACTCGCCGATGCC AY321492 
 copD TTTCATCTTGGACCGTCACTGCAACAATCGCTGCGCGACGGCCAGTACCTCATCGCCGCGAACGCGCTGC AY321492 
 copP ATTTGACGCTCCAGCGACACAGGATTTGATCAAAGAAGCTTTATTAGATGCTGGGCAAGAAGTGGTGTGA AE000511 
 cueO GCTAATGGAGAAATATGGCGATCAGGCGATGGCCGGGATGGATCACAGCCAGATGATGGGCCATATGGGG U00096 
 cueR AAACGGCGCACGCTGGAGAAGGTGGCGGAGATCGAACGACACATTGAGGAGCTGCAATCCATGCGCGACC U00096 
 cutA GCTGGAATGCCTGAAGTCTCATCATCCATATCAAACCCCGGAACTTCTGGTTTTACCTGTTACACACGGA U00096 
 cutF ACGGAACATGGGTGATGAATGAGCGTTATCTCGGTGCTCGTGAAGAACCTTCCTCCTTCGCTTCCTACGG U00096 
 dipz TGGGCATTTGGTGCGACGCATACCGCGCAAACTCAGACGCATCTCAACTTTACACAAATCAAAACGGTAG U00096 
 int TGGACGGTGAGTTGCGTGATAAAGGTAGCTCGCTGGTAACCGGGATTGTCGACGCGCGTCTCAATAAGCA U00096 
 pcoA TGAAAATGACGGTCGTGGCTGCAGATGGCCAGTATGTAAACCCGGTTACCGTTGACGAATTCAGGATTGC AY378100 
 pcoB TACTCCAGCCATCCTATGAGGTGAATTTCTACAGTCAGGATGATGAATCGCGGGGTCGCGGCAGGGGACT AY378100 
 pcoC ATTCTCAGGTGCAAAATTAACGATGACGGGTATGAAAGGCATGTCATCACATTCTCCGATGCCGGTCGCG AY378100 
 pcoD GCTGGATTGTCAGGCTCTGTGCCCTGTTTACCACACTCGGTGCTTTGTTCCTTTACACTAATAAGAGAGT AY378101 
 pcoE CACATCGATTTGTTAATAATGCCTCAGCCGTCAGTCATGTGAACTCCTCGACGCATGAAAACTTACCGGA AY378102 
 pcoR TTCTGCTTGAGTTGCTGCTGCAACGCACCGGAGAAGTGTTACCCAGGAGTCTTATCTCGTCCCTGGTCTG AY378103 
 pcoS TGCTCCGACGTGCTTTCAGTAACCTGCTTTCCAATGCAATCAAGTATTCTCCCGATAACACCTGTACAGC AY378104 
Copper/Silver    
 cusA CTGGTTTCTCAAATATGAGCTAAAAACCATCCCTGACGTTGCGGAAGTGGCGTCGGTGGGCGGTGTGGTG CP000468 
 cusB CGAGTATCAGTATGCCATTGTGCAGGCCCGCGCCGCCGGGTTTATCGACAAGGTGTATCCGCTTACCGTG CP000469 
 cusC GCATCGCTGCAAATTACTTTGCAACGGGCGCGGGCATTATATCAGCACGGCGCAGTAAGTTATCTGGAAG U00096 
 cusF CTGCAAGTCGCAATGTTCAGTCTGTTTACCGTTATTGGCTTTAATGCCCAGGCTAACGAACATCATCATG U00096 
 cusS GAGATTAGCGCCACCCTTGAACGGGTACTAAATCACCCTGACGAAACGCAAGCCCGACGCTTAATGACGC U00096 
Copper/Zinc/Cadmium   
 copABCD GCCGCGATCCGAGCCGCACGATAGAGCTGCACCTGACCGGCCACATGGAGAAATTCGCCTGGTCGTTCAA 
                  
AY321492                 
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 czcA TGAGTGGGCGAAATATCCGGGAAAGCGTCCACTGGAGTGTTGATAAAACTATAAGTCCCAAAAAATAAAA AE000511 
 czcA 2 GCCGCGATCCGAGCCGCACGATAGAGCTGCACCTGACCGGCCACATGGAGAAATTCGCCTGGTCGTTCAA AY321492 
 czcB 1 GTCTTTAGGCTGTGAGCCTTGAATATACATTTCTACCATTTCCCCCACATGGTAATTGCCCTCATCTAAT AE001439 
 czcB 2 GCGCGCTTCAATGTGCCTAATCTTAAATTGCTTTATTACCCTAACATGTTCGCTCAAGTAGAAATCTTTC AE001439 
 czcC CTGACCGTCAGCGTCGGCAGCCAGTACAGCCGCGAAGAGCGCGAACGGGTCAACGTAGTGGGTCTGTCGA CP000058 
 cznA TTTTCCATTTCTTCAGGGCTAGAGCCGGGGAGTTTTAAAATGATTTTAACTTGAGTGGGCGAAATATCCG              CP000241              
Iron    
 iroA CAGACATACGGCATTAAAAAACCAAGTGAAGGAGGGGAATATTTCCTGGCGGAGGGCGAGAGTGAGCTCA X69214 
 iroB GGCTGCGGGATTATCCCCGGCAACGTCGGCCTGTCGAGTAACATGATCAATGCTTTCCTCAACAATCGCT AY365116 
 iroC GGCGCTGATTGTTGCACATCGTCTGACCACCGCGCAACGCTGCGATCTGATTGCCGTTATTGATAAGGGG AY365116 
 iroD TGGTGCTCAGCCACTCTCCTTCAATGTGGTGGACGCCAGAAAGAACCAGTCGACCAAGCTTGTTCAGCGA AY365116 
 iroE CGTGGCTGTCGGGTATCAGACCAACTTCCCTTTCGATCTCAACAGCAGGGCTTACGACTATACGCCAGCA AY365116 
 iroN TGAACTGGAATACCAATGCCACATGGATGATCACTTCGGAGCAAAAAGACACCGGTAATCCTCTGTCGGT AY365116 
Iron/Aluminum    
 pmrA AATATAGGCCGCCATCAGGCATGGAGGGATGGACAGGAACTGACCCTGACGCCTAAGGAGTACGCGCTGC AL627282 
 pmrB GATCGCCATTCACAGCTCCACGCTTGAGATTGAGTCCGTCGTCTCGGCGATCAATCAACTGGTTACGCGT AL627282 
Lead    
 pbrA GAATTCAACGCGCTGCCCGGTCGGGGTGTGCAAGGCCAAATCAACGGTGCGACCTACCATCTGGGCAACC AY378100 
 pbrBC GATGGCTGTGTTCGCCGATATGGGTGCCAGCTTGCTTGTTGTCGGCAACGGCTTGAGGTTGTTGCGCCGA AY378100 
 pbrR TCGCCAAGCGCTCTGGGTGCGAGGTCGTGACCATCCGCTACTACGAGAAGGAAGGGCTACTGCCAAAGCC AY378100 
Mercury    
 merA TCCGAAGGGGACGGCGCAAATCGCTACCGACCCCGGCACTTCGACGGATGCGCTGACTGCGGCCGTGGCC CP001068 
 merE TGCAGGAACAGCACTGGGATCATACTTCACGGAATTTAAAAATGTTATTTTCATCATGATGGGTCTGTTA AB066362 
 merP  TGATGTTGCTATCCCTTATGCTAGTGGTTAGTGCATGCAGTAACGAACAAGAAGTCCAAAAAACTGAAGT AB066362 
 merR CTGAGAGAAACGATGGCTCCATATCTAACAATGGCAGAAGGATTGAAGCTGGCTGTCCTAACTTTTGATA AB066362 
 merR1 TGCTGATGGATCTTAAAGAAAGATGTCCCGAAAACAAAGATATTTACGAATGCCCCATTATTGAAACACT AB066362 
 merR2 TTTATTTAACAAGCCTACTTCAAAAGAGTGTAACATCCAATCTACTAAGTACTTAGATCGAATTATTAAG AP006716 
 merT CACTAATCTTGATTCCCCTTGGACTCACTGGGTTTGCAGGCGCAATCGCATTCTACTCGTTGAAGTATCG AB066362 
Nickel    
 ncrC GGATACGCTGGCGCGGCGGGCTCCATACTTCTCAAGCGTACTGATTGCACTTGTCGGCATTTACATGGGC DQ517331 
 ncrX AGGCTCTAGCCTGGCAAATGCTTTAATCAGCATCTCATCAACCATGTCCATAGCAGGCCGTTCTGAAACG AF322866 
 ncrY AGGCAATGTTGTCAGCCAGCAGCAGGACGAGTGGTATACGTTCCGCGACCCAACCGGTACCATCAAAGTC DQ517331 
Nickel/Cobalt/Cadmium   
 nccB TTTTATAAACAGCGACCACAGACGCATCAAAACTCAAGCTCTGCACCACAGAGCTTTTACTATCAAAATC AE000511 
Silver    
 silA CAACCGGGATCAAAAGCCCGATAGGTATCAAAGTGTCCGGGACTGTTCTGTCCGATATCGACGCGACGGC AF067954 
 silB ATTCAAAGGCTGCGTTCAACCCGCACAATCCAGACCCGTTTTACCATTAAAGCACCTATTGATGGTGTCA AF067954 
 silC TGCCAGAGGATTGTATGCAAGTGGTGCTGTCAGTTACATCGAAGTGCTGGATGCAGAACGTTCCCTCTTC AF067954 
 silE TGTCGGGATCCAGGGGACTGCACCTCGTATGGCCGGTATGGACCAGCATGAACAGGCCATTATTGCTCAT AY009387 
 silP CGACCTGATGATACTGAACAGGGCCCGTCATCTGTCAGAGATCACCATGAAAAATATCCGACAGAATCTG AF067954 
 silS GTTCAGAAGGGCGATCAATAATCTGTTATCCAATGCCCTGCGTTATACCCCGGAGGGACAGGCAATCACC AY378100 
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 sliR TCACGGAAAGCCAGTTTAGGGTGGCTGATCTCTCGATGGATCTCGTATCCAGAAAAGTCAGTCGCGCCGG AY378100 
Tellurite    
 tehA TGCAGAGCGATAAAGTGCTCAATTTGCCGGCAGGCTACTTTGGTATTGTGTTGGGGACGATAGGGATGGG CP000468 
 tehB AGAGGGGGAATTACGTCGATATTACGAAGGCTGGGAGAGGGTGAAATACAATGAAGACGTCGGCGAGCTG CP000468 
 terA ACCTTTTGCTCAATTAGATGGAGATGACAGAACAGGAAGTAATACACAAGGAGAAAATTTAAGAATAAAT AM180355 
 terB ATATATTTTGTAGCGAGTGTGGAGCAAAGTGTTTAAAAGGAAGCAAGTTTTGCAGTGAATGTGGAACGGA AM180355 
 terC CGCGTTTCATCATTCCTCGGCGCTATCGTGCAGATTATGCTGCTGGATATTATCTTCAGCCTCGACTCGG CP000468 
 terD CTATAGTAGTAGCTGAAATATATAAGCACAATGGAGAATGGAAGTTTAATGCACTAGGTTCTGGCTTTGA AM180355 
 terE TTAGATGTAAGTGTTTTCATGGTTGGAGAATCTCAAAGAGTTGAAAAAGATGAAGATTTTATATTCTACA AM180355 
 terY CCTTTAAGCACGAGTGGTGGCACCCCTTTAGATCAAGCGTTTAGATTGGCTAAGGATCTTATTGAAGATA AE000511 
Transferable Copper   
 tcrB TCGAAGGTGGATCTAGTCACCCTATCGCTCAGTCAATTATTAGTTACGCAGAACAGCAAGGGATACGTCC AY048044 
 tcrZ GCCAATACAGTGCAAGAAAAATTTTCAGCTATTGAAGGGGTTGAATCTGTAGAGGTTGATTTAGCGACTA AY048044 
Zinc    
 ybgR CGCGTGGCGACTGTTGAAAGATAGTGTGAATGAATTACTTGAAGGTGCACCGGTATCGCTGGATATCGCT CP000468 
 zraP TCGTTAGATGAGTTACGGGTGAAACGAGATATTGCGATGGCTGAAGCGGGTATTCCGCGCGGTACCGGAA CP000468 
 zraR CTGGTGGAAGTCGAAAAAGAGGTGATTCTGGCGGCGCTGGAGAAAACGGGCGGCAACAAAACCGAAGCCG CP000468 
 zraS TGCAAACAGCCGGGAGATCCAGTTACGCTTTACCGCCAACGACACATTACCGGAAATTCAGGCCGATCCG CP000468 
Plasmids and Trasposons 
Class I Integrons    
 intI 1 AAAACCGCCACTGCGCCGTTACCACCGCTGCGTTCGGTCAAGGTTCTGGACCAGTTGCGTGAGCGCAT DQ787712  
 intI1 2 CTACTTGCATTACAGTTTACGAACCGAACAGGCTTATGTCAACTGGGTTCGTGCCTTCATCCGTTTCCAC AY458224 
 intl 1 3 ATCAGTTGGAAGAATTTGTTCACTACGTGAAAGGCGAGATCACCAAGGTAGTCGGCAAATAATGT DQ274503 
Insertional Elements   
 IS1182 CGGGCCGCCAAATACAAAATATGCTGATAGATAGTATTCGGATGCGCTGCTTATCTCAAGAGCAATTCCC AF516335 
 IS150 AAAAGGGAACTGAGGGTTCACTGATTCTACATTCAGATCAAGGATGGCAGTATCAGATGCCACAATATCA AF516335 
Plasmids    
 Alpha 1 CCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCCGGGAA AY333433 
 ColE1 CGCTCTGCTAATCCGGTTACCAGTGGCTGCTGCCAGTGGCGTTAAGGCGTGCCTTACCGGGTTGGACT V00270 
 incN oriT ATGATGTATTTTTGATGTACTTTTGTTGTACTGGCTACCTCAGTACCAGATAATGATGTAATTCTGTTGT M30197 
 incP oriT GGTGCGAATAAGGGACAGTGAAGAAGGAACACCCGCTCGCGGGTGGGCCTACTTCACCTATCCTGCCCGG X54459 
 IncQ ACCCTCAGCCGAAATGCCTGCCGTTGCTAGACATTGCCAGCCAGTGCCCGTCACTCCCGTACTAACTGT M28829 
 incQ oriT TCGTAGGCTATCATGGAGGCACAGCGGCGGCAATCCCGACCCTACTTTGTAGGGGAGGGCGCACTTACCG M28829 
 incW oriT CATCATTGTAGCACCATCATAGCATTATAGTTGCATCATTGCTGCACGATAACCCAATGCGCATAGCGCA X51505 
 M13 GTTCTAGAGCGGCCGCCACCGCGGTGGAGCTCCAGCTTTTGTTCCCTTTAGTGAGGGTTAATTGCGCGCT U46018 
 mphC AGTGGAAAGTACATGCAAAAGACCTTATTGCTTACCCAAAACTTACAGGTAAACCCGCAGCCACAATAG AF167161 
 Orf14 ACCGATACCGTTTACGAAATTGGAACAGGTAAAGGGCATTTAACGACGAAACTGGCTAAAATAAGTAAACAG EF525477 
 orf46 hirt CTGATCGAAAAATACCGCTGCGTAAAAGATACGGAAGGAATGTCTCCTGCTAAGGTATAT AB264038 
 pAD1 TTTTGAACCAGAGAGGAAGCAATTTATAGCGCCTAAATTAATCAGAGCAGCTACTAAGGGATTTAGGCTA X62658 
 pAM alpha 1 GTGCTAAGTTATTGTTTTCGATTTTAAGGTGCTTATTTTGCGTTCTAAGCGTCTCGAAATCTTTCGTAAT AF503772 
 pBR322  AGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCT J01749 
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 pMMB66EH TTCAAGCGGTACAACGGCAAGACCCCGGAGAAGGGCGGGGCACAGAAGACCGAAGCGCTCAAGCCCAAGG X15234  
 pSLT GTACATAATGAGACTCAGGAAAGGTCATGGATTGACGTTGGTCACACTTGCGTGTTTATCCCTGCTGGGC AE006471 
 pUC19 TCCCTTCGGGAAGCGTGGCGCTTTCTCAATGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCG X02514 
 qnrS1 CAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACA DQ885572 
 RP4 IncP CGAGCTTGCGCCGGCTTCGATTGAAGGCTGGCCTCTCCCTGCGAAGCGTGAGGACAGTCGGCCCAACAGC X59793 
Transposons    
 res AATGGCTGGTGTTAACCAATTAGAGCGAGATCTTATTCGGATGAGACAACGTGAAGGGATTGAATTGGCT AF516335 
 Tn916 CCAGTGATAAGAGTATTTATCACTGGGATTTTTATGCCCTTTTGGGCTTTTGAATGGAGGAAAATCACAT EFU09422 
 Tn925 CACACGTCCGTAAAAGCATGAGCCAAAGAGGCGAAATTTTAATGCACTTAAAAGAACTAGACGCAAAGCG AY855841 
 tnpA GATGATCAAAACGCAGGTTGTCAAACTGACTACGTTCACGCGGCGATTATAGCCGATCAAATGATGAGCA AJ628353 
 tnpM CCAATGGAGGAACACCACCATGAACGCCAATGAACCGAGCACCAGTTGCTGCGTGTGCTGCAAGGAAATC AJ628353 
 trans CGGGACACACAAGCAGCCTATGCTTTTCTTAAGCGGTTAGTGAAGCAGTTTGATGAACCGAAGGTTGTAG AF516335 
 trans-1 GAAGGCGGTGCTTCTTCACTTGAGAGCCAAAAAAGGGGCAGAAAAATTAGTATGAATTCCAAGCTAAACA AF516335 
Controls 
Positive Control    
 23S CGGAACGCTAGTTTCGATGGAGGCGCTGGTGGGATACTACCCCTGCGTTATGGCCACTCTAACCCGCACCAC AY116904   
 23S rRNA ATCAACCTGTTGTCCATCGCCTACGCCTATCGGCCTCGGCTTAGGTCCCGACTAACCCTGGGCGGACGA AE016830  
 EUB ‟ CCTGGGGAGTACGGCCGCAAGGCTAAAACTCAAAGGAATTGACGGGGGCTCGCACAAGCGGTGGAGCAT DQ787712 
 EUB 2 ACGCTGTAAACGATGAAAACTAGATGTTAGTCCAGCTATTAAATCATAATTAATAAACTGATATGATTTA DQ787712 
 Frye 1 AGTCGGAATCGCTAGTAATCGTGGATCAGAATGCCACGGTGAATA EU779389 
 Frye 2 CTAACTCCGTGCCAGCAGCCGCGGTAATACGGAGGGTGCAAGCGT EU779389 
 Frye 3 TGCTGACGAGTGGCGGACGGGTGAGTAATGTCTGGGAAACTGCCT EU779389 
Negative Control    
 buffer     
 H2O     
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 Abstract   
Salmonella enterica is an important enteric pathogen consisting of many serovars that can 
cause severe clinical diseases in animals and humans.  Rapid identification of Salmonella isolates 
is especially important for epidemiological monitoring and controlling outbreaks of disease. 
Although immunological and DNA-based serovar identification methods are available for rapid 
identification of isolates, they are time-consuming and/or costly.  In this study we developed and 
validated two molecular methods for identification of Salmonella serovars.  A 70mer 
oligonucleotide spotted microarray was developed that consisted of probes which detected genes 
responsible for genetic variation between isolates of Salmonella that can be used for serotyping.  
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A multiplex PCR assay was also developed that are capable of identifying 42 serovars and 
provided a valuable prediction of the pathogenicity of the isolates by detecting the presence of 
virulence genes sseL, invA, and spvC.  The gene spvC was the best predictor of pathogenicity.  In 
a blind study, traditional serological methods correlated 93.3% with the microarray-based 
method and 100% with the multiplex PCR- based serovar determination.    
 Introduction 
Gastrointestinal tracts of both humans and animals are a major habitat of Salmonella.  In 
2005, over 36,000 clinical cases of salmonellosis were reported to the CDC
10
.  Of these, 15,000 
resulted in hospitalization and 400 were fatal
22
.  Salmonella enterica subspecies enterica, with 
the majority of clinical cases belonging to subgroup I, is categorized into serogroups (based on 
lipopolysaccharide or O antigen) and serotypes (based on the flagellar or H antigens)
40
.   
In order to identify the individual serovars (based on O and H antibody-antigen tests) of 
Salmonella, testing is routinely performed in state reference laboratories and several veterinary 
laboratories, which due to high number of samples submitted, may lead to long turnaround times.  
In an attempt to streamline the process, molecular techniques have been developed such as 
ribotyping
14
, PCR single-strand conformation polymorphism analysis
34
, restriction fragment 
length polymorphism
23
, pulsed-field gel electrophoresis
4,25
, IS200 fingerprinting
15
 automated 5‟ 
nuclease PCR
24
, and random amplified polymorphic DNA analysis
43
 are major improvements in 
serovar determination, but the success of these assays require high technical skill, are prone to 
inter-laboratory variation, are time consuming, and are incapable of processing large number of 
samples.  Multiplex PCR assays are efficient platforms that detect many gene targets in a single 
sample preparation by incorporating multiple primer-pairs.  In the past, they were limited to 
identifying a small number of serovars, and these assays did not attempt to predict the overall 
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pathogenicity of Salmonella isolates
2,6,26,46
.  A recent study described multiplex PCR procedure 
consisting of two multiplex PCR panels for determining 30 clinically relevant serovars of 
Salmonella
27
.  The objective of the present study was to increase the number of serovars 
identified using the multiplex procedure, and to develop an additional multiplex PCR panel 
called Salmonella Typing Virulence (STV) that determines the presence or absence of the genes 
spvC, invA, and sseL, to allow us to predict the overall pathogenicity, invasiveness and 
replication ability of the Salmonella isolates respectively.   
DNA microarrays, which work on nucleic acid hybridization principles are widely used, 
and have multiplex capability to detect hundreds of thousands of genes in a single experiment
8
.  
Spotted DNA microarray platforms are cost-effective, flexible, and easy to use in any laboratory 
with basic facilities and equipment
11
.  This technology has been used in high throughput 
detection of pathogens such as methicillin-resistant Staphylococcus in hospitals
44
 and in the 
identification of antimicrobial resistance genes
16,36
.  More recently three studies
29,42,50
 have 
focused on molecular serotyping of Salmonella using microarray protocols.  These microarrays 
could identify only a limited number of serovars, and required multiple probe sets for each 
serovar.  For example, 414 probes and a software program were necessary to identify 14 
different serovars
42
.  Since there are presently 1531 Salmonella enterica subspecies enterica 
group I serovars
19
, such assays can get complicated and expensive.  Therefore, the objective of 
our study was to develop an economical, high throughput and adaptable microarray that is 
capable of determining a large number of common serovars using a limited number of probes, as 
well as to compare the results with a modified multiplex PCR assay and established serological 
assays.  
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 Materials and Methods 
 
Bacterial strains, culture and DNA extraction  
Salmonella isolates used in this study were acquired from human clinical sources, or 
isolated from the feces of feedlot cattle in Midwestern USA, or from various other sources 
including turkey, swine, horse, and reptiles.  Isolates were sent to Kansas State University – 
Veterinary Diagnostic Laboratories (KSU-VDL) for species and serogroup identification and 
later to The National Veterinary Services Laboratories (NVSL) for serotyping by traditional 
antibody -based methods, using the Kauffman-White scheme.  Isolates were grown overnight at 
37ºC on Tryptic Soy Agar
a
, and a single colony was picked and inoculated into 5 ml of Tryptic 
Soy Broth
a
 and grown at 37ºC with shaking.  Bacterial genomic DNA was extracted from 500 μl 
of overnight cultures using DNeasy Tissue Kit
b
 according to the manufacturer‟s instructions.  
Final DNA concentrations were determined using a Nanodrop ND-1000 spectrophotometer
c
 (). 
  
STV multiplex PCR and primer design  
 A new multiplex panel to detect virulence genes was developed.  Primers to 
amplify sseL gene
13,41
 were designed using Primer 3 version 4.0 software
d
 , based on conserved 
sequences from GenBank (Accession # AE008802) so that the melting temperature (Tm) and 
product size was compatible with other reactions in the multiplex panel (Table 3).  Potential 
primer candidates were checked with BLAST searches for nucleotides until an acceptable set 
was found.  The primers PT4 (amplifying sequences of a S. Enteritidis phage type 4 strain) and 
STM 7 (amplifying sequences of a S. Typhimurium strain) and sseL were combined with primers 
for  spvC and invA, to create a unique multiplex PCR (STV).  All the primers included in this 
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panel were analyzed using AutoDimer v1 software
e
 to ascertain that they do not form homo- or 
hetero-dimers
47
. 
 
Multiplex PCR reaction protocols   
The multiplex PCR was modified from Kim et al. 2006
27
.  The protocol consisted of two 
multiplex PCR assays each consisting of 5 primer sets.  The primer sets correspond to arbitrary 
regions on the genome of Salmonella Typhimurium
33
 (STM) and Salmonella Typhi
35
 (STY) as 
determined by microarray analyses
27
.  The completed multiplex PCR reactions were 
electrophoresed on agarose gels, and the amplicons were numbered 1 through 5 based on their 
sizes (1 being the largest amplicon). If the PCR products were detected at a predicted location on 
a gel it was considered positive for that reaction. For e.g., in the STM multiplex PCR reaction, if 
products corresponding to STM 1 and STM 5 primer sets amplified, then the amplicon code for 
STM reaction for that particular isolate will be designated 1, 5. Similar amplicon codes were also 
generated for the STY multiplex panel.   Occasional faint, non-specific bands did appear which 
was consistent with the previous study
27
, however, only the most prominent bands were 
considered for amplicon coding.  The incidences and the prominence of these bands were 
considerably reduced when the Qiagen Multiplex PCR kit
b
 was used.   
The STM assay was modified to use the Qiagen Multiplex PCR Kit
b
 as per the 
manufacturer‟s instructions.  Briefly 12.5μl of 2x Buffer was added to 4 μl of Q Solution with 
50-100 ng of template DNA for a final volume of 25 μl.  The reaction conditions included initial 
denaturation step at 94ºC for 15 min, followed by 35 cycles of 94ºC for 30 sec, 62ºC for 45sec, a 
step down to 58ºC for 45 sec, and 72ºC for 1 min, and a final extension of 72ºC for 5 min.  All 
reactions were performed on a Mastercycler Gradient thermocycler
f
. 
182 
 
The STY assay was modified to contain 1.25 units Takara Hot Start Taq
g
, 1.6 X reaction 
buffer, 0.2 mM dNTPs, and 50-100 ng of template DNA for a final volume of 50 μl.  The STV 
reaction contained 1.25 units Taq polymerase
h
, 1 X Ex Taq reaction buffer
g
, 0.2 mM each of 
dNTPs, and 50-100 ng of template DNA at a final volume of 50 μl.  Both STY and STV used the 
same cycling parameters: 1 cycle of 94ºC for 6 min, followed by 35 cycles of 94ºC for 30 sec, a 
step up to 62ºC for 15 sec, 58ºC for 15 sec, and 72ºC for 1 min, and a final extension of 72ºC for 
5 min.   
 
 Sample analysis and scoring of multiplex PCR products 
PCR products were separated by electrophoresis in a 3% agarose gel
h
 in 1 X TBE (90 
mM Tris, 90 mM Borate, 20 mM EDTA [pH 8.0]) for approximately two hours at 5.6 V/cm.  
The gel was stained using ethidium bromide (10 mg/ml), visualized under UV light
h
  and 
captured by a digital imaging system
i
.  PCR amplicon sizes were determined by comparison to 
molecular weight markers
j
  and scored as described above. 
 
Microarray probe design and printing   
Initially, three to eight candidate probes for each gene target were selected (a total of 63 
probes) and printed in replicates of three or ten.  These corresponded to genetic regions 
determined to be important for serovar differentiation by previous studies and with our multiplex 
PCR assays discussed above
27,39
.  These genetic regions were originally chosen since 
heterogeneity in the region was reported to be helpful to differentiate between common serovars 
of Salmonella
39
.  Based on their sensitivities, intensities of signals, and correlation with 
multiplex PCR data, 37 probes were selected (Table 4, supplementary data) and were considered 
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for further studies.  The remaining 26 probes were excluded during our validation step (described 
later) from further consideration because of low intensity/negative hybridization, false 
positives/increased background, or signal inconsistency (data not shown).  Candidate oligos were 
designed using OligoWiz 2.0
48
 and synthesized
k
.  On each microarray, the positive hybridization 
controls EUB (16S region conserved in all Eubacteria)
49
, and rpoB 
1
 were included.  Negative 
controls including H2O, hybridization buffer only and a 25 bp DNA probe without homology to 
any listing in GenBank were also printed
38
.  Two fields containing the 70mer oligos were printed 
on Ultra Gap slides
l
 using a Genetix QArray2 System slide printer
m
 at a concentration of 35 M 
each in replicates of 3 or 10. After printing, the DNA was cross linked in a UV Stratalinker 
2400
n
  at 600 mJ and stored in the dark at room temperature until used. 
 
Microarray DNA labeling and hybridization 
Extracted genomic DNA was labeled directly using the BioPrime Plus Array CGH 
Genomic Labeling System
o
  as per manufacturer‟s protocol with slight modifications.  After 
random primer hybridization, an additional 1.5 μl of 1 mM Cy3 or 1 mM Cy5-dCTPp was spiked 
into the labeling mixture to improve dye incorporation and amplification.  For all DNA labeling 
reactions, the efficiency of labeling was determined using the „Microarray Feature‟ on Nanodrop 
ND-1000 spectrophotometer
c
, which measures the fluorescent dye incorporation in the sample 
DNA.  The labeled DNA was mixed with an equal volume of 2X Hybridization Solution #7
q
 and 
used for hybridization.  The microarray chips were prehybridized in blocking solution (0.1% 
BSA, 5X SSC, 1% SDS) at 42
o
C for one hour with shaking, and then spun at 2200 x G to dry.  
The labeled DNA mixture was hybridized overnight at 42
o
C, followed by washing for 10 min in 
each of the buffers: 10X SSC, 0.2% Sarkosyl; 10X SSC; and 0.2X SSC.  Lastly, the slides were 
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quickly dipped in water, spun dry at 2200 x G and visualized on a GenePix 4000B slide reader
r
.   
Other in vitro labeling kits including Ares Alexa Fluor 546 and 647
o
, DNA labeling kits 
(Indirect)
o
, and Array 900DNA Labeling Kit for DNA
q
 were employed, but the BioPrime Plus 
Array CGH Genomic (Direct) Labeling System
o
 was used in further experiments since it 
provided a consistently higher efficiency of dye incorporation as evidenced by Nanodrop ND-
1000 spectrophotometer
c
 and by total spot fluorescence on microarray chip as measured by a 
GenePix 400B slide reader
r
.  
 
Validation of molecular methods 
For the multiplex blind study, 111 Salmonella culture samples, and 31 bacterial DNA 
samples were submitted to our laboratory.  All samples were processed with STM, STY and 
STV multiplex PCR and scored as described above.  For the microarray blind study, 20 
Salmonella pure culture samples, and 36 bacterial DNA samples were submitted to our 
laboratory.  All samples were hybridized to serotyping microarray chips and STM, STY and 
STV scoring was conducted.  Serotyping results were compared against results from traditional 
antibody-based serotyping and statistical analyses (see below) were conducted. 
 
Data analyses   
The fluorescent hybridization signals from the array were visualized using a GenePix 
4000B slide reader
r
 and matched to the GenePix Array List (GAL) file previously created by the 
microarray slide printer.  A GenePix Report (GPR) file was generated measuring the overall 
intensities.  Each target region was represented by 3 or 10 replicate spots.  The fluorescence 
signals from each set were averaged and used for further analyses.  Data were analyzed using the 
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TIGR MultiExperiment Viewer (TMEV) program
s
 with one color setting.  Data were also 
analyzed using an relative pathogen signal (RPS) ratio method previously described
45
.  Briefly, 
the averaged signal intensities for each probe were divided by signal intensities of positive 
control spots to attain an RPS ratio.  Mean hybridization signals to spots containing a unique 
DNA probe (25 bp) that shares no significant homology to sequences in GenBank were 
subtracted from the RPSs of test spots
38
. A final ratio was determined from this, and values over 
0.25 were considered positive, and values below 0.25 were considered negative.   
The sensitivity and specificity of multiplex and microarray were calculated using the 
antibody based testing as the gold standard.  Specificity is number of true negatives/(number of 
true negatives + false positives) and sensitivity is true positives/(number of true positives + false 
negatives). 
 Results 
Multiplex PCR assay development and validation   
Our multiplex PCR panels successfully identified 42 serovars of Salmonella.  This 
included   Bareilly, Choleraesuis , Kentucky, London, Meleagridis, Minnesota, Muenster, Orion, 
Reading, Senftenberg, Tennessee, and Uganda (Figure 1, Table 1); as well as the 30 serovars 
published previously
27
 (data not shown).   
A third multiplex panel STV containing five sets of PCR primers was created to predict 
the virulence of a Salmonella isolate and to further discriminate some serovars (Figure 2).  The 
amplicons for sseL (169 bp) and invA (244 bp) were present in all isolates tested.  As previously 
noted, invA has been used as a genetic marker for all pathogenic Salmonella
12
.  The PCR 
targeting spvC gene amplified a 571 bp product only from serovars Choleraesuis , Dublin, 
186 
 
Enteritidis, and Typhimurium (Figure 2).  Amplicon codes were generated as described above, 
for all serovars tested, including the 12 new serovars (Table 1; Table 2).  
In the blind study, the multiplex PCR based serovar determination correlated with the 
traditional antibody-based serotyping results (performed by NVSL) 100% of the time (total 111 
isolates) belonging to 23 serovars when their serogroup was known.   In the absence of the 
serogroup data the multiplex PCR assay successfully identified the serovars of 135 out of 142 
Salmonella isolates, in which case, the overall sensitivity and specificity were both 95.3%. 
 
Microarray serovar identification  
A spotted microarray platform was developed containing 70mer probes for STM, STY, 
and STV genes.  Based on the hybridization patterns, unique signatures were developed for 
tested serovars. This array of 37 probes was successful in determining all serovars of Salmonella 
tested (total of 86 isolates belonging to 40 serovars, ten of these isolates are shown in Figure 3).   
The correlation between the signals generated in microarray and bands amplified in 
multiplex PCR matched 30 out of the 30 isolates tested in our initial validation step (data not 
shown).  In the blind study, we successfully identified serovars of 52 out of 56 total isolates 
representing 28 different serovars (Table 2).  The sensitivity and specificity of the microarray 
based serotyping assay were determined to be 93.3%.  Since many of the isolates used in the 
blind study were submitted as DNA samples from diagnostic labs from across the country, the 
serogroup data was unknown. 
 Discussion 
In this study the discriminatory power of a multiplex PCR assay for molecular serovar 
identification of Salmonella was greatly improved from the existing techniques
27
 with addition of 
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a new multiplex PCR panel (STV), that not only incorporated two gene targets STM 7 and PT4 
that differentiates certain serovars
27
, but also detects the presence of the virulence markers spvC, 
invA and sseL.  All isolates tested were positive for virulence genes invA and sseL.  Since only 
strains of Salmonella isolated from clinical sources were included in this study, the presence of 
these genes in less virulent strains, especially those from environmental sources is not known. 
 The invA gene encodes an invasion protein and has been reported to be present in most 
strains of Salmonella isolated from animals and humans
31
.  The sseL encodes a deubiquitinase 
enzyme that contributes to intracellular survival and invasion by Salmonella in macrophages, and 
is claimed to be present only in highly virulent strains
13,41
.  The virulence gene spvC is generally 
carried in a plasmid, but may also be present in the genome, and has been shown in previous 
studies to improve the survival in the presence of starvation stress in host tissues
7,12,20,28
.  The 
spvC gene encodes a phosphothreonine lyase that has significant similarity to OspF of Shigella 
flexneri, and has an inhibitory effect on signal transduction mediated by ERK and JNK 
pathways, and NFkB activation in eukaryotic cells, thereby inhibiting proinflammatory cytokine 
responses
32
.  Previous studies have reported that spvC gene is predominant in four serovars 
tested including Typhimurium, Choleraesuis, Dublin, and Enteritidis
12,20
, with Salmonella 
Typhimurium and Enteritidis being the most common serovars isolated from diarrheal patients
20
.  
Therefore, the presence of spvC gene may predict the ability of a Salmonella strain to survive in 
a host environment, its capacity to infect other hosts, and the possibility of causing an outbreak.  
The potential of the assay was demonstrated by the testing of 111 blinded isolates with a 
sensitivity of 100% when serogroup data was available.  When calculations were performed 
without considering the serogroup data (135/142 isolates), the sensitivity and specificity was 
determined to be 95.3%.   
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Microarray has been used previously to identify serovars of bacteria such as E. coli
3,21
, 
Salmonella
9,18,29,30,39,50
, and Bartonella
5
, due to the rapidity of the assay and its ability to provide 
high throughput and consistently reproducible results.  Also the charged coupled device (CCD) 
detection of fluorescent spots in microarray has been reported to provide high sensitivity
17
.  The 
microarray developed in this study consisted of probes that targeted the genetic regions shown to 
be important for serovar differentiation by previous studies
39
 and our multiplex PCR assays.  The 
data from microarray-based serotyping was compared with analysis of the same isolates using a 
multiplex PCR, and the sensitivity and specificity was determined to be 93.3% (see materials and 
methods).  A previous multiplex PCR study by Arrach et al. noted that some target DNAs may 
not be amplified due to intra-serovar variation at the primer binding regions which could lead to 
the compiling of false amplicon codes
2
.  In this study, the 95.3% concordance of multiplex PCR 
and microarray; suggests that such mutations may not significantly affect the effectiveness of 
multiplex PCR to determine the serovar of a Salmonella isolate.  
This study describes two rapid molecular methods that can accurately identify the 
serovars of
 
common clinical isolates of S. enterica subsp. enterica.  The multiplex PCR is 
straightforward and can currently be applied in any laboratory with access to PCR and gel 
electrophoresis equipment. The growing number of Salmonella genome sequences available for 
analysis, and comparison by complete genomic hybridization and other methods, will identify 
future targets to further improve the discrimination of serovars that may share the same amplicon 
codes.  Of the 1531 serovars of Salmonella enterica currently known
19
, our blind studies only 
covered a relatively limited number of them.  While our studies and those conducted by Kim et 
al. 2006
27
 included isolates of some of the most common serovars encountered
20
, larger 
validation studies will be necessary for using these test as a diagnostic tool.  Also, higher 
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throughput for diagnostic samples may be achieved by performing a fluorogenic 5' nuclease PCR 
assay. 
All blind samples (n=142) were processed for multiplex PCR and a subset (n=56) were 
also tested by microarray analysis (Table 2). The smaller number of samples used in the 
microarray blind studies were due to the relatively higher costs to perform the assay.  
Conventional antibody-based serotyping has become increasingly expensive in the recent past 
due to high costs associated with licensing and transportation of live or frozen cultures via mail; 
maintenance of freezers to store these cultures; and production of large collection of specific 
antisera.  Expense of the microarray can be reduced by low density arrays with support matrices 
such as nitrocellulose, by multiple arrays printed on each glass slide and each array hybridized 
with DNA labeled by different fluorescent markers from different isolates, as well as by labeling 
targets with colorimetric instead of fluorescent dyes.   
While multiplex PCR arrays provide a molecular method to rapidly identify the serovar 
of a Salmonella isolate, microarray has the potential to acquire over one million data points in a 
single experiment.  Also, a microarray probe set can be easily incorporated into any established 
diagnostic microarray protocol, thereby increasing the overall strength of that platform.  For 
example, we have incorporated the serovar identifying array in an antimicrobial resistance gene 
array to provide a platform that evaluates resistance profiles of Salmonella serovars
37
 
(Supplemental Figure 1).   
We have identified multiplex PCR amplicon codes for 42 serovars, and have determined 
microarray hybridization profiles for 40 serovars of Salmonella enterica.  In this study we report 
a newly developed multiplex PCR reaction (STV) that detects virulence genes (sseL, invA, and 
spvC).  The presence or absence of spvC was successful in identifying a subset of serovars that 
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have been shown previously to cause significant human and animal diseases.  We believe that the 
tests developed in the present study will aid in the understanding the epidemiology and diversity 
of Salmonella. 
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 Figures and Tables 
 
Figure C.1 STM (A) and STY (B) multiplex PCR products of 12 previously unscreened 
serovars. If PCR products (five primer-sets for STM and five primer-sets for STY) were 
present at the predicted location on a gel it was considered positive for those reactions.  An 
amplicon code was designated based on the bands that were present.  For example, serovar 
Bareilly (in panel A; second lane) had PCR products for primer sets STM 2 and STM 5.  
Therefore, the amplicon code for STM multiplex PCR for Bareilly is 2, 5 (see Table 1 for 
amplicon codes for all serovar tested in this study). 
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Figure C.2 Multiplex PCR STV products of 29 serovars for which STM and STY were 
screened previously 
27
 (A and B). Multiplex PCR STV (Salmonella Typing Virulence) 
products of the 12 new Salmonella enterica serovars (C). An amplicon code was designated 
based on the bands that were present.  For example, serovar Agona (in panel A; second 
lane) had PCR products for primer sets STV 2, STV 4, and STV 5.  Therefore, the 
amplicon code for STV multiplex PCR for Agona  is 2, 4, 5 (see Table 1 for amplicon codes 
for all serovars tested in this study). 
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Figure C.3 Results from microarray (A; black is positive and white is negative) and 
multiplex PCR (B) for the STM 1-5 (STM), STY 1-5 (STY), and STV 1-5 (STV) genes of 
ten Salmonella isolates representing seven serovars. 
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Figure C.4 (Supplementary Data) Microarray slide showing Salmonella Typhimurium 
DNA hybridization to probes for serovar identification.  Each 70mer probe was printed 
randomly in triplicate. Probes for serovar identificiation are listed for STM (blue), STY 
(green), and STV (orange).  Positive hybridizations appear as red signals and negative 
hybridizations appear as green signals (due to hybridization by the print and hybridization 
control 25mer probe)
38
.   The Salmonella serovar determining probe set was incorporated 
into a microarray chip containing probes for virulence factors, antimicrobial resistance 
genes, and metal resistance genes
37
. 
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Table C.1 Complete list of all amplicon codes for STM, STY and STV.  An * indicates 
serotypes previously unscreened by STM and STY, and ND indicates that amplicon code 
was not determined in our study. 
 
 
 
 
 
 
 
 
 
Serotype STM STY STV  Serotype STM STY STV 
1. Agona 2, 3 5 2, 4, 5  23. Montevideo 5 2, 4 2, 4 
2. Anatum 1, 2, 3, 4, 5 0 2, 4  24. Muenster* 1, 2, 5 2, 4 2, 4 
3. Bareilly* 2, 5 2, 4 2, 4, 5  25. Muenchen 1, 2, 5 0 2, 4, 5 
4. Berta 2, 3, 5 2, 3 2, 4, 5  26. Newport 1, 2, 3, 5 0 2, 4 
5. Bovismorbificans 2, 3, 5 0 2, 4  27. Ohio 2, 5 0 2, 4 
6. Braenderup 2, 5 0 2, 4, 5  28. Oranienburg 2, 5 2, 4 2, 4 
7. Brandenburg 1, 2 2 2, 4  29. Orion* 1, 3 4 2, 4 
8. Chester 1, 2 0 2, 4  30. Paratyphi B 1, 2, 4, 5 0 2, 4, 5 
9. Choleraesuis* 2, 5 2, 5 1, 2, 4, 5  31a. Poona 1 1, 5 1, 2 ND 
10. Derby 1, 2, 3, 5 5 2, 4  31b. Poona 2 1, 2 1, 2 2, 4 
11. Dublin 2, 3, 5 3 1, 2, 4  31c. Poona 3 1, 5 2 ND 
12. Enteritidis 2, 3, 5 3 1, 2, 3, 4  32. Reading* 1, 2, 4, 5 0 2, 4, 5 
13. Hadar 3, 5 0 2, 4, 5  33. Saintpaul 1, 2, 3, 4, 5 0 2, 4, 5 
14. Heidelberg 1, 2, 4, 5 2 2, 4, 5  34. Senftenberg* 1, 2, 3 1, 2, 4, 5 2, 4, 5 
15. Infantis 2 2 2, 4  35. Stanley 1, 2, 5 2 2, 4, 5 
       16a. Java 1 1, 2, 4, 5 0 ND  36. Tennessee* 2, 3, 5 1, 5 2, 4, 5 
       16b. Java 2 2, 4 0 ND  37. Thompson 2, 3, 5 5 2, 4 
17. Javiana 1, 2 2, 5 2, 4  38. Typhi 1 1, 2, 3, 5 2, 4, 5 
18. Kentucky* 2, 5 2, 5 2, 4  39. Typhimurium 1, 2, 3, 4, 5 4 1, 2, 4, 5 
19. London* 1, 2, 4, 5 0 2, 4  40. Uganda* 1, 2 2, 5 2, 4, 5 
20. Mbandaka 2, 3, 5 2, 5 2, 4  41. Weltevreden 1, 2, 4, 5 1, 4, 5 2, 4 
21. Meleagridis* 1, 2, 5 2, 5 2, 4, 5  42. Westhampton 1, 2, 3 1, 2, 4, 5 2, 4 
22. Minnesota* 1, 2, 5 2, 5 2, 4      
203 
 
Table C.2 Complete list of all serotypes tested in this study with multiplex PCR and 
microarray in the blind study.  The numerator indicates total of number of isolates that 
were correctly identified molecularly, and the denominator indicates total number tested 
with serotypes identified by traditional antibody tests.  An * indicates serotypes previously 
unscreened by STM and STY multiplex PCR assays. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Serotype Multiplex PCR Blind Study Microarray Blind Study 
Agona 5/5 2/2 
Anatum 4/6  
Berta 2/2 2/2 
Bovismorbificans 2/2 2/2 
Braenderup 2/2 2/2 
Brandenburg 2/2 2/2 
Chester 2/2 2/2 
Cholerasuis* 2/2  
Derby 3/3  
Dublin 7/7 3/3 
Enteritidis 1/1 1/1 
Hadar 2/2 2/2 
Heidelberg 2/2 2/2 
Infantis 5/5  
Javiana 2/2 2/2 
Kentucky* 3/4  
London* 1/1  
Mbandaka 3/3 1/1 
Meleagridis* 4/4  
Minnesota* 3/3 3/3 
Montevideo 20/20 1/1 
Muenster* 8/8  
Muenchen 3/3 1/1 
Newport 7/7 3/3 
Ohio 2/2 2/2 
Oranienburg 3/3 1/1 
Orion* 4/4  
Paratyphi B 2/2 2/2 
Poona 2 2/2 2/2 
Reading* 3/3 2/2 
Saintpaul 3/4 1/2 
Stanley 2/2 2/2 
Tennessee* 2/2  
Thompson 2/2 2/2 
Typhimurium 6/6 2/2 
Uganda* 8/8 4/4 
Weltevreden 1/2 1/2 
Westhampton 0/2 0/2 
Total 135/142 52/56 
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Table C.3 List of primers used in STV multiplex PCR assay. 
 
Gene 
NCBI 
accession 
no. 
Primer Primer sequence  (5’→ 3’) 
Amplicon 
size (bp) 
Reference 
spvC M64295 
SPVC-1 ACTCCTTGCACAACCAAATGCGGA 
571 
12 
SPVC-2 TGTCTTCTGCATTTCGCCACCATCA 
      
invA M90846 
INVA-1 ACAGTGCTCGTTTACGACCTGAAT 
244 
12 
INVA-2 AGACGACTGGTACTGATCGATAAT 
      
PT4 
AF37071
6 
PT4 F GGCGATATAAGTACGACCATCATGG 
225 
27 
PT4 R GCACGCGGCACAGTTAAAA 
      
sseL 
AE00800
2 
sseL F TTCCGCGACAACCGACCTTTCTAA 
169 This study 
sseL R TTCTTGAACCAGACCTTGCGTTGC 
      
STM 7 
AE00879
5 
STM2150F CATAACCCGCCTCGACCTCAT 
101 
27 
STM2150R AGATGTCGTGAGAAGCGGTGG 
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Table C.4 (Supplementary Data) 70mer probes used in this study for serotyping Salmonella 
enterica. 
 
 
 
 
 
 
 
 
Assay 70mer Oligo Primer sequence NCBI accession no. 
STM 1 STM 1 0716F_441-510 A TGCGGCTACGCCCTTGCTGATAAAGGGATTGATACACGACTCATACAGGACTATCTGGGGCACAGGAATA AE008729 
 STM 1 0716F_416-485 B ACATCCTCATATGCTGCGACATGCCTGCGGCTACGCCCTTGCTGATAAAGGGATTGATACACGACTCATA  
    
STM 2 STM 2 1350F_1077-1146 A ATGAACACCGATGGTTATGCCGCCACCGGTGTAGAAATTAAAATCGTGGATGAAGATCGCAATACGCTTC AE008758 
 STM 2 1350F_373-442 B AATGTCAGGCTAAAATATTCTTCGCCCCCACCGTGTTCAAACAGAATCGTCCGGTCGATCTTATCCTTCC  
 STM 2 1350F_768-837 C TTTTTAATCGGGGCGCGTAGCGTATTGCTGGACATCTTTACCCCAGAAGCCTGCCTTACCTTATTAGCGC  
 STM 2 1350F_407-476 D GTTCAAACAGAATCGTCCGGTCGATCTTATCCTTCCGCTACAAAATCAACTGCGCCATCTGACGCATATT  
 STM 2 1350F_1005-1074 E TTGAGTATTTACGGTTCTACAGAAAGTTCTCCACACTCGATGGTTAATCTGGGTGATTCGACTTCACGCA  
    
STM 3 STM 3 0839F_461-530 B TGAAGTTGAGGATATCGAAGGCGTATGGATGCGTACCTATGGTGCTGATTGCTTTGGGCTACCAGATTTC AE008735 
 STM 3 0839F_255-324 D GATACTTCACCTTTAGAGCAATATGTTGCGTTGGCTGTGGTTGCAGGTGCATTAAGTAACATGGGGGCTG  
 STM 3 0839F_111-180 E CATGTAATATCGATGGTTGGATTTAAAACGCCTTACCCTCAGGAATCAATCGAACAATGCGTCGCGCCAG  
 STM 3 0839F_424-493 G TCCCGCTGACCTCTCTATTTTGTGGATTTGTGAAATATGAAGTTGAGGATATCGAAGGCGTATGGATGCG  
    
STM 4 STM 4 4525F_1081-1150 C GTTCTTTACCAAAGGCACGGTCACCAATCCGCATCAGGATAAAAACTGCACCGATGACGTGTGGGTGTAT AE008913 
 STM 4 4525F_82-151 D CTCCTATCAAAACTACGTCAATGAACTCGCCTCGCTGCTGTTTTTGAAAATGTGCAAAGAGACCGGCCAG  
    
STM 5 STM 5 4538F_666-735 A CCCATTACGTTTGGTACGGGAGAAGCGAAAACCCATGTTCAGGACATTATTAACGACATCATGCCTTGTC AE008913 
 STM 5 4538F_635-704 B GATGACGGCCTCCATGATTGATATCACCATTCCCATTACGTTTGGTACGGGAGAAGCGAAAACCCATGTT  
 STM 5 4538F_285-354 C GTGGCGATGGAGGAGAAAAATAGCCAGCAGAAAGAGATGGACGCCAGTTCTATCGATAACGTCAAAGCGT  
 STM 5 4538F_691-760 D CGAAAACCCATGTTCAGGACATTATTAACGACATCATGCCTTGTCTGCTGCCGTTAATTAGCTTCGCCAT  
    
STY1 STY 1 0312R_281-350 A TGTGGGCTATGACTCTCCTTCTGTTGGTGCTACGGATATCTGGGGATTATTTTCCGTCAGTCCGAAAACA AL627266 
 STY 1 0312R_92-161 B ATCAAATATCCCGGTGTTTGATTTGGCTAAATTAAATCAGGAAGGGCTTGCCGAGACACAGGCTCAGGCA  
    
STY 2 STY 2 0346F_384-453 A ATGGAAGTGACTCTGGGAGGACGGTCACTGACCACCACCAATTCTGTACTGGAAGCTAAAACCCTGTTCC AL627273 
 STY 2 0346F_149-218 B GGTTCAGAAGGATATTACCGTCACTGCCAATATTGACAGTACACTTGAACTGCTGCAGGCCGATGGTTCA  
 STY 2 0346F_178-247 C ATATTGACAGTACACTTGAACTGCTGCAGGCCGATGGTTCATCCCTCCCGTCGACTATGAAGCTGGATTT  
 STY 2 0346F_97-166 D TTATTGCCGCAGCTGTGGCATTGGCCACCGTTTATTCTTTTTCTGTTTCTGCGGTTCAGAAGGATATTAC  
    
STY 3 STY 3 2299F_19-88 A ATGGGAGCGTTTGGGTTCCTTGGATCACGACTTACATCCTACTTCGAAAGTCGACATACTGTGATTGGCT AL627273 
    
STY 4 STM 4 3845F_92-161 A TCCTTTTCGTGTGTGGTGGCAAAGTCGATGTACGTGCACCAATTCCCCCCAGTTTTAGGGATAGACTACT AE008879 
 STM 4 3845F_63-132 B TAACTTCAATGTTGATATATCTCATCGTCTCCTTTTCGTGTGTGGTGGCAAAGTCGATGTACGTGCACCA  
    
STY 5 STY 5 2349F_122-191 A AAAAATTCCAGTTTTGGCCAGCCAGGGCGAACAGCTTTACAAGACCCAAAAGTATGCCAAAGCACTCGAC AL627273 
 STY 5 2349F_490-559 B AGGTTAATTTTCAGGGTTACTGGTTCGGTTTAATGGGGATCTACTTCGGCCCCAATATCGGCGAGTTCTA  
    
STV 1 spvC 3364-3436 GAAAAATAATTTCAACTCCTTGCACAACCAAATGCGGAAGATGCCGGTATCCCACTTTAAAGAGGCGCTG D14490 
    
STV 2 invA 78-147 ACCTACCTATCTGGTTGATTTCCTGATCGCACTGAATATCGTACTGGCGATATTGGTGTTTATGGGGTCG U43273 
 invA 2 1885-1950 TTATTGATTGCACATAAAGATCTTGTCCTCCTTACGTCTGTCGATGTCCGTCGATTTATTAAGAAA  
    
STV 3 PT4 3452-3521 AAATTTTGTGGTGCGGTGCCTGGTGCCTCCAGGTGACATTAACCAGTTAACAATTAATGCCGACTTAAAC AF370716 
 PT4 2 3425-3494 ATCATAGCCCCTCCATTTCTGGTAAATAAATTTTGTGGTGCGGTGCCTGGTGCCTCCAGGTGACATTAAC  
 PT4 3 3492-3561 AACCAGTTAACAATTAATGCCGACTTAAACCACCCATACTGATTCAGGGAGTTTTAACTGTGCCGCGTGC  
    
STV 4 sseL 18937-19006 TTTACAGAACAATGTACCCAACGGCTGTGGTCTATTTTGTTACCATACAATTCAACTCTTATCGAATGCC AE008802 
 sseL 2 18702-18771 GCACTCAGCTACTTGAAAAGATTGCTCAATCAGGATTATCTCACAATGAAGTCTTCCTGGTAAATACAGG  
    
STV 5 STM 7 2150F_315-384 E CTGCAACCGCAGGGAGCAACGGATTGTATTGCGTTAAAAGATGTCGTGAGAAGCGGTGGCTATACTTTTA AE008795 
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Appendix D - Effects of two oxytetracycline dosing regimens on 
horizontal transfer of antimicrobial resistance plasmids in an in 
vitro pharmacodynamic model  
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 Abstract 
Objective – To evaluate the impact of oxytetracycline exposure on the horizontal transfer of an 
antimicrobial resistance plasmid. 
Study model – In vitro pharmacodynamic model. 
Procedures - Mixed populations of plasmid donor (Salmonella) and recipient bacteria (E. coli) 
were assigned to one of two simulated oxytetracycline dosing regimens (High peak concentration 
207 
 
– short elimination half life / Low peak concentration – long elimination half life) or untreated 
control.  Donor, recipient and transconjugant (E. coli that has acquired the plasmid) bacteria 
populations were quantified by plating on selective bacterial growth media at 12, 24 and 36 
hours following oxytetracycline administration.   
Results - The ratio of transconjugant to donor bacteria was significantly reduced in the 
oxytetracycline exposed replicates compared to the controls at 12 hours.   At the 24 and 36 hour 
timepoints, the high concentration treatment was not significantly different from its respective 
control (p=0.24 and 0.98, respectively), while the comparison of the low concentration treatment 
to its control approached significance at both timepoints (p=0.057 and 0.062, respectively).  The 
oxytetracycline concentration at these timepoints (12 hours in the high concentration regimen 
and all 3 timepoints in the low concentration regimen) were in excess of the minimum inhibitory 
concentration of the recipient bacteria.    
Conclusions and Clinical Relevance - These observations suggest that transfer of antimicrobial 
resistance plasmids can be suppressed in vitro by oxytetracycline exposures above the minimum 
inhibitory concentration of the recipient bacteria.   
 
 Abbreviations 
HC-SHL High Concentration – Short Half Life 
LC-LHL Low Concentration – Long Half Life 
IVPM   in vitro pharmacodynamic model  
 Introduction 
The remarkable adaptive abilities of bacteria have lead to the phenomenon of 
antimicrobial resistance.  Just 30 years ago, we were “closing the book on infectious diseases”1.  
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Today, we face a global pandemic of re-emerging infectious diseases brought around, in part, by 
antimicrobial resistance
2
.  Three key factors have been recognized in the emergence of bacterial 
resistance:  mutation, bacterial genetic exchange, and selective pressure in health care and 
community settings
3
.  Of these factors, the primary focus has been investigating methods to 
decrease the selective pressure within health care and the community by focusing on prudent 
drug use
4,5,6
.  The importance of prudent antimicrobial use has also been recognized in veterinary 
medicine as evidenced by the American Veterinary Medical Association‟s policy statement on 
judicious therapeutic use of antimicrobials
7
.  For veterinarians, the prevention of antimicrobial 
resistance has important implications in our obligations to both public health and the successful 
treatment of our patients.  This is particularly true in production animal medicine where these 
goals are often depicted as contradictory in the public debate. 
 The roles of mutation and dosing strategies to minimize resistance development have 
been studied extensively, giving rise to theories such as the Mutant Prevention 
Concentration
8,9,10,11
.  There is also a plethora of literature in regard to the mechanisms of 
bacterial gene exchange
12
; however, relatively little has been published regarding the influence 
of drug exposure on the rates of conjugative transfer
13
. 
The issue of antimicrobial resistance has resulted in a paradigm shift with regard to 
investigation of antimicrobial therapeutics.  Since the late 1990‟s, researchers have sought dosing 
regimens that impart not only clinical efficacy, but also minimize the development of 
antimicrobial resistance.  Consistent with these goals, the objective of this research was to 
evaluate the impact of oxytetracycline exposure on the horizontal transfer of an antimicrobial 
resistance plasmid in an IVPM.  Our hypothesis was that different oxytetracycline exposures 
would result in differential frequency of plasmid transfer between bacterial species.  Results of 
209 
 
this study provide information for the development of oxytetracycline dosing regimens that 
minimize the horizontal transfer of antimicrobial resistance genes. 
 Materials and Methods 
 Bacterial Species/Strains 
 In this study, we used a clinical isolate of Salmonella enterica subspecies enterica 
serovar Typhimurium strain number 5678 containing a 100kB type A conjugative plasmid that 
had been used in previous plasmid transfer experiments
14
.  This low copy number plasmid 
contains a blaCMY-2 ESBL gene (with resistance to ampicillin, ceftriaxone, and cefoxitin) as well 
as resistance markers for chloramphenicol, streptomycin, sulfisoxazole, trimethoprim-
sulfamethoxazole, and tetracycline.  The resistance gene that supplies the resistance to 
tetracycline/oxytetracycline is present on an IS26-like portion of the plasmid and was shown by 
PCR amplification to be positive for the tetA efflux pump (data not shown).  Monitoring of 
transconjugants indicated that this plasmid transfers all resistance genes, as is shown by the 
ability to screen on ampicillin.  Additional tests indicated that other antibiotic markers were 
present as well (data not shown).  The recipient bacterium, E. coli C600N, is a laboratory strain 
that carries a chromosomally encoded resistance marker for nalidixic acid.  Aliquots of stock 
bacteria were stored separately at -80º C. 
 Determination of Minimum Inhibitory Concentration (MIC) 
The minimal inhibitory concentration for each of the study bacteria was determined by 
modification of CLSI recommended procedures
15
.  Fresh cultures of donor and recipient bacteria 
were separately grown overnight on a rotary shaker (37º C, 150 rpm) in ten milliliters of fresh 
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Luria-Bertani (LB) broth. Ten microliters of a standardized bacterial suspension (OD600 =0.03) 
were pipetted into 11 mL of (LB) broth
A
.  Aliquots of the bacterial suspension (100 µL) were 
added to a 96 well plate
B
.  One hundred microliters of oxytetracycline solution had been 
previously added to the wells, so that the final concentrations tested were: 0, 1, 5, 25, 50, 75, 
100, 125, 150, 175, 200, 250, 500, 750, and 1000 ng/mL.  Testing was done in duplicate for the 
donor and recipient strains.    
The plates were placed in an incubated spectrophotometer
C
 set to read absorbance at 600 
nm with readings taken hourly.  The inhibitory concentration was determined to be the lowest 
concentration at which optical density readings were reduced.   
 Experimental Stock Culture 
 Single frozen aliquots of the Salmonella and E. coli were thawed at room temperature.  
The bacteria were streaked for isolation on LB agar plates
D
.  A single colony of each bacteria 
was transferred to separate flasks containing 10 mL of sterile brain-heart infusion broth
E
 and 
incubated overnight at 37º C on a rotary shaker
F
.  The entire 10 mL of the overnight cultures 
were transferred into separate flasks containing 90 mL of sterile brain-heart infusion broth.  Both 
bacterial cultures were grown to logarithmic phase growth (ODA600 = 0.6)
G
.  Once the desired 
optical densities were reached, the Salmonella and E. coli were transferred to syringes
H
 in a 1:5 
volumetric ratio.  Five mL of the bacterial mixture was inoculated into each central reservoir of 
the IVPM systems.  A one hour growth interval was observed in the systems prior to 
oxytetracycline administration. 
 In vitro Pharmacokinetic Model (IVPM) 
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Variations of the model used in this study have been described by others
16,17,18,19
.  The 
model consists of a 500 mL central reservoir (CR)
I
, a 4 L fresh media reservoir
J
, a 4 L waste 
collection reservoir
K
, reservoir caps
L
 and connecting tubing
M
 (Figure 1). All components were 
autoclaved prior to system assembly.  For each experimental run, four of the above described 
systems (two designated oxytetracycline treatments and two associated controls) were 
assembled.  During the experiment, the central reservoir of each system was housed in an 
incubator
N
 at 37 C.  The central reservoir media was constantly stirred by use of a stir rod/plate
O
 
setup. 
Fresh media pump speed was based on equation 1, to achieve a specified half-life.  Waste 
media pump speed was set slightly faster, with the exit port set just above the CR fluid line to 
maintain a constant CR volume.  Dual pump heads were used to control the fresh and waste 
media flow for a given treatment and the associated control arm. To eliminate residual effects in 
the samples, a single CR port was designated for bacterial inoculation and oxytetracycline 
dosing.  A separate port was designated for bacterial and antimicrobial sampling.  Three 
replicates of each treatment (High Concentration / Low Concentration) and the associated control 
were conducted. 
Equation 1: Pump calculations in the IVPM 
 
The two dosing regimens were modifications of intravenous
20
 and intramuscular
21
 dosing 
of oxytetracycline in swine.  The intravenous dose was designed so that initial peak 
concentrations were above 1000 ng/mL and time within the 150-1000 ng/mL range would be 
minimized.  The intramuscular simulation was designed so that drug concentrations would 
212 
 
remain within the 150-1000 ng/mL range for a comparatively longer period of time.  Each of the 
three (3) replicate runs included: HC-SHL, HC-SHL control, LC-LHL, and LC-LHL control.   
 Antimicrobial Treatment 
Analytical grade oxytetracycline as the hydrochloride salt was diluted in fresh brain-heart 
infusion broth prior to dosing in the IVPM.  Corrections for salt and purity were made to achieve 
oxytetracycline concentrations outlined in Table 1. 
 Bacterial Quantification & Determination of Plasmid Transfer 
Samples were collected from the central reservoir of the IVPM at 12, 24 and 36 hours 
after oxytetracycline administration.  The entire sample (approximately 1mL) was centrifuged at 
5,000 x g for 10 minutes.  The supernatant was pipetted into cryovials and stored at -70º C for 
oxytetracycline quantification as described below.   
The bacterial pellet was resuspended with phosphate buffered saline (PBS), then serial 
dilutions of the bacterial resuspension were made to the 10
-8
 dilution.  Transconjugant bacteria 
were quantified by duplicate plating of 50 µL of the -1, -4, -6 and -8 dilutions on Hektoen enteric 
agar containing 50 µg/mL of ampicillin and 12 µg/mL nalidixic acid.  Salmonella (the donor) 
were quantified by plating 50 µL of the -4, -6 and -8 dilutions on Hektoen enteric agar 
containing 50 µg/mL of ampicillin.  E. coli (the recipient) were quantified by plating 50 µL of 
the -4, -6 and -8 dilutions on Hektoen enteric agar containing 12 µg/mL nalidixic acid.  Colony-
forming unit counts were determined as by Equation 2. 
 
Equation 2: Colony forming unit calculation for transconjugant, 
donor and recipient bacteria 
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Equation 3: Calculation of Transconjugant (TC) ratio 
 
 Oxytetracycline Quantification 
 Sample preparation 
All chemical reagents were analytical grade.  Briefly, 50 µL of internal standard 
(doxycycline
P
 2,000 ng/mL) was added to 50 µL of sample. The analyte and internal standard 
were extracted using 10 µL of concentrated phosphoric acid
Q
 followed by the addition of 150 µL 
of deionized water.  The samples were loaded on HLB solid phase cartridges
R
 for the extraction 
procedure.  Following the first elution with 5:95 (methanol:water), the columns were washed 
with 500 µL of 5:95 (Methanol:Water) and dried under high vacuum (≈ 20 inches Hg) for 10 
minutes.  Oxytetracycline was recovered from the SPE cartridge using a methanol wash (300 
µL).  A 150 µL sample was then transferred to a HPLC vial and stored at 4°C in the sample 
carousel until analysis 
 
 
HPLC/MS/MS methods 
Quantitiation of oxytetracycline was performed using high performance liquid 
chromatography and triple quadrupole mass spectrometry (HPLC/MS/MS). Chromatographic 
separation was achieved using a gradient elution of 100% (0.2% glacial acetic acidS in H2O) moving 
to 5% (0.2% glacial acetic acid in H2O):95% (0.2% glacial acetic acid in acetonitrileT) on a HPLC 
systemU with a C18 analytical column
V. Injection volume was 2 μL and flow rate was 0.35 mL/min 
with a total run time of 5 minutes. Retention times for oxytetracycline and doxycycline (IS) were 
214 
 
2.12 and 2.15 minutes, respectively.  Mass spectrometry utilized an electrospray ionization sourceW. 
The instrumentX was set to operate in positive ion mode. Transitions were monitored at m/z 461 → 
426 for oxytetracycline and m/z 445 → 321 for doxycycline (internal standard). The standard curves 
were prepared daily and consisted of 7 non-zero points ranging from 20 to 14,000 ng/mL. 
The run was accepted if the concentrations of the standards were within 15% of the 
expected concentration and the fit of the curve was at least 0.99.  Two low (350 ng/mL) and two 
medium (6000 ng/mL) quality controls were run; one low QC was more than 20% different from 
the expected value.  The accuracy and coefficient of variation of the remaining QC samples were 
± 19% and ± 17%, respectively. 
 Corrections for Protein Binding 
Protein binding was determined in brain-heart infusion broth by ultrafiltration / 
centrifugation. Triplicate 200 μL aliquots of the low (20 ng/mL), medium (500 ng/mL) and high 
(14000 ng/mL) calibration solutions from the standard curve were pipetted into centrifugal filtration 
vialsY. The vials were centrifuged at 14,000 x g for 30 minutes. The preparation and quantification 
procedures were as detailed previously with the following exception: the standard curve for protein 
binding estimate was fit with a quadratic equation (R2 = 0.9998) consisting of 6 points across the 
range of concentrations. Accuracy of the standards was within ± 3% of expected concentration. The 
analytic run consisted of only the standard curve and 9 ultrafiltered samples. Protein binding was 
calculated using equation 4.  
Equation 4: Calculation of protein binding 
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For filtered samples at the low concentration, the centrifuged / filtered sample concentrations 
were above the LOD but below the LLOQ. For these samples, concentration was calculated by 
dividing the area ratio of the sample by the area ratio of the standard and multiplying by the known 
concentration of the standard.   
Equation 5:  Protein binding correction for oxytetracycline in brain – heart infusion broth 
 
 Statistical Analysis 
Statistical analyses were performed using a commercial software package
Z
.  
Transconjugant (TC) ratios were logarithmically (base 10) transformed prior to statistical 
analysis.  The lower limit for the calculation of the transconjugant ratio is detailed in equations 
6-8.  The TC ratios were analyzed by timepoint using one-way ANOVA with treatment as the 
independent variable.  Significant treatment differences were further evaluated by use of two-
way contrast statements.  Statistical significance was set a priori at the p=0.05 level. 
Equation 6: Upper limit of quantification for donor 
 
 
Equation 7: Lower limit of quantification for transconjugants 
 
 
Equation 8: Lower Limit for TC ratio 
 
 
Results 
 Determination of Minimum Inhibitory Concentration 
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Bacterial growth reductions were generally seen following 8-12 hours of incubation.  The 
oxytetracycline MIC for the E. coli (recipient bacteria) was 125 ng/mL.  The MIC for the 
Salmonella (donor bacteria) was 60,000 ng/mL. 
 Oxytetracycline Protein Binding in brain-heart infusion broth 
Protein binding in brain-heart infusion broth was non-linear between 20 and 14,000 
ng/mL (Figure 2).  For concentrations > 700 ng/mL, protein binding was estimated at less than 
15% and was not corrected.  For the Low concentration dosing regimen, one concentration 
measurement was above 700 ng/mL (751), but for consistency, all data for this regimen were 
corrected for protein binding according to equation 5.  For the High concentration dosing 
regimens, the 12 hour samples were above 700 ng/mL and the 36 hour samples were below the 
LLOQ of the assay, so no corrections were applied.  The 24 hour sample for all High 
concentration replicates was corrected for protein binding.   
 Transconjugant Ratio Determination 
Four replicate-timepoints in antimicrobial treated regimens had transconjugant ratios of 
zero (no transconjugant colonies).  These values were mathematically set equal to the lower limit 
of the TC ratio as detailed in equation 6-8 above.  Three of these time points were at 12 hours (2 
LC-LHL and 1 HC-SHL), while the fourth time point was a LC-LHL replicate at 36 hours (Table 
1).   
The mean transconjugant ratios for the two control simulations were not significantly 
different at any of the three timepoints.  At 12 hours, the transconjugant ratios for the High 
Concentration and Low Concentration treatments were statistically less than their respective 
controls (p=0.01 for both contrasts).  At the 24 and 36 hour timepoints, the High Concentration 
treatment was not significantly different from its respective control (p=0.24 and 0.98, 
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respectively), while the comparison of the Low Concentration treatment to its control 
approached significance at both timepoints (p=0.057 and 0.062, respectively).  The transfer rate 
comparison of the High concentration to Low concentration treatment was not significantly 
different at 12, 24 or 36 hours (p= 0.65, 0.70, and 0.13), respectively.  Results are presented 
graphically in figure 3. 
 Oxytetracycline Concentrations 
In the HC-SHL simulations, average free (non-protein bound) oxytetracycline 
concentrations were approximately 750 and 65 ng/ml at 12 and 24 hours, respectively.  
Antimicrobial concentrations were below the limit of detection at 36 hours for these dosing 
simulations. 
In the LC-LHL simulations, average free concentrations were 515, 383, and 225 ng/ml 
for the 12, 24 and 36 hour timepoints, respectively.  Table 1 summarizes these results. 
   
 Discussion  
There is a growing body of in vitro evidence suggesting that the development of 
antimicrobial resistance within a population of bacteria can be suppressed by extrapolating the 
pharmacokinetic/pharmacodynamic indices associated with clinical efficacy
22,23,24
.  The primary 
focus of these studies have been on the outgrowth of resistant bacteria: either originating from 
genetic mutation or pre-existing within the population.  In contrast, the study reported here 
focuses on the development of antimicrobial resistance due to emergence of resistant organisms 
following the acquisition of a horizontally transferred plasmid.    The importance of this 
mechanism of resistance development in bacterial populations has been discussed 
previously
2,25,26
. 
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The IVPM is an ideal laboratory tool to study the most basic interactions between 
antimicrobials and pathogens.  A limitation to the one-compartment IVPM utilized here is the 
dilution effect on the bacteria caused by inflow of fresh media to the central reservoir.  Because 
the transconjugant ratios of the HC-SHL and LC-LHL controls were not significantly different at 
any time during the experiments, the effect of dilution rate was considered negligible.  Another 
limitation of the IVPM under the described conditions is the favorable advantage given to the 
bacterial population.  The type of growth media, the constant inflow of nutrients and removal of 
waste products, inoculum size, timing of treatment and temperature at which the experiments are 
conducted, and lack of a functional immune system give every conceivable advantage to the 
bacterial pathogen.  For the present study, conjugative events may also be favored (compared to 
filter mating studies) given the absolute number of donor and recipient bacteria present in the 
culture system, and the constant stirring present in the IVPM.  Results of the present study 
should be interpreted as the “best case” scenario for plasmid transfer given the in vitro conditions 
of the experiment.   
The transfer rates in the present study are in agreement with the conjugative rates found 
by Showsh and Andrews
27
.  Using two Bacillus strains, the authors reported filter mating transfer 
rates ranging from 1 x 10
-1
 to <1 x 10
-8
, when the donor was pre-grown in the presence of 
tetracycline (10 µg/mL).  These authors also demonstrated that at low tetracycline concentrations 
(during mating) the conjugative frequency was enhanced.  Although transfer rates noted in the 
previous work were achievable in our research, the conclusions are quite different with regard to 
the effects of drug exposure on plasmid transfer.  The conclusions from Showsh and Andrews 
suggest that tetracycline exposure during either the pre-growth or mating period increases 
conjugation frequency, while in the present study oxytetracycline exposure suppressed transfer 
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rates.  The previous authors hypothesized that the enhanced conjugation was a direct effect on 
the donor strain, not antibiosis of the recipients.  
In a paper by Torres et al
28
, conjugal transfer rates were also shown to be enhanced in the 
presence of tetracycline for E. faecalis.  Filter matings were performed at static concentrations 
(10 µg/mL) of tetracycline, as compared to the dynamic pharmacokinetics in liquid culture 
described here.  Due to the static drug exposures in the Showsh et al. and Torres et al. and the 
dynamic drug exposures in the present study it is difficult to make direct comparisons of the 
results.  In fact, it could be argued that in the studies by Showsh et al. and Torres et al. the 
oxytetracycline exposures were not true static exposures due to oxytetracycline degradation.    
Loftin et al.
29
 demonstrated that static concentrations of oxytetracycline at 35°C – pH 7, 
degraded with a half-life of 19 hours. Stability estimates from the product monograph report a 
half-life of 26 hours under similar conditions
30
.  This is in agreement with experiments in our 
laboratory that demonstrated an average half-life of 24 hours for „static‟ concentrations (Lubbers, 
et al., unpublished data).  Failure to account for the actual drug exposure limits the conclusions 
that can be drawn from static concentration experiments.  To the author‟s knowledge, there have 
been no studies investigating the effects of oxytetracycline on conjugative plasmid transfer with 
simulated in vivo antimicrobial exposures.   
Previous static concentration experiments (Peterson and Narayanan, unpublished data) 
with the donor and recipient bacteria used here had shown that plasmid transfer was most 
efficient at concentrations up to 1000 ng/mL.  The results presented here show that conjugation 
was suppressed when antimicrobial concentrations exceeded the inhibitory concentration of the 
recipient strain.  In contrast to the previous cited research (Torres et al, Showsh et al), at no time 
points did oxytetracycline exposure enhance the conjugation rates.  The discrepancy may be a 
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result of differences in either the laboratory conditions (filter vs. liquid culture) or the drug 
exposure profiles (static vs. dynamic).   
The use of the transconjugant ratio has been described previously and was calculated 
using Equation 3 above
31
.  Because the transconjugant ratio is a hybrid of two individual 
measures, both require examination to make inferences about the ratio.  One limitation of this 
study was that the plating procedures were not normalized for sample volume, however the use 
of the transconjugant ratio rather than actual numbers of transconjugant bacteria accounts for 
this.  However, the Salmonella population in the control replicates was numerically greater than 
in the treated replicates.  The potential impact on the transconjugant ratio due to changes in the 
Salmonella population alone is approximately 0.5 log decrease for the oxytetracycline exposed 
populations.  The decrease in the transconjugant ratio seen here was driven by relative fewer 
transconjugants formed in the treated populations, not by a comparative increase in the number 
of donor organisms (See Figures 4 and 5). 
The results presented here show suppression of conjugative transfer in both 
oxytetracycline treated systems at 12 hours when compared to the respective controls (p = 0.01). 
Although not statistically significant, the transconjugant ratio in the low concentration regimens 
was numerically suppressed (compared to controls) at the 24 and 36 hour time points (p = 0.057 
and 0.06, respectively).  This suppression was not present at 24 or 36 hours in the high 
concentration regimen (p = 0.24 and 0.98, respectively).  Taken together, transconjugant ratios 
were suppressed at all times when corresponding oxytetracycline concentrations were above the 
MIC of the recipient bacteria (Figure 3 and Table 1).  Two observations merit discussion:  the 
peak rate of plasmid transfer occurred early in the time course of the study and the development 
of transconjugant bacteria were suppressed by exposure to oxytetracycline.  Both observations 
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can be related to effects of bacterial growth.  If conjugation is a function of bacterial growth, 
then a change in bacterial growth due to either the inherent growth properties of the bacterial 
population (stationary / death phase) or the induction of bacterial stasis due to the presence of an 
antimicrobial, would suppress horizontal gene transfer as was seen in the present study for the 
treated bacterial populations.   
It is inappropriate to use low power estimates to infer differences where statistical 
significance was not obtained.  However, numerical differences within relatively low powered 
studies are legitimately used as an incentive for further studies with greater power.  Using the 
difference in means and standard deviations in the low concentration regimens at 24 and 36 
hours, 3 replicates of each treatment gives a study power of approximately 0.57 or a probability 
of > 0.4 for a false negative result.  These findings provide preliminary insight into the 
relationship between drug exposure and the development of antimicrobial resistance due to 
horizontal gene transfer.  Future studies are needed to investigate other antimicrobial-pathogen 
combinations and to validate these findings in vivo. 
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 Figures and Tables 
Figure D.1 Schematic diagram of the in vitro pharmacodynamic model. 
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Figure D.2 Oxytetracycline protein binding in brain-heart infusion broth. 
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Figure D.3 Log transconjugant ratios for antimicrobial treated and control regimens over 
time. 
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Figure D.4 Colony Forming Unit /mL counts for Salmonella [Donor Bacteria]. 
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Figure D.5 Colony Forming Unit/mL counts for transconjugant bacteria. 
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 Summary 
Cattle are a primary reservoir of Escherichia coli  O157:H7, a major foodborne pathogen.  
The organism causes hemorrhagic colitis which can lead to serious complications, including 
hemolytic-uremic syndrome.  Although E. coli O157:H7 is widely prevalent in cattle and cattle 
environments, the number of human cases remain relatively low, suggesting possible strain 
diversity and differences in virulence between human and bovine strains.  Shiga toxins, Stx1 and 
Stx2, are the major virulence factors.  Differences in Stx2 production between human and bovine 
strains have been demonstrated previously, and isolates possessing the stx2 gene, but not 
producing Stx2 (toxin non-producing [TNP] strains) have been identified.  In this study, 150 
isolates (56 human, 94 bovine) were tested by PCR for stx2 upstream regions associated with 
TNP and the Q933 gene, which has been previously associated with toxin production.  A reverse 
passive latex agglutination test was used to evaluate 107 isolates (50 human, 57 bovine) for Stx1 
and Stx2 production.  The percentages of human and bovine isolates positive for presence of the 
TNP regions were similar (57.1% and 53.1%, respectively), while a higher percentage of human 
isolates was positive for Q933 gene (89.3% vs. 54.3%).  Stx2 production of ≥1:8 was found in 
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86.0% of human isolates compared to 26.3% of bovine isolates.  Bovine isolates with the 
presence of the TNP regions were associated with significantly lower Stx2 production (p < 0.05), 
while the Q933 gene was associated with higher Stx2 production (p < 0.05).  However, the 
presence of the TNP region was not associated (p > 0.05) with low Stx2 production in human 
isolates.  Therefore, Q933 was a better indicator of high Stx2 production by human and bovine 
isolates and may be a useful screening method to assess their potential to cause human disease.   
 
 Introduction 
Shiga-toxin producing (STEC) Escherichia coli  O157:H7 remains an important cause of 
food-borne disease, resulting in an estimated 73,000 illnesses annually (Mead et al., 1999).  
Escherichia coli  O157:H7 infections in humans cause hemorrhagic colitis which can lead to 
serious complications, including hemolytic-uremic syndrome (HUS).  Cattle are asymptomatic 
reservoirs for E. coli O157:H7 (Renter and Sargeant, 2002; Gyles, 2007; Hussain, 2007) and 
either direct or indirect contamination of food products by cattle feces has been implicated in 
numerous outbreaks (Mead and Griffin, 1998; Rangel et al., 2005; Hussain, 2007).  Although E. 
coli O157:H7 is frequently isolated from cattle, with reported prevalence estimates from 0 to 
41.5% (Lejeune et al., 2004; Callaway et al., 2006; Gyles, 2007), the overall number of human 
infections remains relatively low despite the low infectious dose of the organism (Tuttle et al., 
1999; Strachan et al., 2001).  The apparent discrepancy between high prevalence in cattle and 
their environment and the relative rarity of human infections suggest possible strain diversity and 
differences in virulence between human and bovine strains (Boerlin et al., 1999; Baker et al., 
2007). 
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Studies have indicated that bovine and human E. coli O157:H7 strains come from separate 
lineages with the bovine lineage less likely to cause disease or spread effectively from cattle to 
humans (Kim et al., 1999; Dowd and Williams, 2008).  Differences among genotypes of Shiga 
toxin-encoding bacteriophage insertion sites found in bovine and human isolates also exist 
(Besser et al., 2007).  Among several virulence factors, Shiga toxins 1 (Stx1) and 2 (Stx2), which 
are cytotoxic to vascular endothelial cells, are crucial to infections in humans (Besser et al., 
2007; Gyles 2007); stx2 positive O157:H7 isolates are five times more likely to be associated 
with severe disease than negative isolates (Boerlin et al., 1999).  Similarly, Stx2 is about 1,000 
times more toxic to microvascular endothelial cells of human kidneys than Stx1 (Gyles, 2007).  
Escherichia coli  O157:H7 isolates of bovine origin generally appear to produce lower amounts 
of toxin than isolates of human origin (Richie et al., 2003; Baker et al., 2007).   
 Several studies have suggested possible factors affecting stx2 gene expression 
resulting in altered Stx2 production.  A study by Koitabashi et al. (2006) evaluated E. coli O157 
strains, primarily from non-clinical sources that carried the stx2 gene, but produced little or no 
Stx2 due to a nonfunctional promoter sequence in the stx region.  A PCR assay (TNP-PCR) was 
developed to detect these toxin non-producing (TNP) strains, and subsequently it was determined 
that the lack of toxin production was attributable to both a nonfunctional stx2 promoter as well as 
a weak antitermination activity of the Q protein (Koitabashi et al., 2006).  A similar study 
utilizing E. coli O157:H7 isolates from human clinical cases and asymptomatic individuals found 
that strains producing low or no Stx2 were most often associated with asymptomatic carriers and 
regulation of toxin production appeared to be influenced by both a mutation in the promoter 
region of the stx2 gene, as previously reported (Koitabashi et al., 2006), and absence of the Q933 
gene (Matsumoto et al., 2008).  The Q933 gene was associated with higher levels of Stx2 
233 
 
production and was more often identified in isolates from clinically ill humans than from healthy 
cattle (Lejeune et al., 2004).  Although these studies have looked at genetic differences among 
STEC strains and resulting variations in virulence, further investigation into alterations in 
distribution or regulation of the stx genes is necessary (Pradel et al., 2001; Besser et al., 2007).     
The objectives of this study were to 1) assess the frequency of occurrence of toxin non-
producing strains (Koitabashi et al., 2006) and Q933 genes among human clinical and bovine 
isolates, and 2) assess the amount of Stx2 produced for isolates with different genetic profiles 
and from different sources.  
 Materials and Methods 
A total of 150 E. coli O157:H7 isolates were used:  Fifty-six isolates were from human 
clinical cases reported between May 2002 and November 2004 in Kansas and 94 isolates were 
from cattle (91 fecal, 2 environmental, 1 carcass) collected between May 2001 and June 2007 
from Kansas and Nebraska.  Human isolates were provided by the Kansas Department of Health 
and Environment, while bovine isolates were selected from an isolate bank of over 2,000 bovine 
isolates.  In addition, for bovine isolates, pulsed-field gel electrophoresis (PFGE) analyses were 
available for 58 isolates and all had different PFGE patterns (Sargeant et al., 2006).  For bovine 
isolates without available PFGE patterns, no isolates collected on the same day from the same or 
adjacent pens were used.  Presence or absence of stx1 and stx2, Q933 and Q21 genes was 
determined by PCR according to previously published methods (Fagan et al., 1999; Lejeune et 
al., 2004).  Primers for all reactions are listed in Table 1. 
 
TNP-PCR 
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Isolates stored in protect beads were cultured on blood agar plates and DNA extracted by 
boiling cells in distilled water from a single colony.  The toxin non-producing PCR (TNP-PCR) 
procedure described by Koitabashi et al. (2006) was performed on all human and bovine isolates.  
Briefly, four separate PCR reactions (TNP-A, TNP-B, TNP-C and TNP-D) were carried out with 
seven primers (Biosynthesis Inc., Lewisville, TX) listed in Table 1.  The reaction mastermix 
contained 0.25 µM of both forward and reverse primers, 200 µM dNTPs, 1.5 mM MgCl2 and 0.5 
U Taq DNA polymerase (all Promega, Madison, WI) as well as 1 µL sample DNA for a total 
volume of 20 µL.  The four PCR reactions yielded amplicons of 458 bp, 694 bp, 268 bp, and 549 
bp, respectively.  An isolate was considered TNP-PCR positive if expected amplicons were 
observed in all four reactions (Koitabashi et al. 2006). 
In order to simplify detection of the region from the q gene to the stx2 gene previously 
targeted by the TNP-PCR procedure, a new PCR procedure (NM-PCR) was developed utilizing a 
new set of primers (NMf and NMr, Table 1).  Using Vector NTI Suite 8.0 (Invitrogen, Carlsbad, 
CA) and BLAST (NCBI, Bethesda, MD) software, a 604 base pair region of the approximately 
1,650 bp TNP-PCR target was identified and confirmed as highly conserved among O157:H7 
strains.  Mastermix, as previously listed, with 1 µL (0.5 µM) of each forward and reverse primer 
was used for a total reaction volume of 20 µL.  A Takara Thermal Cycler (Takara Bio Inc., 
Takara, Japan) was used for all PCR reactions with initial denaturation at 96ºC for 5 min, 30 
amplification cycles with conditions dependent on primers used (Table 1) and a final extension 
round for 7 min at 72ºC.  All PCR products were separated by gel electrophoresis using 1.5% 
agarose gel in 1X Tris-Borate-EDTA (TBE; Sigma-Aldrich, St. Louis, MO) buffer and stained 
with ethidium bromide to allow visual confirmation of amplicons by ultraviolet 
transillumination. 
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Stx1 and Stx2 Assays 
Fifty human isolates and 57 bovine isolates where tested for Stx1 and Stx2 production 
using a commercially available reverse passive latex agglutination kit (Oxoid VTEC-RPLA 
Toxin Detection Kit, Remel, Lenexa, KS) according to manufacturer‟s instructions.  In order to 
minimize the possibility of testing clonal isolates, multiple human samples submitted from the 
same county within thirty days and with the same gene profile (stx1 and stx2, Q933 and Q21) 
were excluded from the toxin assay.  Briefly, isolates were cultured overnight on brain-heart 
infusion agar at 37°C.  Colonies were then suspended in 1 mL 0.85% sodium chloride solution 
containing 5,000 U of polymixin B.  The suspensions were adjusted to an absorbance of 1.5 at 
600 nm wavelength and incubated for 30 minutes, shaking periodically.  Samples were then 
centrifuged for 20 min at 4,000 rpm.  A serial two-fold dilution of a 25 µL aliquot of the 
supernatant was performed using a 96-well V-bottom microtitre plate and test reagents were 
added according to manufacturer‟s directions.  Results were read after 24 hours.  The toxin titer 
was defined as the reciprocal of the highest dilution of the test sample that produced an 
agglutination reaction.  Toxin titers ≤ 1:2 were considered negative.   
 
Statistical Analysis 
Data analyses were performed using SAS version 9.1 (SAS Institute Inc., Cary, NC).  For 
all proportions, binomial exact 95% confidence intervals (CI) were calculated.  Agreement 
between PCR methods for toxin non-production (TNP-PCR and NM-PCR) was measured using 
a kappa statistic (Dohoo et al., 2003).  Variables assessed for potential association with Stx1 
production included presence of the stx2 gene and the source of isolate (human or bovine), while 
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variables of interest for Stx2 production included presence of the stx1 gene, source of isolate, 
TNP-PCR and/or NM-PCR results, and presence of Q933 gene.  Separate multivariable 
cumulative logistic regression models using generalized estimating equations (Proc Genmod, 
SAS v9.1), with the Stx1 or Stx2 titers as ordinal dependent variables, were built using a series 
of previously described model building steps (Dohoo et al., 2003).  An initial screening step was 
performed to evaluate unconditional associations between outcomes and potential variables of 
interest.  Each variable associated with an outcome (P < 0.2) was then added into a multivariable 
model, and then removed using backwards selection until all variables were significant (P < 
0.05).  First order interactions between main effects were subsequently entered into the model 
and removed by backwards selection until all remaining variables and interactions were 
significant (P < 0.05).  Two-sided significance testing was used for hypothesis testing. 
 
 Results 
Proportions of stx1, stx2, and Q933 in the human and bovine isolates used in this study are 
shown in Table 2.  Of the 56 human isolates used, 1.8% (0.1-9.6%) were positive for stx1 gene 
only, 58.9% (45.0-71.9%) were positive for only stx2 gene and 39.3% (26.5-53.2%) were 
positive for both genes.  For the 94 bovine isolates analyzed, 6.4% (2.4-13.4%) were positive for 
stx1 gene only, 44.7% (34.4-55.3%) were positive for only stx2 gene and 48.9% (38.5-59.5%) 
were positive for both genes.  The Q933 allele was found in 87.5% (75.9-94.8%) of human 
isolates compared to 54.3% (43.7-64.6%) of bovine isolates (Table 2). 
Occurrence of TNP-PCR positives was similar for both human (57.1%; 43.2-70.3%) and 
bovine isolates ( 51.1%; 40.5-61.5%).  Also, results were similar across both human (57.1%; 
43.2-70.3%) and bovine isolates (52.1%; 41.6-62.5%; Table 2) for presence of NM-PCR positive 
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region.  The kappa value for the previously published TNP-PCR method and the new NM-PCR 
procedure was 0.936.  Overall, results for the two PCR methods were consistent, with 
discrepancies only for three bovine isolates out of 94 tested.  Of the three isolates, two were 
positive for NM-PCR and negative for TNP-PCR and the third isolate was negative for NM-PCR 
and positive for TNP-PCR.  The three isolates were from different pens from two feedlots and 
were genetically dissimilar (< 95% Dice similarity) according to PFGE analyses.   
The Stx1 and Stx2 toxin assay results for human and bovine isolates are shown in Tables 
3 and 4, respectively.  Based on previously listed criteria, six human isolates were not tested for 
toxin production.  Of the human isolates tested, 18 (36.0%; 22.9-50.8%) had Stx1 toxin titer > 
1:2 (mode 1:128, range 1:16 to 1:128) while 44 (88.0%; 75.7-95.5%) had Stx2 toxin titer ≥ 1:4 
(mode 1:32, range 1:4 to 1:128).  For the bovine isolates tested, 34 (59.7%; 45.8-72.4) isolates 
were positive for Stx1 toxin titer > 1:2 (mode 1:64, range 1:4 to 1:128) while only 15 (26.3%; 
15.5-39.7%) isolates had Stx2 toxin titer ≥ 1:4 (mode 1:16, range 1:8 to 1:64).  Overall, 36.0% 
(22.9-50.8%) of human isolates produced Stx1 toxin of ≥ 1:8 compared to 54.4% (40.7-67.6%) 
of bovine isolates.  However, 86.0% (73.3-94.2%) of human isolates produced Stx2 toxin of ≥ 
1:8 compared to only 26.3% (15.5-39.7%) of bovine isolates.  Only one bovine isolate was 
positive for Stx2 at 1:64 titer and none at 1:128, while 10 human isolates were positive at 1:64 
and 6 were positive at 1:128.   
For high Stx2 producing isolates (titer ≥ 1:8), 24 human isolates were TNP-PCR and 
NM-PCR positive (55.8%; 39.9-70.9%) while 4 bovine isolates were positive by TNP-PCR and 
NM-PCR (26.7%; 7.8-55.1%).  Titers for Stx2 ranged from 1:8 to 1:128 (mode 1:32) for human 
isolates while toxin titers were1:8 for two and 1:16 for the remaining bovine isolates.  Of the 
three isolates with disparate TNP-PCR and NM-PCR results, TNP-PCR incorrectly identified 
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one bovine isolate as toxin non-producing (Stx2 = 1:8) while NM-PCR incorrectly identified one 
bovine isolate as toxin non-producing (Stx2 = 1:8) and another isolate lacking the stx2 gene as 
toxin non-producing positive. 
Of the Q933 positive isolates tested for toxin production, only 15.9% (7.9-27.3%) had Stx2 
titers ≤ 1:2 while 82.5% (70.9-90.9%) produced Stx2 toxin at levels ≥ 1:8.  Of the Q933 positive 
isolates producing low levels of toxin (titer < 1:8), 8 were bovine and 2 were human isolates.  In 
contrast, 12 bovine isolates and 40 human isolates were positive for the Q933 gene and produced 
high amounts (titer ≥ 1:8) of Stx2 toxin (Table 3 and Table 4).  Of 6 human isolates that had Stx2 
toxin titers of 1:128, 5 (83.3%; 35.9-99.6%) were Q933 positive.   
In regard to Stx1 production, the only variable significantly associated with altered toxin 
production was presence of the stx2 gene which resulted in significantly (P < 0.01) lower Stx1 
titers.  In the initial unconditional models for Stx2 toxin, all variables were significantly 
associated with production.  In the multivariable model, presence of the stx1 gene (P < 0.05), 
isolates from bovine sources (P < 0.01), and isolates positive for NM-PCR (P < 0.05) were 
associated with significantly lower Stx2 toxin production while presence of the Q933 gene (P < 
0.01) was positively associated with Stx2 toxin production.  No interaction terms were 
significant 
 
 Discussion  
A number of isolates from both human and bovine sources possess a stx2 gene, but 
produce low or undetectable levels of toxin (Zhang et al., 2005; Koitabashi et al., 2006; Dowd et 
al., 2008; Matsumoto et al., 2008).  Whether this decreased toxin production is due to differences 
in transcriptional or translational regulations has not been established (Besser et al., 2007).  Two 
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primary lineages of E. coli O157:H7 have been reported, of which lineage I strains produce more 
Stx2 than lineage II strains and are more often associated with human disease (Dowd et al., 
2008).  Differences in conserved genomic regions encoding suspected virulence factors have 
been hypothesized, including a possible hemolysin activation protein and a suspected iron 
transport system in lineage I strains (Kim et al., 1999; Steel et al., 2007).  However, recent work 
indicates that differences in virulence between the lineages may result from absence or 
incomplete functioning of late-regulatory machinery needed for Stx2 production in lineage II 
isolates (Dowd et al., 2008).   
In an earlier study by Koitabashi et al. (2006), 41 E. coli O157 isolates, primarily from 
cattle sources were evaluated for presence of the stx2 gene with little or no Stx2 production.  In 
these toxin non-producing (TNP) strains, the Q gene appeared highly homologous to the Φ21 
phage, but not that of the 933 phage, leading to poor antiterminator activity of Q protein which is 
essential for strong transcription.  Therefore, the lack of toxin production by these TNP strains 
was attributed to both a nonfunctional stx2 promoter as well as weak antitermination activity of 
the Q protein (Koitabashi et al., 2006).  The low toxin and toxin-non producing isolates have also 
been identified by a study using 68 human E. coli O157:H7 strains (Lejeune et al., 2004).  Our 
study examined toxin production for both human and bovine isolates.  In addition, new primers 
were designed (NM-PCR) to identify toxin non-producing strains.  Overall, TNP-PCR and NM-
PCR performed equally well, with identical results for all human isolates, but with differing 
results for just 3 out of 94 bovine isolates.  There was a high level of agreement between TNP-
PCR and NM-PCR methods, and the NM-PCR procedure was equally accurate in identifying 
toxin non-producing strains.  Therefore, a similarly performing NM-PCR assay requiring a single 
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PCR reaction was definitely advantageous compared to using four separate PCR reactions 
required for TNP-PCR assay. 
A recent study by Matsumoto et al. (2008) using E. coli O157:H7 isolates from human 
clinical cases and asymptomatic carriers supported previous findings that stx2 gene expression in 
isolates producing low or no measurable Stx2 was caused by mutation in the stx2 promoter 
region.  Substitution of the Q21 gene in place of the Q933 gene also seemed to affect Stx2 toxin 
production, although isolates producing high levels of toxin with only the Q21 gene present were 
reported.  Of the 56 high toxin producing strains identified, 96.4% carried the Q933 gene which 
was similar to the Q933 gene frequency of 87.5% among human isolates in our study and the 
study by LeJeune et al. (90%).  In addition to presence of the Q21 gene, all low or no toxin 
producing strains possessed the stx2vh-a gene variant (Matsumoto et al., 2008).  While differences 
in frequency of stx2 gene variants have been previously reported among isolates from human and 
animal origin (Beutin et al., 2007), further work is needed to determine whether differences in 
Stx2 toxin production exist among all stx2 gene variants.   
For the bovine isolates used in this study, presence of the TNP region, as identified by 
NM-PCR, was associated with lower toxin production as previously reported (Koitabashi et al., 
2006).  Due to the high level of agreement between TNP- and NM-PCR methods, one would 
expect TNP-PCR to also be associated with decreased Stx2 production.  However, this was not 
demonstrated; possibly because of inadequate sample size.  Although interactions between 
source of isolate (bovine/human) and NM-PCR result were not statistically significant in regards 
to Stx2 production, the relationship between positive TNP- or NM-PCR results appeared to be a 
better predictor of decreased or no production of Stx2 toxin for bovine isolates than for human 
isolates.  For the human isolates tested by both PCR methods (TNP and NM), 48.0% (33.7-
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62.6%) were misclassified for low Stx2 toxin production (toxin titer actually ≥ 1:8) compared to 
7.0% (1.9-17.0%) of bovine isolates.  Screening of additional isolates for the targeted sequence is 
needed to further elucidate differences in the ability to predict toxin production between human 
and bovine isolates.  In contrast to other studies, a marked difference in Stx1 toxin production 
between bovine and human isolates was not observed (Boerlin et al., 1999). 
In this study, as previously reported, presence of the Q933 gene appeared to be associated 
with higher levels of Stx2 production (Lejeune et al., 2004; Ahmad and Zurek, 2006) and was 
found more often in isolates from clinically ill humans than from healthy cattle (Lejeune et al., 
2004).  Although it has been hypothesized that variations in the frequency of Q933 in bovine 
E.coli O157:H7 strains exist among countries and regions, the occurrence of Q933 for both 
human and bovine isolates was similar to previous findings in isolates from the United States, 
Scotland, Australia, and Japan (Lejeune et al., 2004; Matsumoto et al., 2008). 
A limitation of this study was that isolates with neither stx1 nor stx2 were not available for 
comparisons.  In order to minimize the possibility of testing clonal isolates, some human isolates 
were not tested for Shiga toxin production.  Because bovine isolates were chosen non-randomly 
to decrease the likelihood of testing clonal strains, it is possible that the differences between the 
frequency of gene occurrence or virulence of isolates from human and bovine sources were due 
to selection bias rather than any physiological variation.  However, our finding that presence of 
the Q933 gene was associated with higher levels of Stx2 production agree with the study of 
Lejeune et al., (2004).  Additionally, details regarding further testing of clinical samples were not 
available due to confidentiality concerns; so for seven human isolates with Stx2 titer < 1:8, we 
were unable to determine if they were the sole pathogen recovered or if additional pathogens 
were involved. 
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Overall, bovine isolates produced lower amounts of Stx2 than human clinical isolates.  These 
findings are consistent with several previous studies which have observed higher pathogenicity 
in isolates from human clinical cases than those from clinically healthy cattle (Baker et al., 
2007).  Our findings support the suggestion that only a subset of E. coli O157:H7 strains from 
cattle have the potential to cause human clinical disease (Kim et al., 1999; Baker et al., 2007; 
Besser et al., 2007).  In our study, presence of the toxin non-producing region, as detected by the 
NM-PCR method, was associated with decreased Stx2 toxin production while presence of the 
Q933 gene was associated with increased Stx2 toxin production.  Our data indicate that while 
both methods were acceptable predictors of toxin production for bovine isolates, presence of the 
Q933 gene appeared to be a better predictor of Stx2 production for human isolates.  However, 
further work is needed to clarify underlying regulatory mechanisms for Stx2 toxin production 
and sites at which the toxin non-producing region and the Q933 gene may alter expression of the 
stx2 gene in both human and bovine isolates. 
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 Tables  
 
Table E.1 Primer sequences and running conditions for toxin non-producing (TNP) and 
new method (NM), Q933, stx1 and stx2 PCR reactions. 
 
PCR 
assay 
Primer sequence Denaturation 
temp. 
Annealing 
temp. 
References 
TNP-A F 5‟CCATGAGCAAATGATGATTG3‟ 
R 5‟TTTAGTTCTCTTATGCCCAC3‟ 
94° C 55° C Koitabashi et 
al., 2007 
     
TNP –B F 5‟CTAAATTCATGGAGAGCGTG3‟ 
R 5‟TTAACGTCAGGCACAAAGAG3‟ 
94° C 55° C Koitabashi et 
al., 2007 
     
TNP –C F 5‟AACCGGAAACGTGTAGAG3‟ 
R 5‟TTAACGTCAGGCACAAAGAG3‟ 
94° C 55° C Koitabashi et 
al., 2007 
     
TNP-D F 5‟GAACATATCAAAATCAGGC3‟ 
R 5‟GGGAATAGGATACCGAAG3‟ 
94° C 55° C Koitabashi et 
al., 2007 
     
NM  F 5‟CGCATGGGTTTATTCAGGTC3‟ 
R 5‟GTTGCTCATTTGCTCAACGA3‟ 
94° C 55° C This study 
     
Q933 F‟ CGGAGGGGATTGTTGAAGGC3‟ 
R‟ CCGAAGAAAAACCCAGTAACAG3‟ 
94° C 52° C Lejeune et al., 
2004 
     
stx1  F 5‟ACACTGGATGATCTCAGTGG3‟ 
R 5‟CTGAATCCCCCTCCATTATG3‟ 
95° C 58° C Fagan et al., 
1999 
     
stx2  F 5‟CCATGACAACGGACAGCAGTT3‟ 
R 5‟CCTGTCAACTGAGCAGCACTTTG3‟ 
95° C 58° C Fagan et al., 
1999 
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Table E.2 Proportions of Q933 gene and toxin non-producing region determined by toxin 
non producing (TNP) and new method (NM) PCR in bovine and human isolates of 
Escherichia coli  O157:H7 
 
Source Number of 
isolates 
Q933 positive Toxin non-producing region 
TNP-PCR 
positive 
NM-PCR 
positive 
Bovine     
stx1
+
/stx2
+ 46 34 16 16 
stx1
+
/stx2
- 6 1 0 1 
stx1
-
/stx2
+  42 16 32 32 
Total isolates 94 51 48 49 
Human     
stx1
+
/stx2
+ 22 20 5 5 
stx1
+
/stx2
- 1 1 0 0 
stx1
-
/stx2
+ 33 28 27 27 
Total isolates 56 49 32 32 
Total bovine and human isolates 150 100 80 81 
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Table E.3 Shiga toxin 1 production by human and bovine isolates in relation to toxin non-
producing (TNP) region or Q933 gene. 
 
Toxin titer Number of 
isolates tested 
stx1 positive Q933 positive TNP-PCR 
positive 
NM-PCR 
positive 
Human      
≤2 32 1 27 25 25 
16 1 1 1 0 0 
32 3 3 2 1 1 
64 4 4 4 1 1 
128 10 10 9 3 3 
Total isolates 50 19 43 30 30 
Bovine      
≤2 23 0 4 19 20 
4 3 3 1 0 0 
8 4 4 2 2 0 
16 5 4 3 2 2 
32 7 7 4 4 5 
64 9 9 6 5 6 
128 6 6 0 2 2 
Total isolates 57 33 20 34 35 
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Table E.4 Shiga toxin 2 production by human and bovine isolates in relation to toxin non-
producing (TNP) region or Q933 gene. 
 
Toxin titer Number 
isolates tested 
stx2 positive Q933 positive TNP-PCR 
positive 
NM-PCR 
positive 
Human      
≤ 2 6 6 2 5 5 
4 1 1 1 1 1 
8 3 3 3 2 2 
16 9 9 9 4 4 
32 15 15 13 10 10 
64 10 10 10 6 6 
128 6 6 5 2 2 
Total isolates 50 50 43 30 30 
Bovine      
≤ 2 42 36 8 30 31 
8 4 4 2 2 2 
16 9 9 8 2 2 
32 1 1 1 0 0 
64 1 1 1 0 0 
Total isolates 57 51 20 34 35 
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 Impacts 
 
 Human clinical strains of E. coli O157:H7 produced more Shiga toxin 2 (Stx2) than strains 
isolated from cattle. 
 The percentages of human and cattle isolates positive for the nonfunctional promoter region 
for Stx2 were similar, while a higher percentage of human isolates was positive for Q933 
gene, which encodes for a protein with weak antitermination activity.   
 Presence of Q933 was a better indicator of high Stx2 production by E. coli O157:H7 than the 
nonfunctional promoter region and may be a useful screening method to assess potential of 
cattle strains to cause human disease. 
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Appendix F - Microarray Protocol 
Microarray Labeling Protocol (In the Dark) 
1. Extract genomic DNA and Nanodrop. The readings should be between 1.7 and 2.0 for 
both 260/280 and 260/230 readings.  
2. Start with between 1.0 and 1.5ug of genomic DNA, and use reagents from Invitrogen 
BioPrime Plus Array CGH Genomic Lableing System. 
3. To an amber tube in the dark add: 
 
Alexa Flour 555 or 647 Panomer :  20ul 
Genomic DNA approx 1.5ug       : X ul  
Sterile water                                 : q.s. to 42.5ul 
4. Incubate at 95degC for 10 minutes and cool on ice for 5 minutes. 
5. On ice, add: 
10X Nucleotide Mix 555 or 647:  5ul 
                  Cy3 or Cy5 dCTP (Amersham) :  1.5ul *Optional* 
Exo-Klenow Fragment               :  1ul 
 
6. Mix gently and centrifuge.  
7. Put into sealed film canister and incubate for 2 hours in the dark. 
8. Optional: add 5ul of Stop Buffer (0.5M EDTA), or, if necessary, store overnight in -
20degC.  
9. Generally, before you start fragment purification, you can start slide preps (see below).  
10. Purify labeled fragments by using provided columns. Can also use Qiagen PCR 
purification column. 
11. For Invitrogen kit, add 200ul of Binding Buffer B2 to fragments.  
12. Add to spin column and centrifuge for 1 minute at 10K x g. 
13. Discard flow through. 
14. Add 650ul of Wash Buffer W1 with EtOH added. 
15. Centrifuge at 10K x g for 1 minute and discard flow through. 
16. Spin again with caps open for 3 minutes at 12K x g to dry membrane. 
17. Add column to a new amber tube.  
18. Add 15ul of Elution Buffer E1 and incubate for 1 minute at RT.  
19. Centrifuge at 11K x g for 2 minutes.  
20. Repeat elution steps 17-18.  
21. Nanodrop with “microarray” feature to determine dye incorporation efficiency.  
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Slide Preparation 
 
1. After printing, store slides in dark, and keep dry. 
2. When ready to use, crosslink at 600mJ in UV crosslinker. 
3. Prehyb slides in blocking solution (0.1% BSA, 5X SSC, 1% SDS) at 42oC for one hour 
with shaking. 
4. Spin dry slide either on slide spinner or in 50ml tube in the centrifuge at approx 4000 
RPM. 
5. Add elevated coverslips over oligo fields.  
6. Slides are now ready for hybridization mix. 
 
Preparation of Hybridization Mix (In the Dark) 
 
1. After fragments are purified and nanodropped, dry down the volume to 14ul in a 
speedvac. Adjust with H2O as necessary.  
2. Add 15ul of 2X Hybridization Mix, and 1ul of appropriate 25mer.  
3. Heat at 80degC for 5 minutes and then cool on ice.  
4. Spin down to get condensation off the sides of the tubes. 
5. Add directly to slides so that it travels under the coverslip. 
6. Hybridize in chambers overnight at 42degC in the dark. 
 
Slide Washing (In the Dark) 
 
1. Remove slides from hybridization chambers, and without disturbing coverslips transfer 
them to slide wash container with first wash. 
2. Agitate slightly under Wash 1 solution until coverslips float off. 
3. Wash 10 minutes in 10X SSC + 0.2% Sarkosyl. 
4. Wash 10 minutes in 10X SSC. 
5. Wash 10 minutes in 0.2X SSC. 
6. Quickly dip in distilled H2O and spin dry. 
7. Read on slide reader. 
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Appendix G - RNA Extraction Protocol 
RNA Extraction Protocol 
 
1. Centrifuge tubes at 5k x g for 10min 
2. Pour off RNA later 
3. Add 1mL of TRIzol and vortex 
4. Incubate at RT for 5min 
5. Add 200uL of Chloroform and mix 
6. Centrifuge at 12k x g for 15min at 4degC 
7. Remove aqueous phase and add to a new tube 
8. Add 500uL of isopropyl alcohol 
9. Incubate samples at RT for 10min 
10. Centrifuge at 12k x g for 10min at 4degC 
11. Remove supernatant 
12. Wash with 1mL of 75% EtOH 
13. Vortex and centrifuge at 7.5k x g for 5min at 4degC 
14. Remove EtOH and allow samples to dry 
15. Resuspend in 50uL of RNase-Free H2O 
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Appendix H - Southern Blot Protocol 
Southern Blot Protocol 
1. Depurination: 
Pour 0.25M HCl onto the gel surface and leave for 20 minutes. Check every few 
minutes that the gel surface is still covered, adding more 0.25M HCl with a transfer 
pipette if necessary. At the end of 20 minutes, remove the HCl with a transfer pipette. 
2.   Denaturation:  
1.5M NaCl 87.66g 
0.5M NaOH 20.00g 
In 1L Milli-Q H2O. 
Increase vacuum to 50cm H2O. Pour onto gel and denature for 20 minutes. 
Remove the solution with a transfer pipette 
      3.   Neutralization: 
1.0M Tris (base) 121.10g 
2.0M NaCl 116.88g 
In 1L Milli-Q H2O.  
Adjust to pH 5.0 
1. Pour onto gel and neutralize for 20 minutes. Remove the solution with a transfer pipette. 
2. Transfer DNA as per standard method using 20X SSC for transfer buffer 
3. Crosslink DNA to nitrocellulose by using the quick hyb feature on crosslinker 
4. Store in 20X SSC at 4degC until used 
5. DIG label DNA by adding 1ug to 16uL total volume of H2O 
6. Denature DNA by heating at 95degC for 10min and cooling on ice 
7. Add 4uL of DIG-High Prime (vial 1) to DNA mixture 
8. Incubate o/n at 37degC 
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9. Stop reaction in morning by adding 2uL of 0.2M EDTA 
10. Prepare pre-hyb solution by adding 128mL (in two 64mL quantities) to DIG Easy Hyb 
Granules (bottle 7) 
11. Dissolve by stirring immediately for 5min at 37degC 
12.  Pre-heat DIG Easy Hyb solution to 42degC 
13. Add 13uL of DIG-labeled probe to a separate tube and denature by heating at 95degC for 
5min and then cool on ice 
14. Add the 13uL to 25mL of DIG Easy Hyb solution that has been pre-heated 
15. Pour off pre-hyb solution and add probe mixture 
16. Incubate 4hrs to o/n at 47degC (for blaCMY2) 
17. After incubation, wash 2 x 5min in 2xSSC, 0.1% SDS at 15-25degC 
18. Wash 2 x 15min in 0.5x SSC, 0.1% SDS that was warmed to 65-68degC 
19. Membrane is now ready for antibody detection 
20. Make the following solutions: 
 
1. Maleic Acid 0.1M, 0.15M NaCl 
Add 11.6g of Maleic acid and 8.7g of NaCl to 700mL of H2O 
Adjust pH to 7.5 with NaOH  (this will take a lot of NaOH) 
QS the final volume to 1L 
2. Wash Buffer: 0.1M Maleic acid, 0.15M NaCl, and 0.3% Tween 20 
Take 500mL of Maleic acid solution (pH 7.5) and add 1.5mL of Tween 20 
3. Detection Buffer: 0.1M Tris, 0.1M NaCl 
Add 6.05g Tris and 2.9g of NaCl to 500mL of H2O 
Adjust pH to 9.5 
4. Blocking Solution: Add 225mL of Maleic Acid to 25mL of Blocking Solution (vial 
6) 
5. Antibody Solution: Add 20mL of blocking solution to 4uL of anti DIG antibody 
(vial 4) 
6. Color Substrate Solution: Add 200uL of NBT/BCIP (vial 5) to 10mL of Detection 
Buffer 
7. TE Buffer: 10mM Tris-HCl, 1mM EDTA pH 8.0 
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21. After hybridization and stringency washes, rinse the membrane briefly (1-5 min) in Wash 
Buffer 
22. Incubate for 30min in 100mL of Blocking Buffer 
23. Incubate for 30min in 20mL of Antibody Solution 
24. Wash 2 x 15min in 100mL of Washing Buffer 
25. Equilibrate 2-5min in 20mL of Detection Buffer 
26. Incubate in 10mL of Color Substrate Solution in the dark for up to 16hrs 
27. To stop the reaction, add H2O or TE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
